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1.! Thesis abstract 
 
 
 
This thesis was completed by Della Nicolle for the degree of Doctor of Clinical Psychology 
at Cardiff University. The thesis is a systematic review and an interpretative 
phenomenological analysis investigating the impact of anti-NMDAR on cognitive 
functioning and identity respectively. This thesis was submitted on the 26th May 2017 and is 
comprised of a thesis abstract followed by three papers. Paper one has been prepared for 
submission to Archives of Clinical Neuropsychology and paper two for submission to 
Psychology & Health.  
Paper one presents a systematic review of current published neuropsychological case 
studies and series with people with a diagnosis of anti-NMDAR encephalitis. The review was 
conducted to investigate the emerging cognitive profile for people diagnosed with anti-
NMDAR encephalitis. It assessed the quality of these studies using a quality assessment tool 
created for the purpose of the study. The neuropsychological results were synthesised and the 
results discussed narratively. A review revealed difficulties with memory, particularly verbal 
memory, executive functioning and attention/processing speed.  
Paper two is an interpretative phenomenological analysis of women with a diagnosis 
of anti-NMDAR encephalitis. The aim of this study was to explore the experience of women 
diagnosed with anti-NMDAR encephalitis and the phenomenon of identity change. Using a 
semi-structured interview the women were interviewed about their experience of having the 
illness, with a focus on impact on identity. These interviews were analysed for themes using 
the IPA method and four superordinate themes were discussed with direct quotes. Four 
superordinate themes were revealed ‘Re-finding the ‘normal’ self; ‘A ‘special’ identity’; 
‘Evolving from the illness’ and ‘Revised roles. Analysis revealed themes common to many 
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severe physical illnesses such as, not feeling oneself and post-traumatic growth. However, 
themes emerged specific to anti-NMDAR such as feeling abnormal due to the rarity of the 
disease and its psychiatric symptoms, feeling viewed as special and concerns around fertility 
and motherhood.   
Paper three is a Commentary on the former two studies. This paper offers critical 
appraisal and reflection on the research process, the strengths and limitations of the papers 
and line of enquiry, as well as implications for further research, clinical practice and 
personal/professional development, and finally proposals for dissemination. 
The term ‘patients’ will be used within the systematic review because of its common 
usage in the target journals, however, it is recognised that its origins are from the medical 
perspective and other terms that are more person-centred could also be chosen.  
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2.1 Abstract 
A systematic review was conducted to investigate the emerging cognitive profile for people 
diagnosed with anti-NMDAR encephalitis. Ten papers met the review criteria including five 
neuropsychological case studies and five case series; three of the ten studies used matched 
controls. The cognitive functioning of 54 patients (46 female: 8 male) was studied. A range of 
neuropsychological test batteries were used across the studies, administered between one to 
four times. Paper quality assessment was undertaken and outcomes summarised. 
Neuropsychological results during the acute phase (≤ 12 months) and chronic phase (>12 
months) were extracted. A narrative review of the papers’ findings revealed difficulties with 
memory, particularly delayed verbal memory, and executive functioning. This may be 
consistent with the role of NMDA receptors in the limbic system, specifically the hippocampus, 
which are thought to be essential to aspects of learning and memory. To date, there is a paucity 
of high quality neuropsychological and psychological research concerning the impact of anti-
NMDAR encephalitis on cognitive function and psychosocial well-being, both of adults and 
particularly of those under 18 years. Significant limitations of the literature reviewed include 
lack of attention to pre-morbid functioning, insufficient rationale for neuropsychological 
battery choice, use of samples of convenience and limited translation of neuropsychological 
findings into rehabilitation.  
 
Keywords: anti-nmdar; encephalitis; autoimmune; neuropsychology; cognitive; functioning 
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2.2 Introduction  
Anti N-methyl-D-aspartate receptor encephalitis (anti-NMDAR) is a rare form of autoimmune 
encephalitis, officially categorised and named only in 2007 (Dalmau et al., 2007). It is an acute 
and often severe illness caused by the body’s antibodies attacking, predominantly, the NR1 
subunit of the NMDA receptors in the brain (Dalmau et al., 2008). It is often associated with a 
teratoma tumour, frequently ovarian in women and possibly testicular in men (Irani et al., 
2010). However, there are an increasing number of cases reported with no identifiable tumour 
(Lim et al., 2014). The California Encephalitis Project (CEP), studying the epidemiology of 
encephalitis, found 65% of anti-NMDAR cases occurred in patients aged 18 or younger, with 
women significantly more affected than men (Gable et al., 2012). The illness typically initiates 
with prodomal influenza or viral type symptoms, such as headache, fever and nausea (Dalmau 
et al., 2011). Symptoms such as delusional thinking, mood disturbances and aggression then 
frequently develop (Kayser et al., 2013). These symptoms mean that 77% of patients first 
present for assessment by a psychiatrist (Kuppuswamy, Takala, & Sola, 2014) and that there 
is a risk of anti-NMDAR going undiagnosed, (Lennox, Coles, & Vincent, 2012) or resulting in 
a protracted time to diagnosis. This is significant given that quicker diagnosis and treatment is 
thought to improve prognosis (Kuppuswamy, Takala & Sola, 2014; Byrne et al., 2014).  
Following the initial phase, most patients proceed into a period of alternating between 
catatonia and agitation with symptoms such as decreased levels of consciousness, 
hypoventilation, autonomic instability and oro-lingual-facial dyskinesias (involuntary 
repetitive movements of the mouth and face) (Dalmau et al., 2011a; Iizuka & Sakai, 2008; 
Titulaer et al., 2013). Loughan et al., (2016) report that in around 50% of anti-NMDAR cases, 
MRI scans of the brain have been normal (Dalmau et al., 2011; Maneta & Garcia, 2014) and 
any abnormalities found are usually small/transient despite the severity and duration of 
symptoms (Dalmau et al., 2011). Dalmau et al., (2011) reported that single photon emission 
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topography (SPECT) results have been variable, with some studies finding variable multifocal 
cortical and subcortical abnormalities, which change during the course of the disease (Llorens 
et al., 2010), and other studies finding no abnormalities (Iizuka & Sakai, 2008). Therefore, 
confirmation of the clinical diagnosis is typically determined via positive identification of 
NMDA antibodies in the cerebrospinal fluid and/or serum (Gresa-Arribas et al., 2014; Barry et 
al., 2015). For all patients, management of anti-NMDAR consists of first-line immunotherapy, 
including corticosteroids, intravenous immunoglobulins or plasma exchange (Dalmau et al., 
2011; Chen et al., 2016). Teratomas are resected if identified (Irani et al., 2010). Some patients, 
such as those with a delayed diagnosis, will go on to have second-line immunotherapy, such 
as Rituximab (Dalmau et al., 2011).  
Incidence and prevalence rates of anti-NMDAR encephalitis have yet to be established. 
However, research so far suggests that most patients recover fully medically or have mild 
sequelae, although a minority die or remain severely disabled (Dalmau et al., 2008). In a 
longitudinal study of 501 patients, Titulaer et al., (2013) found that 81% had a favourable 
outcome and 9.5% of patients had died after a median follow-up of 24 months. Three 
independent factors were predictive of good outcome: the rapid commencement of 
immunotherapy; tumour resection if needed; and less severe symptoms (i.e. not needing 
intensive care unit support). Titulaer et al., (2012) found 12% of their patients relapsed within 
24 months, particularly when there was no associated tumour or undetected/recurrent tumours. 
However, the authors also found relapses were less frequent when patients received second-
line immunotherapy (Titulaer et al., 2013). 
With regards cognitive function, amnesia during the initial stages is often reported 
(Leypoldt et al., 2012; Titulaer et al., 2013). Dalmau et al., (2008) stated that, in their study of 
100 patients with anti-NMDAR (91 women; mean age 23 years), 23 presented with short-term 
memory loss. Language is also affected, with a reduction of verbal output, some echolalia 
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(often together with echopraxia), and in some cases mutism (Dalmau et al., 2011). However, 
clinicians suggest memory difficulties and other neurocognitive abnormalities can be 
overlooked due to the dominance of psychiatric symptoms (Parfene et al., 2016) and speech 
difficulties, which interfere with the assessment of memory (Dalmau et al., 2008; Dalmau et 
al., 2011). Memory deficits are said to be consistent with the distribution and function of 
NMDARs in the brain, which are required for long-term potentiation in the hippocampus, 
thought to be the centre for learning and memory (McKeon et al., 2016; Rezvani, 2006). 
Research into the long-term neurophysiological and structural consequences of anti-NMDAR 
is still lacking given the relative infancy of the disease categorisation. Most research has been 
undertaken by Finke et al., (2012; 2013; 2016). Using resting state fMRI, Finke et al., (2013) 
found significantly reduced bilateral functional connectivity between the hippocampus and the 
anterior default mode network (aDMN). This was shown to be correlated with individual 
memory performance, despite normal routine clinical MRI and grey matter morphology. The 
DMN is found to be more active in resting, internally focused tasks and researchers suggest it 
is involved in episodic memory processing and imagination (Finke et al., 2013). These findings 
are consistent with the knowledge that the CA1 region of the hippocampus has the highest 
density of NMDARs in the brain (Finke et al., 2013). Whilst neuroimaging results are 
important in understanding the neurophysiological and structural impacts of anti-NMDAR, 
neuropsychological studies are needed to establish a cognitive profile and understand the 
impact of any cognitive difficulties on functioning and wellbeing.   
Although this research is starting to emerge, a systematic review of neuropsychological 
studies of anti-NMDAR has not yet been completed. The aim of this study is to systematically 
investigate current literature on neuropsychological sequelae, to evaluate its quality and to 
attempt to establish a cognitive profile for this clinical population, both in the acute (≤ 12 
months) and chronic (>12 months) phases.  
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2.3 Method 
In this review of the literature, a systematic approach was adopted following the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidance (Moher et 
al., 2009). The following search string was used: anti-NMDAR OR Anti-N-Methyl-D-
Aspartate AND encephalitis AND Neuropsycholog* OR cogniti*. Appropriate studies were 
identified using PsycINFO, MEDLINE, Scopus and Web of Science. The search was limited 
to the English language. Given that anti-NMDAR was only officially categorised in 2007, the 
period of 2007 to March 2017 was searched, accepting articles and reviews. Studies of children 
(under age 18, based on a typical UK research cut-off) were excluded, due to the specificities 
of neurodevelopmental level on cognitive functioning (Johnson, Blum, & Giedd, 2009).  
The search was devised to identify papers where the search terms appeared in the title, 
abstract or keywords. The abstracts identified in each of the four databases were downloaded 
into a reference manager and duplicates automatically removed. Titles and abstracts were 
screened and relevant papers’ full texts were downloaded. Reference sections were then hand 
searched for any further relevant papers. Figure 1 shows the search process. Single case studies 
were included given the limited literature in this area.  
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Figure 1: Overview of searching and screening process PRISMA (Moher et al., 2009) 
 
2.3.1 An assessment of methodological quality 
An examination of existing standardised quality appraisal checklists (Critical Appraisal Skills 
Programme (CASP, 2017); QUADAS-2 diagnostic study checklist (Whiting et al., 2011); 
Scottish Intercollegiate Guidelines Network (SIGN, 2017)) was carried out. It was concluded 
that they did not meet the specific requirements of this review of neuropsychological case 
studies/series. Therefore, a checklist was developed for the purpose of this review. This was 
based upon the foregoing existing checklists and guidance from: Evans (2010) on potential 
contra-indicators to neuropsychological testing validity; guidelines on psychometric testing 
(Psychologists Board New Zealand, 2015); information on single-case methodology in 
325 citations identified through 
electronic and hand searching  
229 citations remain after 
removing duplicate records 
Titles/abstracts of 229 citations 
screened (Stage 1) 
218 citations excluded 
Full text of 11 citations 
assessed for inclusion (Stage 
2) 
3 full-text citations excluded as 
2 poster abstracts 
1 full-text could not be obtained 
References searched of 8 
citations 
10 included citations 
2 additional citations found 
!
! 10!
neuropsychology (Crawford, 2017) and guidance on reporting of medical case studies (Cohen, 
2006; Green & Johnson, 2006; McCarthy & Reilly, 2000). Each article was reviewed and given 
an overall score (possible maximum of 33; Appendix C) based upon which criteria were met. 
For ease of reference, articles are referred to as ‘Low’ (0-11), ‘Medium’ (12-22) or ‘High’ (23-
33) quality, depending on their score. Given the small number of papers meeting the inclusion 
criteria, no articles were excluded on the basis of their score on the quality checklist, rather, 
this was used to critically appraise the quality of current literature and provide 
recommendations for future research. Two independent raters piloted the quality of the 
assessment tool, any differences in scoring were discussed and the tool’s wording changed 
accordingly. An independent rater then formally reviewed a total of five articles, which 
demonstrated high inter-rater reliability (k=0.72). All the scores were within the same category 
(Low, Medium, High), aside from Vahter et al., (2014), which the first author rated as ‘Low’ 
quality and the second rater as ‘Medium’ quality (one point difference).  
 
2.3.2 Data extraction 
Data were extracted from the articles by the first author and divided into acute (≤12 months), 
and chronic cognitive deficits, (>12 months). This was in an attempt to establish a cognitive 
profile, firstly for the ‘acute’ neuropsychological phase of the illness i.e. from the onset of the 
symptoms (the period when most treatment is commenced and completed). Secondly, for the 
‘chronic’ phase, for any cognitive difficulties remaining once treatment had ceased and which 
may affect patients’ resumption of day-to-day life. It should be noted there is currently little 
agreement as to the definition of ‘acute’ and ‘chronic’ periods and papers largely base this on 
medical and treatment criteria. McIvor & Moore (2007) refer to the acute stage as 4–6 weeks 
after symptom onset; post-acute stage as 2–6 months and the chronic stage as 6–13 months. 
However, time to treatment is under-reported across the ten articles: patients may not start 
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treatment until several months after symptom onset (Urakami, 2016); or it may be unknown 
(McKeon et al., 2017). Therefore, the ‘acute’ phase for the purpose of this neuropsychological 
review was defined as 0-12 months on the premise that if patients were still recovering from 
the systemic effects of the illness and if treatment was still being received, this would affect 
cognitive functioning. The terms chronic and acute were used as opposed to short and long-
term to reduce confusion with short and long-term memory references. 
 
2.4 Results  
 
2.4.1 Search results and characteristics of studies 
The search and screening process identified ten eligible articles, including five case studies 
(one single case study, four with multiple) and five case series (four with a single case and one 
with multiple; Appendix A). Three studies had matched controls and all patients’ 
neuropsychological test results were compared to normative samples. The data was derived 
from 54 patients diagnosed with anti-NMDAR from eight different countries. The time of 
neuropsychological testing since diagnosis varied considerably from eight days to 6.5 years 
(Appendix A). Seven articles described time since disease/symptom onset, one described time 
since diagnosis and one reported time since treatment completion. Five of the studies carried 
out neuropsychological testing with patients who had medical treatment only, four with those 
who had treatment and rehabilitation and one with a patient who had no treatment or 
rehabilitation. Eight articles were rated as ‘Medium’ quality, one ‘High’ quality and one ‘Low’ 
quality (Appendix E). Consistent with the current evidence on epidemiology of anti-NMDAR 
(Titualer et al., 2012), there were more female participants than males (46F:8M).  
The articles varied in their methodology, for example, with different patients tested at 
different times in their recovery, variability in the numbers of patients tested and presence or 
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absence of a control group (Appendix A). Additionally, many different neuropsychological 
tests were used to measure cognitive functioning across studies (Appendix F). Therefore, 
comparison of the articles was difficult and data-synthesis was not appropriate. As such, a 
narrative synthesis of the results was undertaken. The main results are presented under different 
cognitive domains, based on Lezak (2012) and the DSM-5 approach to classifying 
neurocognitive disorders (Sachdev et al., 2014). Five of the studies were case series, four of 
which assessed patients both during the acute and chronic phases, and as such the relevant 
results are discussed in the acute and chronic sections (Martin-Monzon et al., 2012; Vahter et 
al., 2014; Urakami, 2016; McIvor & Moore, 2017). Bach (2014) reported three case studies, 
but only the two patients assessed with formal neuropsychological testing, within the first 
twelve months, were included in the ≤12 month analysis. The patient assessed at 30 months 
did not undergo formal neuropsychological testing; data reported derives from behavioural 
observations and clinical judgement. 
 
2.4.2 Synthesis results 
The results of the synthesis are presented below; however, it should be stressed that the results 
are based on relatively small numbers of cases, particularly in the acute phase. The number of 
patients who were found to have cognitive difficulties for the cognitive domain are indicated 
alongside the relevant references (for example, N=13). Reflected in the quality assessment tool, 
a common methodological limitation of the case studies and series was inadequate reporting of 
the procedure of neuropsychological assessment and of patient demographics (Appendix E). 
For example, pre-morbid functioning was not assessed in half of the papers studied and as such 
any cognitive deficit found cannot be solely attributed to the effects of the illness. Therefore, 
the results below should be interpreted with caution, with close examination of both the number 
of patients included within each result summary and the quality assessment scores of the papers 
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included. Furthermore, there was a great deal of disparity with regards to how cognitive 
functions were classified and described by the articles. This is particularly evident for memory, 
which was subdivided differently by each of the articles. To present the results for memory, 
the most referred to memory subdivisions within the articles are summarised in each of the 
results sections.  
 
2.4.3 Acute cognitive effects (≤12 months) 
 
2.4.3.1 Description of articles 
Seven of the ten articles included in this review assessed patients within the first 12 months 
from either diagnosis, symptom onset or at the start of rehabilitation, and are discussed below 
(Martin-Monzon, Trujillo-Pozo and Romeron, 2012; Marcos-Arribas, Almonacid & Dolado, 
2013; Vahter et al., 2014; Bach, 2014; Loughan et al., 2016; Urakami, 2016; McIvor and 
Moore, 2017). A total of thirteen participants were assessed across the seven articles. The mean 
age of the patients was 28.7 (range: 19 to 47 years), with a higher ratio of female patients (10F: 
3M). All but one article (Loughan et al., 2016) conducted case series where patients were 
assessed at two or more time points within the first 12 months. The case series or studies were 
judged as ‘Medium’ quality, except Vahter et al., (2014), which was of ‘Low’ quality and 
Loughan et al., (2016) which was ‘High’ quality, both largely due to the level of detail provided 
in the participant background section of the quality measure.  
2.4.3.2 Memory 
Memory was tested in all seven of the articles (N=13) with each study reporting some form 
of memory difficulty.  
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2.4.3.2.1 Working/Short-term memory. Working/short-term memory difficulties were 
specifically noted in three articles (Bach, 2014; McIvor & Moore, 2017; Urakami, 2016; N=9), 
with McIvor and Moore (2017) and Urakami (2016) reporting working memory deficits 
persisting at 12 months following treatment and treatment with rehabilitation respectively.  
 
2.4.3.2.2 Episodic recall. Immediate recall difficulties were reported in four of the studies 
(Marcos-Arribas et al., 2013; Martin-Monzon et al., 2012; McIvor & Moore, 2017; Vahter et 
al., 2014; N=4) and delayed recall difficulties were reported in six articles (Bach, 2014; 
Loughan et al., 2016; Marcos-Arribas et al., 2013; Martin-Monzon et al., 2012; McIvor & 
Moore, 2017; Vahter et al., 2014; N=7). Visual memory difficulties were cited in four of the 
articles (Marcos-Arribas et al., 2013; Martin-Monzon et al., 2012; McIvor & Moore, 2017; 
Urakami, 2016; N=9) and verbal memory difficulties reported in all seven articles (Bach, 2014; 
Loughan et al., 2016; Marcos-Arribas et al., 2013; Martin-Monzon et al., 2012; Vahter et al., 
2014; McIvor & Moore, 2017; Urakami, 2016; N=13). 
McIvor and Moore (2017) reported deterioration in immediate recall, with their 
untreated patient’s immediate memory score at six months dropping from the average to the 
low average range at 12 months. Within this, immediate verbal memory was within the low 
average range and significantly lower than predicted, however, immediate visual memory 
remained within the average range. The patient’s overall delayed recall index score was not 
significantly improved at 12 months. Delayed visual memory in particular had not significantly 
improved from six to 12 months. Marcos-Arribas et al., (2013) reported significant immediate 
and delayed verbal and visual recall difficulties in the first few days of the patient presenting 
in hospital. However, investigation of the raw scores suggests that at four weeks all recall 
difficulties were resolved, although statistical significance was not reported. Vahter et al., 
(2014) found severe impairments in immediate verbal recall at day eight of the onset of the 
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illness, but at eight months and 12 months these had returned to ‘normal’. Delayed verbal 
memory showed improvement in one subtest (Logical Memory II), however, other delayed 
verbal memory tests (Buschke) indicated moderate to severe difficulties, with Vahter et al., 
(2014) concluding that (delayed) verbal memory was the most impaired function at eight and 
12 months. The patient’s immediate and delayed visuospatial memory remained ‘normal’ 
throughout testing. Martin-Monzon’s et al., (2012) patient had immediate recall difficulties at 
six months that were largely consistent at 12 months. Immediate visual recall showed no 
improvement by 12 months, with the patient scoring zero both times. Verbal recall deteriorated 
at 12 months, however it was unclear whether this was for immediate recall only or an average 
of both immediate and delayed recall, as only one score is reported. Loughan et al., (2016) 
reported ‘lowered delayed’ verbal and visual recall scores in their patient when tested at six 
months. One of Bach’s (2014) patients displayed difficulties in delayed verbal memory six 
months after symptom onset, however, no serial assessments were carried out. Urakami (2016) 
found that group level verbal and visual memory difficulties found at six months had shown 
significant improvement after 12 months of treatment and rehabilitation, and had improved in 
relation to patients with herpes simplex encephalitis.  
 
2.4.3.5 Executive functioning 
Deficits in executive functioning were reported in four of the seven articles (Martin-Monzon 
et al., 2012; Vahter et al., 2014; Bach, 2014; Loughan et al., 2016; N=5). Bach (2014), Loughan 
et al., (2016) and Martin-Monzon et al., (2012) reported deficits in executive functions, such 
as planning, organisation, reasoning, problem solving, set shifting and maintenance and 
category fluency at six months, with some difficulties remaining in Martin Monzon’s et al., 
(2012) patient at 12 months. However, no statistical analyses were performed on the latter. 
Bach (2014) reported that one patient’s executive difficulties were sufficiently pronounced to 
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have an impact on her reintegration into education and on her future career. However, whilst 
Vahter et al., (2014) reported deficits in some tests of executive functioning at day eight, 
ranging from severe to mild, these appeared to return to the ‘normal’ range by eight months 
after onset. McIvor and Moore (2017) reported that their untreated participant had some 
difficulty when switching was introduced to the Trail Making Test, however overall they found 
his performance remained largely static and was not strongly suggestive of underlying 
executive dysfunction. Marcos-Arribas et al., (2012) also tested for executive function but 
reported normal scores in these tasks.  
 
2.4.3.6 Attention and Processing Speed 
Six of the seven articles reported difficulties with attention and processing speed (Martin-
Monzon et al., 2012; Marcos-Arribas et al., 2013; Vahter et al., 2014; Bach, 2014; Loughan et 
al., 2016; Urakami, 2016; N=12), however, the majority reported mild to moderate levels of 
dysfunction that resolved at or before 12 months, across a range of attentional processes: 
selective and prolonged (Martin-Monzon et al., 2012); sustained (Loughan et al., 2016); and 
information processing tasks (Vahter et al., 2014; Loughan et al., 2016; Marcos-Arribas et al., 
2013; Urakami, 2016). McIvor and Moore (2017) did not report any specific attentional 
difficulties in their patient and Urakami (2016) concluded patients with anti-NMDAR also 
showed significant improvement in attentional function within 12 months, in comparison to 
patients with herpes simplex encephalitis. 
 
2.4.3.7 Language  
Three articles found evidence of expressive and receptive language impairment (Vahter et al., 
2014; Bach, 2014; Loughan et al., 2016; N=4). However, language impairment was often not 
formally tested and had improved in all three cases after three to six months of treatment. 
! 17!
Vahter et al., (2014) reported that one month after the disease onset, their patient developed 
progressive sensorimotor aphasia. However, three months after the first symptoms the aphasia 
had reportedly subsided. Bach (2014) qualitatively reported their patient had limited 
comprehension and no verbal words in the acute stage of illness. However, this improved 
throughout rehabilitation with only subtle deficits in language remaining. Loughan et al., 
(2016) reported language impairment in the acute phase, for which their patient received speech 
therapy. By the time of neuropsychological assessment six months post-diagnosis, his language 
appeared to have improved, with intact receptive language, and only mild word finding 
difficulties persisting.  
 
2.4.3.8 Visuospatial abilities 
Only one article reported impairment in visuospatial ability specifically (Martin-Monzon et al., 
2012; N=1). Martin-Monzon et al., (2012) reported that their patient had difficulty, at both six 
and 12 months testing, with specific visuospatial skills such as cube analysis, position 
discrimination and number location. However, elementary visual perception (e.g. shape 
detection) and more elaborate functions (recognition of degraded stimuli, object identification) 
were undisturbed.  
 
2.4.3.9 Social cognition 
Social cognition was only investigated in one of the eight articles (Bach, 2014; N=2). The 
author used a 10-item questionnaire to assess patients’ ability to understand other people’s 
mental states and general cognition. Both individual patient and informant versions were given 
to two of the three cases studied in this article. Bach (2014) reported that one patient’s score 
indicated she had newly acquired difficulties in empathising, tactfulness and ability to 
sympathise, together with reduced insight into these difficulties. Another patient reported new 
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difficulties recognising that she said things that upset others, understanding jokes, showing 
sympathy and being tactful. Informant scores corroborated this, however, no formal social 
cognitive tasks were administered.  
 
2.4.4 Chronic cognitive effects (>12 months) 
 
2.4.4.1 Description of cases 
Six out of the ten articles presented in this review assessed patients a minimum of one year 
since disease onset/diagnosis (range 1–6.5 years; Finke et al., 2012; Martin-Monzon et al., 
2012; Finke et al., 2013; Vahter et al., 2014; McKeon et al., 2016; McIvor & Moore, 2017). A 
total of 43 patients were studied across the six articles, mean age 27.6 (the approximate range 
was 16-44, however, two papers only reported the mean). Again, there were more female 
patients than male (37F:6M). All the papers were ‘Medium’ quality, except Vahter et al., 
(2014), which was scored as a ‘Low’ quality paper.  
 
2.4.4.2 Memory 
Memory difficulties persisting after the acute 12-month period were reported in all six articles 
(N=43).  
 
2.4.4.2.1 Working/Short-term memory. Working and short-term memory difficulties were cited 
in five of the studies (Finke et al., 2012; Finke et al., 2013; Martin-Monzon et al., 2012; 
McKeon et al., 2016; McIvor & Moore, 2017; N=42). Finke et al., (2012), in their study of 
nine patients tested at a median of 43 months after disease onset, found significant impairments 
in working memory in four of the participants, in the routine neuropsychological assessment 
of working memory. The authors also administered an additional battery of short-term memory 
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(STM) tasks (delayed match-to-sample tasks), which they claim have been previously validated 
in patients with hippocampal damage (Braun et al., 2008; Finke et al., 2008). Patients were 
required to remember the colour, location or the association of colour and location of visual 
stimuli across delays of 900 or 5000 ms. They found that five patients had delay-dependent 
deficits in some aspect of this battery. However, they reported that three of these patients 
performed normally in the routine neuropsychological assessment of STM memory. Finke et 
al., (2013) also reported that their participants (N=24) showed substantial deficits in working 
memory at a median of 35 months after disease onset. Furthermore, McKeon et al., (2016) 
found the scores of their anti-NMDAR patient group fell significantly below (medium to large 
effect sizes) the control group in working memory. Martin-Monzon et al., (2012) report 
improvements in memory tasks at the 72-month follow-up. However, examination of the 
patient’s raw scores suggests some residual impairment in working memory (on subtests of the 
WAIS-III). McIvor and Moore (2017) found their untreated patient’s visual working memory 
remained largely unchanged from six to 30 months, staying in the low average range. However, 
his visual working memory score was largely impacted by his spatial addition score, which 
was significantly lower than predicted.  
 
2.4.4.2.2 Episodic recall. Immediate recall difficulties were found in four of the six articles 
(Finke et al., 2012; Finke et al., 2013; McKeon et al., 2016; Martin-Monzon et al., 2012 N=41) 
and delayed recall difficulties in five articles (Finke et al., 2012; Finke et al., 2013; Martin-
Monzon et al., 2012; McKeon et al., 2017; Vahter et al., 2014; N=42). Verbal memory 
difficulties were also reported in five of the articles (Finke et al., 2012; Finke et al., 2013; 
McIvor & Moore, 2017; McKeon et al., 2017; Vahter et al., 2014; N=42) and visual memory 
difficulties reported in two articles (Finke et al., 2012; Martin-Monzon et al., 2012; N=10).  
! 20!
McKeon et al., (2016) found that the scores of the anti-NMDAR patient group fell 
significantly below the control group in tests of verbal immediate and delayed recall, but not 
immediate or delayed visual recall. Similarly, Finke et al., (2013) also observed significant 
impairments in immediate and delayed verbal recall, but not visual, across 24 participants. 
Finke et al., (2012) reported significantly impaired immediate and delayed verbal recall in two 
of their nine patients and significantly impaired immediate and delayed visual recall in one 
patient. Vahter et al., (2014) found that 20 months after disease onset there remained a mild 
deficit in verbal delayed memory. They concluded that the most impaired function at long-term 
follow-up was delayed verbal memory, however, significance levels were not reported. McIvor 
and Moore (2017) reported that their untreated patient’s verbal memory index at 30 months 
was comparable to his score at 12 months and so was not deemed to be a statistically significant 
change. However, his immediate and delayed verbal memory scores were in the average range. 
Martin-Monzon’s (2012) single case study showed persistent immediate and delayed visual 
recall difficulties six years after disease onset, whilst verbal memory showed improvement. 
However, it is unclear whether the scores reflected clinically significant change. Furthermore, 
again, verbal memory was not divided into immediate and delayed recall so it is unknown if 
one was preferentially improved. Finke et al., (2012) found that in their specific STM battery, 
five patients had deficits in either STM of locations and/or colour-location associations, 
suggesting difficulties with immediate visual memory. 
 
 
2.4.4.5 Executive functioning  
Executive functioning difficulties were reported in five of the six articles (Finke et al., 2012; 
Finke et al., 2013; Martin-Monzon et al., 2012; McKeon et al., 2016; McIvor & Moore, 2017; 
N=42), with difficulties such as reasoning, rule finding, set shifting and set maintenance, 
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category fluency visuospatial planning/organisation and problem solving. Finke et al., (2012) 
found persistent impairments in executive functioning in five/nine patients. Finke et al., (2013) 
reported substantial group deficits in executive functions (N=24), although this appeared to be 
based only on performance in the STROOP test. Nonetheless, of the 24 patients, five did 
subjectively report executive functioning difficulties. McKeon et al., (2016) found the anti-
NMDAR patients’ group performance was significantly below matched controls for some 
aspects of executive functioning (visuospatial planning/organisation and problem solving) but 
not others (abstraction, response inhibition, flexibility and verbal fluency). They reported that 
aspects of executive functioning were amongst the most severely affected abilities at the 
individual level, but profiles ranged from ‘normal’ to ‘extensive dysfunction’. Martin-Monzon 
et al.,’s (2012) patient showed some improvement in certain tests of executive functioning at 
72 months post-initial onset, however, it is unclear whether these scores fell within ‘normal’ 
ranges. Vahter et al., (2014) found their patient’s test scores in executive functioning remained 
in the normal range at 20 months. McIvor & Moore (2017) found some increased variability in 
individual tasks performance for executive functioning at 30 months, compared to six months. 
However, as before, they concluded his results were not strongly suggestive of underlying 
executive dysfunction. 
 
 
2.4.4.6 Attention and Processing Speed 
Attention and processing speed difficulties were reported in two of the articles (Finke et al., 
2012; McKeon et al., 2016; N=16). Finke et al., (2012) observed impairments in attention in 
four of their nine patients, with one of these four patients also subjectively reporting attention 
difficulties. McKeon et al., (2016) found medium to large effect size differences between the 
anti-NMDAR patients and the control group for both sustained and divided attention and 
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information processing speed. Seven out of 24 patients in the study by Finke et al., (2013) 
subjectively reported difficulties with attention. However, the authors reported 
neuropsychological tests showed intact attention.  
 
2.4.4.7 Language  
Language was investigated in three of the six articles for long-term follow up (Martin-Monzon 
et al., 2012; Finke et al., 2013; McKeon et al., 2016; N=32) but no deficits were found. McKeon 
et al., (2016) reported that expressive language (Vocabulary, Graded Naming Test, 
spontaneous speech) was comparable between the anti-NMDAR group and matched controls. 
Finke et al., (2013) and Martin et al., (2012) both reported that testing revealed language was 
intact in their patients. 
 
2.4.4.7 Visuospatial abilities 
Visuospatial difficulties were reported in one of the six articles (McKeon et al., 2016; N=7) 
and tested in an additional three articles but no impairments were found (Martin-Monzon et 
al., 2012; Finke et al., 2013; Vahter et al., 2014; N=32). McKeon et al., (2016) tested for 
visuospatial organisation via the Rey figure copy and found a significant difference between 
the anti-NMDAR patients and matched controls.  
 
2.4.4.8 Social Cognition 
Only one article tested for social cognition (McKeon et al., 2016; N=7), with this being the 
main aim of the study. McKeon et al., (2016) administered the Mind in the Eyes Test, 
Advanced Test of Malingering (ToM), the Social Situations Test and the Emotion Attribution 
Task to seven patients with anti-NMDAR and compared their scores to matched controls. They 
found significant differences between the groups on using mental-state information to make 
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sense of social situations and judge the severity of interpersonal violations. Subjectively four 
out of the seven participants reported social withdrawal and one patient specifically reported 
occasional misinterpretation of social situations. McKeon et al., (2016) report that subjective 
social dysfunction experienced by patients can correspond to deficits in social cognition tasks 
and that anti-NMDAR may adversely affect the ability to decode and adaptively use mental-
state information. However, the authors recognised their small sample size and that they ran 
many statistical comparisons. Therefore, they suggest the results should be interpreted 
cautiously. 
 
2.5 Discussion 
 
2.5.1 Acute cognitive effects (≤12 months) 
Memory was the cognitive domain most tested, with all seven articles citing significant 
difficulties with some aspect of memory in their patients. Delayed verbal memory was the most 
commonly reported memory difficulty in all seven articles. Immediate and visual memory were 
the next most cited difficulties in four articles. Working/short-term memory difficulties were 
only reported in three of the articles. Attentional and processing speed difficulties were highly 
reported, in six of the seven articles, however these difficulties appeared to largely resolve 
across the first 12 months since disease onset/diagnosis. Four of the seven articles cited some 
form of executive dysfunction, such as difficulties problem solving, rule finding and set 
shifting. Language impairments were found in three articles, with word finding and verbal 
fluency being the most frequently evidenced deficits. Visuospatial difficulties were found in 
only two of the studies. Social cognition was the least explored cognitive domain with only 
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one of the articles examining social cognition. However, formal neuropsychological testing 
was not used.  
 
2.5.2 Chronic cognitive effects (>12 months) 
Memory was, again, one of the cognitive domains most affected in the chronic phase. Persistent 
memory difficulties of some form were reported in all six articles. Delayed verbal memory was 
also the most commonly discussed deficit in the chronic phase, reported in five articles. 
Working/short-term memory difficulties were the second most commonly reported difficulty, 
present in five of the articles. Immediate recall difficulties were reported in four of the articles 
and visual memory difficulties in only two articles. Executive dysfunction was a frequently 
reported deficit in the chronic phase, reported in five of the six articles. However, again, these 
differed greatly between patients, both within studies and between studies, with difficulties 
from problem solving to response inhibition and varying from mild to severe. 
Attention/processing speed difficulties were reported in only two of the articles. Visuospatial 
difficulties were only reported in one article and language difficulties were not found in any of 
the current articles. Social cognition was again the least explored cognitive domain, with only 
one article assessing social cognition and finding impairment. However, they did use formal 
neuropsychological testing, albeit on a small case sample.  
 
 
2.5.3 Summary of findings 
Memory was the cognitive domain most affected by anti-NMDAR in these studies, with all 
articles citing some form of memory difficulty. Deficit in memory is consistent with knowledge 
that NMDA receptors are highly concentrated in the limbic system, particularly the 
hippocampus, and are essential to aspects of learning and memory (Kruse et al., 2014; Lo et 
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al., 2010). Although NMDARs are thought to reactivate after immunological recovery has 
taken place, it is thought not possible for the grey and white matter to be increased (Martin-
Monzon et al., 2012). This was reported by Finke et al., (2016), who found evidence for long-
standing reduced microstructural integrity of both hippocampi, relative to controls. They 
reported that disease severity and duration predicted the extent of hippocampal damage, which 
then correlated with memory performance. They also found volumes of the left hippocampal 
formation correlated with verbal memory performance, which is in line with the theorised 
specificity of the left hippocampus for verbal stimuli and consistent with the findings of 
delayed verbal memory difficulties in all the current ten articles.  
Executive functioning difficulties were reported in eight of the ten articles overall. 
However, results for the executive functioning tasks were variable, with deficits found across 
a variety of different tests, and patient’s scores ranging from normal to severe. This is perhaps 
not surprising given that ‘executive function’ is an umbrella term that overarches a wide range 
of quite divergent skills and functions (Elliott, 2003). Nonetheless, these findings may be 
accounted for by Finke et al., (2013) who found reduced functional connectivity between the 
hippocampus bilaterally and the aDMN. The DMN includes the medial prefrontal cortex, 
which is associated with executive functions and working memory (Finke et al., 2013).  
The findings of this adult population appear to be slightly varied from paediatric and 
adolescent cases, which seem diverse within themselves. Iadisernia et al., (2012) found deficits 
in attention, executive functioning, verbal fluency, and rapid naming in two paediatric patients. 
Poloni et al., (2010) also reported attention difficulties, together with deficits in working 
memory in one paediatric patient. Gitiaux et al., (2013) reported that three of the six children 
tested at follow up (median duration of 12 months; range 10 months to 5 years) received special 
education due to persistent semantic memory deficit (word retrieval difficulties) and visual 
episodic and working memory impairment. Matricardi et al., (2016) found over half of their 
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paediatric patients (total of 11) had residual deficits indicating frontal lobe dysfunction after, 
at least, a one year follow-up. Overall, investigation of neuropsychological sequelae in 
paediatric cases is extremely limited, indicating a need for more larger scale studies.  
 
 
2.5.4 Limitations 
This systematic review provides a summary of cognitive difficulties commonly reported in ten 
neuropsychological case studies/series. However, the results should be interpreted with caution 
given the large number of extraneous variables present. The articles differed greatly, with 
disparities in for example, whether patients received neurorehabilitation and which tests were 
used (Appendix F). Furthermore, the severity of the illness, for example whether there was 
intensive care treatment, is not indexed or reported consistently, nor are details of the 
treatments and when they were commenced and completed. Impact of the treatments, such as 
corticosteroids and Rituximab should also be taken into consideration as these can cause side 
effects such as fatigue, flu-like symptoms and pain (Buchman, 2001; Ikeguchi et al., 2012; 
Cancer Research UK, 2015; Mayo Clinic, 2017), all of which could negatively impact patient’s 
test scores (Lezak, 2004 p. 125). Of particular note is the protracted use of corticosteroids, 
which have been implicated in cognitive difficulties referred to as a ‘steroid dementia’ (Brown, 
2009; Keenan et al., 1996; Sacks & Shulman, 2005; Wolkowitz, Lupien, Bigler, Levin, & 
Canick, 2004; Wolkowitz, Lupien, & Bigler, 2007).  
There remains a scarcity of research in this area, particularly high quality research. 
Most studies in this review were of ‘Medium’ quality. Reporting of the cases was not strong, 
with a significant lack of reporting of important neuropsychological variables such as, pre-
morbid intellectual functioning, psychiatric history and any existing acquired brain injury 
(ABI; Lezak et al., 2004; Hebben & Milberg, 2009). For example, pre-morbid functioning was 
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not estimated in half of the papers studied and even when it was assessed it was often not 
appropriately compared to the IQ score at the time of testing. This is despite analysis of the 
raw scores indicating there was not a statistical difference between the two (Finke et al., 2012; 
13; McKeon et al., 2017). Without sufficient background information, it cannot be confirmed 
whether any cognitive difficulties found represent the direct impact of anti-NMDAR on 
cognitive functioning. Furthermore, often participants acted as their own control, with repeated 
testing, but sufficient discussion was not given to a host of other possible extraneous variables. 
For example, whether there were practice effects, how the participant presented on that day, 
whether the same test conditions were in place each time, and whether the same person 
administered the battery each time. If test scores did differ across administrations, it would be 
difficult to attribute this entirely to a change in cognitive functioning.  
The reporting of the scores was typically weak, often with a mixture of raw scores and 
index scores within the same articles’ results section, and little discussion of whether a change 
in scores across administrations reflected clinically significant change (for example, Martin-
Monzon et al., 2012). Half of the studies were single case studies or series and so only offer 
limited insight into how cognitive difficulties may present in people with anti-NMDAR. The 
chronic cognitive deficits discussed in this study have increased generalisability due to the 
larger case studies included (Finke et al., 2012; Finke et al., 2013; McKeon et al., 2016; N=40) 
and so provide greater evidence of the chronic cognitive effects of anti-NMDAR. This is 
promising given that chronic effects of anti-NMDAR are arguably more pertinent to investigate 
due to their potential impact on important aspects of day-to-day functioning, such as return to 
work.  
Despite the potential for cognitive functioning to impact day-to-day functioning, this 
remained largely unexamined in the current papers. Furthermore, the meaning the individuals 
then ascribed to their level of participation, and overall quality of life (QoL), remained equally 
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unexamined. The latter is important to assess given the mixed findings in other neurological 
conditions of the impact of cognitive functioning on QoL (Baumstarck-Barrau et al., 2011; 
Benedict et al., 2005; Dijkers, 2004; Glanz et al., 2010; Goretti et al., 2010; Ponsford et al., 
2008; Siponkoski et al., 2013; Tate et al., 2005). In a study of 109 encephalitis survivors 
Ramanuj et al., (2014) found that a poor Glasgow Outcome Score was the most strongly 
associated with a poor Health Related QoL (HRQoL). Further, that less than half of participants 
who made a ‘good’ recovery reported a HRQoL equivalent to the general population (Ramanuj 
et al., 2014). This suggests that the impact of encephalitis had adverse effects on many 
survivors’ QoL. However, these patients did not undergo neuropsychological testing, so the 
direct impact of cognitive functioning on QoL cannot be discussed. In the current reviewed 
articles, subjective complaints were only stated in five of the ten papers, and were usually 
reported in table form or only briefly in the main body. Furthermore, only Bach (2014) 
administered a formal measure, finding significant increases in satisfaction at follow-up on the 
QOLIBRI-OS (von Steinbuechel et al., 2012).  
Psychological wellbeing was also only explored in four of the ten articles. This is 
significant given that if individuals perceive themselves to have cognitive difficulties, and feel 
they impact on their participation in their usual day-to-day life, this would likely cause anxiety 
and interact with the person’s ability to engage meaningfully in neuropsychological assessment 
(Lezak, 2004 p. 127). Researchers who did assess psychological wellbeing largely 
administered either the Hospital Anxiety and Depression Scale (Snaith, 2003) or the Beck 
Anxiety and Depression Inventories (Beck 1990; 1996). Only two articles (Bach, 2014; 
McKeon et al., 2016) discussed the impact of mood on functioning and QoL, either in the 
results section or discussion. Specific psychosocial difficulties such as the individual’s 
reconstruction of their identity (Charmaz, 1983; 2000), were also not explored in these articles, 
or any other articles on anti-NMDAR encephalitis to date. 
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A specific battery of cognitive assessments has not yet been devised to screen for 
cognitive deficits in anti-NMDAR (Bornstein, 1990). As discussed, whilst there were overlaps 
between tests used across the studies, there was disparity between the cognitive domains tested 
and which tests were used to examine performance in these domains (Appendix F). Instead a 
‘scattergun’ approach appears to have been used, often with an extensive neuropsychological 
battery administered to see if any impairments can be detected. However, this approach can 
lead to Type I errors (Schatz et al., 2005). An exception to this was Finke et al., (2012) who 
reported that they conducted a neuropsychological assessment using memory tasks they 
claimed had previously been shown sensitive to hippocampal dysfunction.  
Ecological validity of the neuropsychological assessments used was also not discussed, 
which is important given most tests used were not specifically designed to predict real-life 
functioning, such as the ability to live independently or return to work (Chaytor & Schmitter-
Edgecombe, 2003; Sbordone, 2001). In these tests, the real-world context is removed and can 
be completed with few distractions, giving an artificial performance. As such the verisimilitude 
and veridicality approaches should be considered in future research (Spooner & Pachana, 
2006).  
Selection bias was evident across articles as patients typically recruited to the studies 
were opportunistically sampled from referrals to neurology or neuropsychology departments. 
Participants may have been chosen if their presentation was particularly unique (Barić, 
Andrijašević, & Beydoun, 2013; Rison, 2013; Rison, Shepphird, & Beydoun, 2016; Wong, 
2008), which may skew the cognitive profile detected for this population.  
 
2.5.5 Suggestions for theory and further research 
There is an overall lack of research into the neuropsychological sequelae of anti-NMDAR 
encephalitis and larger case studies are warranted to develop a more robust cognitive profile 
! 30!
for this population. Chronic cognitive deficits have been found in seven articles, with two 
studies reporting difficulties up to six and a half years after onset (Martin-Monzon et al., 2012; 
Finke et al., 2013). Therefore, longitudinal neuropsychological testing would be recommended. 
Professional consensus on a neuropsychological battery, grounded in 
neuropsychological theory, is needed to reduce the number of extraneous variables and provide 
replicability and generalisability. In their case series of three adolescents, Hinkle et al., (2016) 
concluded with the recommendation that batteries that formally assess memory, executive 
functioning, as well as language and attention, may be the most sensitive in identifying the 
common cognitive sequelae in anti-NMDAR. However, further professional opinion is needed 
regarding an appropriate battery. 
 Larger scale research projects would also help reduce selection bias and extraneous 
variables and would enable a more scientific approach to developing a cognitive profile for this 
population, rather than opportunistic sampling. Furthermore, careful consideration should be 
given to the utility and ethics of performing neuropsychological tests in clinical settings and 
how these results are fed back to patients (BPS, 2009; Monden, Gentry, & Cox, 2016). 
A small number of studies (N=5) have begun investigating the benefits of 
neurorehabilitation, however, further larger scale studies are needed for the anti-NMDAR 
group. Gracey, Evans and Malley (2009) propose a Y-shaped model for rehabilitation in ABI, 
which identifies key discrepancies, such as between pre-injury and current self, and suggests 
how these could be targeted in rehabilitation. A model such as the Y-Shaped could be a useful 
tool for application with people with an ABI as a result of anti-NMDAR.  
Anti-NMDAR is a relatively newly categorised illness (Dalmau et al., 2007) and as 
such so far there has been a focus on the medical understanding of the illness, with increasing 
drive towards neuropsychological understanding. However, taking into consideration the 
biopsychosocial approach, there is a need for understanding the psychological and social 
! 31!
factors associated with the illness, as well as the biomedical, and the interactions between all 
three (Gracey, Evans & Malley, 2009). Understanding the impact of this illness on QoL is 
crucial if health care professionals aim to provide person-centred care and improve the 
wellbeing of people diagnosed with anti-NMDAR. As such, there needs to be a focus on the 
personal meaning of the illness for the individual (Gracey, Evans & Malley, 2009).  
 
2.5.6 Conclusions 
A systematic review of the current literature suggests that the neuropsychological sequelae for 
anti-NMDAR encephalitis can include memory impairments, particularly delayed verbal 
memory; executive dysfunction and attentional/processing speed difficulties in the acute phase. 
However, further high quality studies are needed in this area to form a more substantial 
cognitive profile for this population. Psychological studies into this client group are so far 
absent and as such studies investigating patient experience of the illness and its impact on 
quality of life should be undertaken in the first instance.  
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           2.7 Appendices 
 
           Appendix A: Table of study characteristics 
 
           Study Setting Participant 
information 
Treatment/Rehabilitation 
as stated by the articles 
Study or Series 
and Time points 
assessed (post 
symptom 
onset/diagnosis) 
Domains assessed 
(as reported by 
articles) 
Cognitive 
domains deficit 
found 
Quality 
rating 
            Finke 
            et al., 
           (2012) 
Participants recruited 
from the Department 
of Neurology, 
University Hospital, 
Germany 
Participants: 
Eight female, 
1 male (mean 
age 28.4 years, 
range 21–44 
years) 
Matched 
controls: 12 
healthy 
subjects 
without a 
history of 
neurological 
or psychiatric 
disorders who 
were matched 
for sex, age 
and 
Five patients received 
first-line 
(immunotherapies 
including corticosteroids, 
intravenous 
immunoglobulin or both) 
during first 3 months of 
the disease, three patients 
received immunotherapy 
later in course of disease 
and one did not receive 
immunotherapy. One 
patient received second-
line immunotherapy with 
methotrexate for 5 years. 
Two patients, ovarian 
teratomas were found and 
removed surgically. No 
rehabilitation. 
Case study 
 
Median 43 months 
after disease onset. 
Range 23-69 
months. 
Perceptual 
organisation; 
attention; 
processing speed; 
verbal and non-
verbal short-term 
memory; working 
memory, verbal and 
non- verbal episodic 
memory; executive 
functioning; general 
intellectual abilities  
 
Working memory, 
episodic memory, 
delay-dependent 
deficits in STM 
tasks; executive 
functioning; 
attention 
18 
Medium 
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educational 
level  
 
         Martin- 
        Monzon  
            et al.,  
           (2012) 
Patient sent for 
neuropsychological 
testing following 
admission to the 
Department of 
Neurology, at the 
Virgen del Rocío 
Hospital (Seville)  
One female 
(aged 35) 
Treatment with steroids, 
intravenous 
immunoglobulins, 
azathioprine, plasma 
exchange and 
cyclophosphamide. 4 
relapses despite of 
adequate treatment. 
Neurorehabilitation over a 
period of 6 years. 
Case series. 
Tested at 6, 12, 72 
months after 
disease onset. 
Orientation; general 
cognitive functions; 
verbal and figural 
short- and long-term 
memory; frontal 
executive functions; 
language; 
visuospatial 
cognition; 
motor skills  
STM, 
anterograde, 
declarative 
memory; 
executive 
functioning; 
attention; 
visuoperceptive 
16 
Medium 
            Finke 
            et al.,  
           (2013) 
Patients were 
recruited in 
Germany and 
Austria between July 
2011 and July 2012 
and were referred to 
the outpatient clinic 
of the Department of 
Neurology of 
Charite Universit, 
Berlin for further 
counseling and 
treatment.  
Participants: 
21 females, 3 
males (mean 
age 27.9 
years) 
Matched 
controls: 21 
females, 3 
males (mean 
age 28.0 
years). 
Immunotherapy reported, 
not specified. No 
rehabilitation. 
Neuropsychological 
battery completed after the 
acute phase.  
Case study. 
Mean 33 months 
(median 35 
months, range 9-72 
months). 
Calculated by the 
first author from 
the reported time 
between first 
symptoms and 
imaging. Working 
on the assumption 
neuropsychological 
testing would have 
been performed 
Verbal memory; 
non-verbal short-
term memory; 
working memory; 
verbal and non-
verbal episodic 
memory; executive 
functioning; 
premorbid 
intelligence 
quotient; general 
intellectual abilities  
 
Working memory, 
verbal LTM; 
executive 
functioning 
14 
Medium 
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around the same 
time. Finke et al., 
reported “Twenty-
four patients with 
anti-NMDAR 
encephalitis after 
the acute stage of 
the disease were 
studied” 
        Marcos- 
         Arribas 
            et al.,  
           (2013) 
Patient sent for 
neuropsychological 
testing following 
admission to the 
Neurology 
Department, 
Hospital Clínico San 
Carlos, Madrid, 
Spain  
 
One female 
(aged 24) 
Neuropsychological 
battery completed on 
admission. The patient 
underwent surgery within 
7 days since admission and 
the diagnosis of mature 
ovarian teratoma was 
confirmed by pathology 
studies. Then nine 
alternate days sessions of 
plasmapheresis were then 
started. After one month 
the neuropsychological 
battery was repeated. No 
rehabilitation.  
Case series: Tested 
at symptom onset 
& 1 month from 
symptom onset 
Short-term memory; 
working memory; 
attention; semantic 
and episodic 
memories, 
visuospatial, 
praxical, thinking 
and language 
functions.  
Short term verbal 
& visual memory; 
retrograde 
amnesia of 2 
months; attention 
14 
Medium 
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          Vahter  
            et al.,  
           (2014) 
Patient sent for 
neuropsychological 
testing following 
admission to the 
Department of 
Neurology, West-
Tallinn Central 
Hospital, Estonia. 
One female 
(aged 29) 
Immunotherapy with 
plasma exchange, 
intravenous IgG, followed 
later by 
cyclophosphamide. 
Neuropsychological 
testing throughout acute 
period. No rehabilitation. 
 
Case series. Tested 
4 times at 
symptom onset, 8 
months, 12 
months, 20 months 
after symptom 
onset 
 
Verbal memory; 
visuospatial 
memory; logical 
memory; executive 
functioning; 
information 
processing speed; 
verbal fluency; 
visuoconstructive 
abilities 
Long term verbal 
memory; 
executive 
functioning; 
attention; 
language; 
visuoconstructive 
11 
Low 
             Bach  
           (2014)  
Participants referred 
to the Specialist 
Acquired Brain 
Injury Unit Outreach 
Team (community 
rehabilitation team), 
London.  
Two female 
participants 
(aged 24 and 
23) 
Surgery (one patient) 
plasma exchange and 
course of intravenous 
immunoglobulin. Outreach 
Team for further 
management and 
rehabilitation. 
 
Case study.  
Tested 
approximately 6 
months after 
symptom onset. 
Determined from 
the narrative 
description of the 
cases.  
Verbal memory; 
working memory; 
immediate memory; 
delayed memory; 
perceptual 
organisation; verbal 
fluency; attention; 
executive 
functioning; 
processing speed 
Memory (long 
term verbal 
memory), 
working memory, 
STM; executive 
functioning; 
attention; 
language; social 
cognition 
13 
Medium 
       Loughan 
            et al.,  
           (2016) 
Participant referred 
for 
neuropsychological 
evaluation, 
Department of 
Neurology, USA 
One male 
participant 
(aged 42) 
 
Plasmapheresis, IV 
steroids, Rituximab, 
Cyclophosphamide. 
Inpatient rehabilitation for 
two months. 
Neuropsychological 
testing completed once 
Case study. Tested 
6 months post 
diagnosis 
Working memory; 
verbal fluency; 
global ability; 
attention; effort; 
executive 
functioning; verbal 
comprehension; 
perceptual 
Verbal memory; 
executive 
functioning; 
attention; 
processing speed; 
language 
24 
High 
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discharged.  
 
reasoning; verbal 
memory; visual 
memory; immediate 
memory; delayed 
memory 
        McKeon  
            et al., 
           (2016) 
Participants recruited 
via Queensland-
based physicians to 
Neuropsychology 
Research Unit, 
Australia  
Participants: 6 
females, 1 
male (mean 
age, 26.4 
years; range, 
16–37 years) 
Matched 
controls: 10 
females, 4 
males (mean 
age, 25.8 
years; range, 
16–38 years) 
without 
significant 
psychiatric or 
neurological 
histories 
Four patients (P2, P3, P6, 
P7) received 
immunotherapy within a 
month of symptom onset, 
and had not relapsed. The 
remaining three patients 
(P1, P4, P5) had lengthy 
psychiatric histories and 
comparatively poorer 
response to 
immunotherapy. No 
rehabilitation. 
 
Case study. Tested: 
Mean 19 months 
(median 22.5 
months; range 7-41 
months). 
Calculated by the 
first author from 
estimated time 
between treatment 
completion & 
neuropsychological 
assessment and 
mean 23 months 
(median 20 
months, range 4-35 
months). As 
calculated from 
estimated time 
between treatment 
initiation & current 
assessment. 3 
patients had 
treatment ongoing 
Episodic memory; 
semantic memory; 
language; auditory 
short term memory; 
working memory; 
attention; 
processing speed; 
executive 
functioning  
Verbal & visual 
episodic memory, 
verbal STM, 
working memory; 
executive 
functioning; 
attention; 
processing speed; 
visuospatial 
organisation; 
social cognition 
20 
Medium 
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at time of testing 
due to residual 
symptoms.  
       Urakami 
           (2016) 
Participants 
undergoing 
rehabilitation at the 
National 
Rehabilitation 
Center for Persons 
with Disabilities, 
Japan  
One male, five 
female 
participants 
(mean age 
33.3 years; 
 range 20 to 47 
years)  
 
Corticosteroids, 
intravenous 
immunotherapy (IVIg) and 
appropriate ovarian 
teratoma removal. 
Rehabilitation of 6 months 
approximately. 
Neuropsychological 
testing both before and 
after neurorehabilitation.  
Case series. Tested 
twice. Mean 6 
months after onset 
of symptoms 
(calculated by the 
first author from 
Table 1) and after 
rehabilitation 
(interval between 
start & end of 
rehab=mean 184.8 
days).  
Attention, verbal 
and non-verbal 
short-term and 
working memory, 
executive 
functioning; general 
intellectual abilities  
 
Working memory, 
verbal memory, 
visual memory; 
attention; 
processing speed 
14 
Medium 
          McIvor  
       & Moore  
           (2017) 
Participant referred 
to Department of 
Clinical 
Neuropsychology, 
The Walton Centre 
NHS Foundation 
Trust, Liverpool 
One male 
participant 
(aged 19) 
No treatment or 
rehabilitation. Spontaneous 
recovery assessed.  
Case series. An 
untreated case 
tested three times 
over 30 months. 
Delayed memory; 
immediate memory, 
visual memory; 
visual working 
memory; auditory 
memory; executive 
functioning; pre-
morbid functioning 
STM, auditory 
memory, delayed 
memory 
19 
Medium 
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Appendix B: Instruction sheet for quality assessment tool 
 
Quality Assessment Tool for Neuropsychological Case Studies/Series (QATNCSS) 
Instruction sheet  
 
 
Accompaniments to this sheet: 
 
a)! Quality assessment tool 
b)! Scoring grid to enable you to record the scores for each paper against the criteria. 
 
 
Eligibility criteria for papers: 
 
1.! Original research papers for inclusion into a systematic review  
2.! Study design must be either a single/multiple neuropsychological case study or series 
 
Method: 
 
Scoring the studies: 
 
1.! Read through the research paper carefully 
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2.! There are 26 quality criteria in the tool 
3.! Read each of the criteria and score from 0, 1, 2 or 3 (depending on the question) to obtain each score.  
4.! This will result in a score out of a maximum of 33 
5.! There are interpretations for the criteria at the end of this document 
 
 
Heuristics for overall quality: 
 
0-11 = low quality 
12-22 = medium quality 
23-33 = high quality 
 
Scoring instructions: 
 
Basic information 
 
A.! Participant information 
This is based on whether the information is or is not present. For multiple cases this information should be presented for all participants 
 
B.! Diagnosis of anti-NMDAR 
Score two if the authors give details about how the diagnosis was given 
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C.! Number of cases studied 
Score zero if one case is studied, one if more than one participant is studied and two if more than 10 participants are studied. 
 
D.! Time since diagnosis/initial onset 
Time since diagnosis needs to be stated for all participants. This needs to be clearly stated either in the main body or table form and not 
left to the reader to extrapolate the time since diagnosis from additional background information. 
 
E.! Treatment e.g. Rituximab 
This should be clearly stated for each participant.  
 
F.! Current medication 
This should be clearly stated for each participant.  
 
G.! Psychoactive medication at time of testing (e.g. anti-psychotic, anti-depressant, steroid, opiate)  
This should be clearly stated for each participant.  
 
 
Participant background information 
 
H.! Previous psychiatric disorder  
This should be clearly stated for each patient. This should be separate from discussion of the psychiatric symptoms that may have presented 
in the initial stages of the illness. 
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I.! Learning disability 
This should be clearly stated for each participant.  
 
J.! Congenital or previous neurological conditions, including brain injury, epilepsy 
There should be discussion of whether there was any other illness or injury that may have caused acquired brain injury to the participant 
and if so relevant details given. This should be discussed in respect of all participants.   
 
K.! Current level of pain 
Pain should be discussed, such as any, side effects of current treatments/medications (for example, Rituximab or corticosteroids) known to 
cause pain in some instances; pain from surgery (for example, tumour resection) or any pain from another cause not related to anti-
NMDAR.  
 
L.! Educational attainment  
This should be mentioned either participant by participant or in reference to matching with a control group, for example ‘all participants 
were matched for educational level’. This is to ensure that educational attainment was considered by the researchers with regards impact 
on scores and tests that are compared to a normative sample.  
 
M.!Substance/alcohol misuse 
This should be clearly stated for each participant.  
 
N.! Participant/Informant perspective on cognitive functioning  
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There should be either the participant’s or an informant’s perspective on the participants cognitive functioning discussed qualitatively. A 
higher score is not given if both perspective is given, as an informant may not have been present/available.  
 
O.! Level of distress e.g. depression or anxiety 
Score one if details are given regarding the participant’s qualitative views on their mood, or if an appropriate scale is used, such as the 
HADS. Score two if both are stated. This should be separate from the discussion around their psychiatric symptoms and mood during the 
acute phase. It should only relate to current mood.  
 
 
Neuropsychological testing procedure 
 
P.! Compared to a control group 
Score one if the participant group are compared to a control group in any form. However, qualitatively it should be noted whether these 
groups were adequately matched on factors such as age, sex, educational level.  
 
Q.! Pre-morbid test of intelligence 
Scores for all participants on a validated test such as the TOPF should be clearly stated.  
 
R.! Effort test 
Scores for all participants on a validated test such as the TOMM should be clearly stated.  
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S.! Full test battery completed, covering main cognitive domains (perception; attention; memory and learning; executive function; and 
language) 
No points should be given if an abbreviated test is administered such as the RBANS. One point should be given if only some cognitive 
domains are tested such as memory alone. Score two if more than one cognitive domain is tested. Note qualitatively whether adequate 
justification has been given to choice of tests.   
 
T.! Repeated testing 
Score one if the battery is repeated more than once; score two if it is administered more than twice.  
 
U.! Replicable detail  
The exact tests used and the procedure of the testing should be clearly stated in the methods section and/or in relevant tables. Any 
researcher should be able to easily replicate administration of the assessment on other cases.  
 
V.! Neuropsychological tools used specific to the language and culture of the participants 
All tests will be assumed to be administered in the appropriate first language of the participant, unless stated otherwise.   
 
W.!Practise effects considered  
This refers to practise effects both within the same neuropsychological battery, for example when multiple tests assessing the same cognitive 
domain are administered, and/or practise of the same tests over repeated testing. 
 
Recovery reported: 
X.! Qualitatively 
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Score one if either the participant, informant or clinicians qualitative view of recovery is reported. A score of three is not offered if all 
three views are discussed as an informant may not have been available.  
Y.! Quantitatively 
Score one if any appropriate quantitative measures have been administered to measure recovery, such as the FIM/FAM, to all participants.  
 
Z.! Neuropsychological assessment informed an intervention/recommendations 
Score one if an intervention/s were either recommended or put into place, such as a neurorehabilitation programme. Or if recommendations 
for clinical practice are suggested.  
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Appendix C: Quality Assessment Tool for Neuropsychological Case Studies/Series (QATNCSS) 
 
 
Basic information 
 
A.! Participant information 
0 = Not reported     
1 = Age and gender reported 
 
B.! Diagnosis of anti-NMDAR 
0 = Not stated   
1 = Stated 
2 = Stated and means of diagnosis given e.g. CSF/serum testing 
 
C.! Number of cases studied 
0 = 1   
1 = > 1 
2 = > 10 
 
D.! Time since diagnosis/initial onset 
0 = Not reported 
1 = Reported 
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E.! Treatment e.g. Rituximab 
0 = Not specified 
1 = Specified 
 
F.! Current medication 
0 = Not reported  
1 = Reported 
 
G.! Psychoactive medication at time of testing (e.g. anti-psychotic, anti-depressant, steroid, opiate)  
0 = Not reported  
1 = Reported 
 
 
Participant background information 
 
H.! Previous psychiatric disorder  
0 = Not reported 
1= Reported 
 
I.! Learning disability 
0 = Not reported 
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1= Reported 
 
J.! Congenital or previous neurological conditions, including brain injury, epilepsy 
0 = Not reported 
1= Reported 
 
K.! Current level of pain 
0 = Not reported 
1= Reported 
 
L.! Educational attainment  
0 = Not reported  
1 = Reported 
 
M.!Substance/alcohol misuse 
0 = Not reported 
1= Reported 
 
N.! Patient/Informant perspective on cognitive functioning  
0 = Not reported  
1 = Reported 
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O.! Level of distress e.g. depression or anxiety 
0 = Not assessed  
1 = Assessed qualitatively 
2= Assessed using self-rating scales  
3= Assessed both, qualitatively and self-rating scales 
 
Neuropsychological testing procedure 
 
P.! Compared to a control group 
0 = No  
1 = Yes 
 
Q.! Pre-morbid test of intelligence 
0 = No 
1 = Yes  
 
R.! Effort test 
0 = Not administered 
1 = Yes, standardised measure used (e.g. TOMM) 
 
S.! Neuropsychological battery covering main cognitive domains (perception; attention; memory and learning; executive function; and 
language) 
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0 = No, only abbreviated/screen test used 
1 = Only one domain tested 
2 = >1 domain tested 
 
T.! Repeated testing 
0 = No repeat reported 
1 = Repeated once more 
2 = Repeated twice or more 
 
U.! Replicable detail  
0 = Could not easily replicate 
1 = Easily replicable 
 
V.! Neuropsychological tools used specific to the language and culture of the participants 
0 = No 
1 = Yes 
 
W.!Practise effects considered  
0 = No  
1 = Yes  
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Recovery reported: 
X.! Qualitatively 
0 = No  
1 = Yes, Participants’ perspective on recovery 
1 = Yes, Responsible clinician’s perspective of recovery 
1 = Yes, Informant’s perspective on recovery 
2 = Yes, a combination of the above 
Y.! Quantitatively 
0= No  
1= Yes, appropriate scales administered (such as QoL measure, FIM/FAM scores, modified Rankin Scale) 
 
Z.! Neuropsychological assessment informed an intervention/recommendations 
0 = No  
1 = Yes 
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Appendix D: QATNCSS scoring table with second raters scores 
 
 
 
Study number 
 
 QATNCSS criteria item 1 2 3- 
Finke 
13 
4 5-Marcos 6-
Martin 
7 8-
McKeon 
9 10- 
Vahter 
                
A Participant information 
 
  1   1 1  1  1 
B Diagnosis of anti-NMDAR 
 
  2   2 1  2  2 
C Number of cases studied 
 
  2   1 1  2  0 
D Time since diagnosis/initial onset 
 
  1   1 1  0  1 
E Treatment e.g. Rituximab 
 
  1   1 1  1  1 
F Current medication 
 
  0   1 0  0  0 
G Psychoactive medication at time of testing 
 
  0    0 0  0  0 
H Previous psychiatric disorder 
 
  0   0 0  1  0 
I Learning disability 
 
  0   0 0  0  0 
J Congenital or previous neurological conditions 
 
  0  1 0  1  0 
K Current level of pain 
 
  0  0 0  0  0 
L Educational attainment  
 
  0  1 1  0  1 
M Substance/alcohol misuse   0  1 1  0  0 
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N Patient/Informant perspective on cognitive functioning  
 
  0  0 0  0  0 
O Level of distress e.g. depression or anxiety 
 
  0  0 0  2  0 
P Compared to a control group 
 
  1  0 0  1  0 
Q Pre-morbid test of intelligence 
 
  1  0 0  1  0 
R Effort test 
 
  1  0 0  1  1 
S Neuropsychological battery covering main cognitive domains 
 
  2  2 2  2  2 
T Repeated testing 
 
  0  1 1  0  2 
U Replicable detail  
 
  1  1 1  1  1 
V Neuropsychological tools used specific to the language and culture of the 
participants 
 
  0  0 0  0  0 
W Practise effects considered  
 
  1  1 0  1  0 
X Recovery reported-Qualitatively 
 
  0  1 0  1  1 
Y Recovery reported- Quantitatively  
 
  0  0 0  1  0 
Z Neuropsychological assessment informed an intervention 
 
 
  0  0 1  0  0 
Total    14 
Med 
 16 
Med 
12 
Med 
 19 
High 
 13 
Med 
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Appendix E: Table of study quality ratings 
Study A B C D E F G H I J K L M N O P Q R S T U V W X Y Z TOTAL 
Finke et 
al., 
(2012) 
1 2 2 1 1 0 0 0 0 1 0 0 0 1 2 1 1 1 2 0 1 0 1 1 0 0 18 
Med 
Martin-
Monzon 
et al., 
(2012) 
1 2 0 1 1 1 0 1 0 1 0 1 1 0 0 0 0 2 2 1 0 0 0 1 0 0 16 
Med 
 
Finke et 
al., 
(2013) 
1 2 2 1 0 0 0 0 0 0 1 0 0 0 0 1 1 1 2 0 0 0 1 1 0 0 14 
Med 
Marcos-
Arribas 
et al., 
(2013) 
1 2 0 1 1 1 1 1 0 1 0 0 1 0 0 0 0 1 1 1 0 0 0 1 0 0 14 
Med 
Vahter et 
al., 
(2014) 
1 2 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 1 2 0 0 0 0 2 0 0 11 
Low 
 
Bach 
(2014) 
1 1 1 1 0 0 0 0 0 0 0 0 0 0 2 0 0 0 2 0 1 0 1 1 1 1 13 
Med 
Loughan 
et al., 
(2016) 
1 2 0 1 1 1 1 1 0 1 1 1 1 1 3 0 1 1 2 0 1 0 1 1 0 1 24 
High 
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McKeon 
et al., 
(2016) 
1 2 2 1 1 1 0 0 0 1 0 0 0 1 3 1 1 1 2 0 1 0 0 1 1 0 21 
Med 
Urakami 
(2016) 
1 2 2 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 2 1 1 0 0 1 0 1 14 
Med 
McIvor 
& Moore 
(2017) 
1 2 0 1 1 1 1 0 0 1 0 0 0 1 0 0 1 0 2 2 1 0 1 1 0 0 19 
Med 
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Appendix F: Table of tests used by each study 
Cognitive function Tests used Cognitive function Tests used 
    
Verbal memory  Attention & Processing 
Speed 
 
Loughan et al., (2012) RBANS: 
List learning & Recall  
Story Memory & Recall  
Loughan et al., (2012) TMT: 
Part A & B 
Finke et al., (2012) RAVLT Finke et al., (2012) TAP 
Martin-Monzon et al., 
(2012) 
WMS III: 
Logical Memory 
Selective Reminding test  
Martin-Monzon et al., 
(2012) 
TMT: 
Part A 
WAIS-III:  
Digit Symbol-Coding  
Finke et al., (2013) RAVLT Finke et al., (2013) None named 
Marcos-Arribas et al., 
(2013) 
WMS-III: 
Logical Memory I & II  
Verbal Paired Associates I & II 
Word Pairs I & II 
Letter-Number Sequencing 
Marcos-Arribas et al., 
(2013) 
WAIS-III:  
Digit Symbol-Coding 
Bach (2014)  WMS-IV: Bach (2014)  TMT: 
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Logical Memory I Part A & B 
Vahter et al., (2014) WMS?: 
Verbal memory (assume all subtests) 
Buschke selective verbal memory, 
controlled long-term retrieval, long-term 
storage & later recall 
Vahter et al., (2014) TMT: 
Part A & B 
McKeon et al., (2016) WMS IV: 
Logical Memory I & II  
Verbal Paired Associates I & II  
McKeon et al., (2016) Digit Span Forwards Visual Scanning Time 
Letter Sequencing Time Number 
Sequencing Time Motor Speed Time Colour 
Naming Time Word Reading Time  
PRP Paradigm 
SART 
Urakami (2016) WMS-R (assume all verbal memory 
subtests) 
Urakami (2016) WAIS-III: 
Coding 
Symbol search  
McIvor & Moore 
(2017) 
WMS IV: 
Logical Memory I & II  
Verbal Paired Associates I & II 
McIvor & Moore (2017) None 
Cognitive function Tests used Cognitive function Tests used 
    
Visual memory  Executive function  
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Finke et al., (2012) ROCFT: 
Copy, Delayed & Recall 
Finke et al., (2012) BADS 
Stroop Test 
Tower of London 
Loughan et al., (2012) RBANS: 
Figure Copy & Recall 
Loughan et al., (2012)  D-KEFS 
Martin-Monzon et al., 
(2012) 
ROCFT: Immediate & Delayed recall  
WAIS-III: 
Design Immediate recall & Delayed recall  
Martin-Monzon et al., 
(2012) 
WAIS-III Matrix Reasoning 
TMT: Part B 
Stroop Colours and words 
Verbal fluency  
Wisconsin Categories 
Marcos-Arribas et al., 
(2013) 
ROCFT: 
Immediate & Delayed recall 
Marcos-Arribas et al., 
(2013) 
None  
Finke et al., (2013) None Finke et al., (2013) Stroop test 
Computerised go=no-go test 
Semantic fluency 
Bach (2014)  None Bach (2014)  BADS: 
Rule Shift 
Action program 
Key search 
Temporal Judgement 
Zoo map 
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Modified six elements  
Vahter et al., (2014) Visual Spatial Memory: Immediate & 
 Delayed recall  
Vahter et al., (2014) Clock drawing 
McKeon et al., (2016) ROCFT: 
Immediate, Delayed & Recall 
McKeon et al., (2016) D-KEFS: 
TMT 
Tower Test  
Verbal Fluency 
Proverbs Test 
Inhibition Test (Stroop Test) 
Inhibition/ Switching Test 
Hayling Test 
Urakami (2016) WMS-R: 
Visual memory (assume all subtests) 
Urakami (2016) None  
McIvor & Moore 
(2017) 
WMS-IV: 
Visual reproduction I & II  
McIvor & Moore (2017) D-KEFS: 
TMT 
Verbal Fluency Test  
Cognitive function Tests used Cognitive function Tests used 
    
Working memory  Visuospatial ability  
Loughan et al., (2012) WAIS-IV: 
Digit Span 
Loughan et al., (2012) WAIS-IV: Block design 
RBANS: Figure Copy 
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Arithmetic 
Finke et al., (2012) WAIS-IV: 
Digit Span 
Block Span 
Finke et al., (2012) ROCFT: Copy 
Martin-Monzon et al., 
(2012) 
WAIS-III: 
Digit Symbol Coding 
Digit Span backwards  
Letter Number Sequencing 
Arithmetic  
Martin-Monzon et al., 
(2012) 
Benton Visual Form Discrimination Test  
WAIS-III: Picture Completion 
Marcos-Arribas et al., 
(2013) 
WMS-III: 
Letter-Number Sequencing 
WAIS-III:  
Digit span 
Marcos-Arribas et al., 
(2013) 
ROCFT: Copy 
Finke et al., (2013) (WAIS?): Digit span backwards  Finke et al., (2013) ROCFT: Copy 
Bach (2014)  WAIS-IV: 
Digit Span 
Bach (2014)  None 
Vahter et al., (2014) None Vahter et al., (2014) Clock drawing 
McKeon et al., (2016) WAIS-IV: 
Digit Span 
McKeon et al., (2016) ROCFT: Copy 
Urakami (2016) WAIS-III & WMS-R (assume digit span, 
arithmetic, symbol & spatial span) 
Urakami (2016) WAIS-III (assume block design) 
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McIvor & Moore (2017) WMS-IV: 
VWMI- Spatial Addition 
& Spatial Span  
McIvor & Moore 
(2017) 
None  
Cognitive function Tests used   
    
Social Cognition    
Bach (2014)  No tests; A 10 item 
questionnaire to assess 
ability to understand 
other’s mental states and 
general social cognition 
  
McKeon et al., (2016) Mind in the Eyes Test  
Advanced ToM Test 
Social Situations Test 
Emotion Attribution 
Task 
  
WMS-R/III/IV (Weschler Memory Scale Revised/Third/Fourth Edition); WAIS III/IV (Weschler Adult Intelligence Scale Third/Fourth Edition); TMT (Trail Making Test); ROCFT (Rey-
Osterrieth Complex Figure Test); RAVLT (Rey Auditory Verbal Learning Test); RBANS (Repeatable Battery for the Assessment of Neuropsychological Status); DT-VMI (Beery-Buktenica 
Developmental Test of Visual-Motor Integration); DTVP (Beery-Buktenica Developmental Test of Visual Perception); DKEFS (Delis-Kaplan Executive Function System); TOL (Tower of 
London test); BADS (Behavioural Assessment of the Dysexecutive Syndrome); TAP (Test battery for the assessment of attention) 
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3.1 Abstract 
The aim of this study was to explore the experience of women diagnosed with anti-NMDAR 
encephalitis and the phenomenon of identity change. Eight women were interviewed; 
transcriptions were analysed with interpretative phenomenological analysis (IPA). Four 
superordinate themes were revealed ‘Re-finding the ‘normal’ self’; ‘A special identity’; 
‘Evolving from the illness’ and ‘Roles and identity’. Analysis revealed themes common to 
many severe physical illnesses such as not feeling oneself whilst unwell and moral and personal 
growth. However, themes emerged specific to anti-NMDAR such as feeling abnormal due to 
the rarity of the disease and its psychiatric symptoms, feeling viewed as special and concerns 
around fertility and motherhood.  This study represents the first psychological study into anti-
NMDAR encephalitis, and it is hoped will provide an initial base from which to build further 
research. 
 
Keywords: anti-nmdar; encephalitis; autoimmune; identity; experience; psychiatric 
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3.2 Introduction 
Anti N-methyl-D-aspartate receptor encephalitis (anti-NMDAR) is a rare form of autoimmune 
encephalitis, first officially categorised and named in 2007 (Dalmau et al., 2007). Psychiatric 
symptoms can be a large feature of the illness, with 77% of patients first assessed by a 
psychiatrist (Kuppuswamy, Takala, & Sola, 2014). However, whilst there are personal 
accounts of people’s experience of anti-NMDAR in the public domain, to date, there are no 
psychological studies investigating how people experience the illness and specifically its 
impact on identity.  
Anti-NMDAR is acute and often severe, caused by the body’s antibodies attacking the 
NMDA receptors in the brain (Dalmau et al., 2008). It has been found to be more common in 
young women, however its incidence and prevalence rates are yet to be fully established 
(Dalmau et al., 2011). Onset is often insidious with prodomic, flu/viral-like, symptoms, giving 
way to psychiatric symptoms, such as anxiety, mania, and paranoia (Dalmau et al., 2011). This 
is often followed by seizures, decreased level of consciousness, abnormal movements (such as 
orofacial/limb dyskinesias) and autonomic instability. All patients are treated with first-line 
immunotherapy, including corticosteroids, intravenous immunoglobulins or plasma exchange 
(Dalmau et al., 2011; Chen et al., 2016). Some patients, such as those with delayed diagnosis, 
will go on to receive second-line immunotherapy, such as Rituximab (Dalmau et al., 2011). 
Most patients fully recover or have mild medical sequelae, however some die or remain 
severely disabled (Dalmau et al., 2008; Titulaer et al., 2013). Tumour removal, if present, early 
diagnosis and treatment have been found to lead to better cognitive outcome (Finke et al., 
2012).  
There is a paucity of literature regarding cognitive difficulties associated with anti-
NMDAR. However, the number of neuropsychological/neurological case studies/series 
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published is gradually increasing, particularly within the adult population (for example, 
McKeon et al., 2016) but less so in the child/adolescent populations.  
Whilst there is increasing medical understanding of the pathology of anti-NMDAR and 
its prognosis and treatment, less has been examined regarding the beliefs people with anti-
NMDAR hold about this form of encephalitis. To date, insights into such health beliefs have 
come indirectly from anecdotal accounts (Brain On Fire: My Month of Madness, Calahan, 
2013), with limited discussion in the neuropsychological case studies/series (Bach, 2015; 
McKeon et al., 2016).  
Research investigating the psychological impact of other illnesses/conditions is well 
established, with identity being a prominent theme (Arroll & Howard, 2013; Medved & 
Brockmeier, 2008; Musser, Wilkinson, Gilbert, & Bokhour, 2015; Roger, Wetzel, Hutchinson, 
Packer, & Versnel, 2014). Research suggests illnesses are often associated with loss of self and 
reconstruction of a new self; changing life roles and contemplation of a new future; loss of self-
worth and post-traumatic growth (Arroll & Howard, 2013; Goodman et al., 2005; Gracey et 
al., 2008; Muenchberger, Kendall, & Neal, 2008; Preston, Ballinger, & Gallagher, 2014). 
Charmaz (1983) was one of the first researchers to describe a loss of self in people with chronic 
illnesses, who she asserts witness their former selves “crumbling away”. This is purported to 
be due to an inability to hold onto previously valued roles in life (Charmaz, 2000) and can also 
relate to experiencing stigma and shame around the illness (Arroll & Howard, 2013; Charmaz, 
1983, 2000). Bury (1982) conceptualised chronic illness as a ‘biographical disruption’ whereby 
an unwell person’s world is interrupted by the illness and everything they thought was certain 
about the world/their life is called into question. This is more recently conceptualised as a 
challenge to the assumptive world and related to illness intrusiveness (Devins, 2010). Nochi 
(1998) investigated identity in ten people who had sustained traumatic brain injury and found 
they experienced loss of self, for example, when comparing their present status with many 
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aspects of their past lives. Conversely, in another qualitative study of people who have suffered 
neurotrauma, Medved and Brockmeier (2008) asserted that participants emphasised an 
unbroken connection between their pre-and post-morbid lives. Faircloth et al., (2004), in a 
study with stroke survivors, also argued that biographical disruption is not the same for all 
people suffering with a chronic illness. They propose that people may give different meaning 
to the experience and ‘bracket off’ the effects of the stroke/chronic illness to maintain their 
sense of self pre-and post-stroke. The authors termed this ‘biographical flow’, other researchers 
have found several emergent strategies that enables this ‘flow’, such as humour and cognitive 
reframing (Roger et al., 2014). However, others take an intermediate stance, asserting that to 
suggest the self remains either completely lost or stable is too simplistic (Gelech & Desjardin, 
2011). Gelech and Desjardin (2011) found, in their qualitative study of four participants with 
ABI, that loss and negative change were fused with features of growth, stability and 
transcendence.  
Understanding the health beliefs of people diagnosed with anti-NMDAR is important 
for supporting both self-management and reconstruction or re-establishment of identity. 
Currently there are no studies primarily investigating this area. Therefore, the aim of this study 
was to explore the experience of women diagnosed with anti-NMDAR encephalitis and the 
phenomenon of identity change; whether anti-NMDAR is viewed by women as a disruption 
that has altered their sense of self, whether the self remains wholly intact or if there has been 
changes on facets of the self.  
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3.3 Method 
 
3.3.1 Methodology selection 
Interpretative Phenomenological Analysis (IPA) is a qualitative method with a focus on 
understanding the individual’s experience. It has been widely applied within health psychology 
to further understand individual experience of illness (Brocki & Wearden, 2007; Biggerstaff & 
Thompson, 2008; Smith, 2011). IPA was chosen due to the lack of psychological research in 
anti-NMDAR encephalitis. The first author’s perspective being that capturing individual illness 
representations and processes affecting identity would be a good basis from which to build 
further psychological research in this area. Furthermore, given that it provides a platform from 
which to hear individual voices, IPA is arguably in line with the drive within the National 
Health Service to acknowledge the service-user voice (Brocki & Wearden, 2007). 
 
3.3.2 Participant sampling 
A total of eight, international female participants (age range approximately 21-35) with a 
diagnosis of anti-NMDAR encephalitis were recruited (Table 1). Most recruitment (N=5) took 
place via a poster advertised on the Encephalitis Society, Research Currently Recruiting 
webpage. The remainder of the participants were recruited via snowballing (N=3). The 
inclusion criteria were women between the ages of 18 and 65 with a diagnosis of anti-NMDAR. 
Interested parties, who met these inclusion criteria, were invited to contact the lead author via 
email for more information. Information and consent forms were then emailed to the 
participants and interested parties completed and emailed them back to the researcher. Of all 
participants who expressed an initial interest, 42.11% were interviewed. An interview time was 
mutually agreed, due to the sample being largely international and time and budget constraints, 
face-to-face interviews were not feasible. Consequently, all interviews took place via Skype, 
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aside from one telephone interview when the participant did not have access to Skype. 
Guidance on using Skype for qualitative interviews was followed (Hanna, 2012; Seitz, 2016). 
Each interview lasted 60-90 minutes; the participants did not receive monetary compensation. 
Due to potential acquired brain injury (ABI) from the encephalitis, capacity to consent to 
participate, and for the interview to be recorded, was sought at the start of each interview, by 
assessing the participant’s understanding of the study and revisiting the details of the consent 
form. All participants were deemed to have capacity by the lead author at the time of the 
interview, in keeping with the terms of the Mental Capacity Act (2005). 
 
3.3.3 Ethics and Procedure 
Ethical approval was obtained from Cardiff university ethics board (EC.15.10.13.4209). 
Pseudonyms are used throughout and all identifiable information has been removed. A semi-
structured interview schedule (Appendix M) was created using guidelines from Smith, Flowers 
and Larkin (2009). A funnelling technique was employed, beginning with the set open 
questions. Reflection and summarising were used to clarify some of the participants’ 
viewpoints and experiences. The Common-sense Model of Illness Representation (Weinman, 
Petrie, Moss-Morris, & Horne, 1996) was used to help structure the schedule; to gain an overall 
understanding of the participants’ representations of the illness and its perceived impact on 
identity.  
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3.3.4 Analysis 
The eight transcripts were analysed for common themes, using guidelines for IPA (Smith, 
Flowers & Larkin, 2009). The transcripts were read multiple times and exploratory comments 
noted for each transcript, focussing on descriptive, linguistic and conceptual details (Smith, 
Flowers & Larkin, 2009). Emergent themes for each transcript were identified by the first 
author from the exploratory comments and grouped together into separate word documents 
 
Pseudonym Age Ethnicity 
Employment 
status Disability 
Time since 
diagnosis 
 
Rachel 26-30 Caucasian Part time Yes- cognitive >5 years 
Jane 26-30 Asian Unemployed No 1-11 months 
Natalie 31-35 Caucasian Unemployed No >5 years 
 
Laura 26-30 Caucasian Part time Yes- cognitive >8 years 
Sarah 26-30 Caucasian Full time No >6 years 
 
Katie 21-25 Caucasian Part time 
Yes-
combination >8 years 
 
Bridget 31-35 Caucasian Full time 
Yes-
combination >3 years 
 
Holly 31-35 Caucasian Part time 
Yes-
combination >2 years 
 
TABLE 1: Demographics Combination disability includes physical, cognitive, sensory, difficulties processing 
information, social, behaviour and emotional difficulties 
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for each transcript. Numbers were placed next to emergent themes that appeared to 
correspond to one another. Once the corresponding numbers were grouped a ‘working 
subordinate theme’ title was assigned to each number. This was repeated for each transcript. 
All ‘working subordinate themes’ across transcripts were analysed and refined into final the 
subordinate themes, via an iterative process of re-examination and discussion between co-
authors (Appendices N-R). Four superordinate themes were created from the eight 
subordinate themes using the processes of subsumption and abstraction; polarisation was also 
considered (Smith, Flowers & Larkin, 2009). Subordinate themes identified appeared in at 
least half of the participants’ transcripts, in keeping with guidance from Smith, Flowers & 
Larkin (2009). Rigour and quality of analysis was ensured via triangulation, transparency and 
bracketing (Yardley, 1997). The respondent verification technique was also used (Appendix 
O). Transparency was achieved by documenting this process of analysis and providing direct 
quotations within the results section to evidence the themes for the reader (Street et al., 
2016).   
 
 
3.4 Results 
Four Superordinate themes were identified from the coded transcripts and all addressed re-
finding and re-constructing identity: ‘Re-finding the normal self’; ‘Special self’; ‘The evolving 
self’ and ‘Revised roles. 
 
3.4.1 Re-finding the ‘normal’ self: ‘I’m kind of starting to getting back to normal’ 
Many of the participants disclosed feeling compromised whilst they were unwell. Holly 
encapsulated this whilst discussing others’ perceptions of her illness: 
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it was all invisible but I was really struggling still and I I was still very compromised as 
a person and I wasn’t back to myself at all you know. (Holly) 
Instead of describing her immune system as compromised, Holly describes being 
‘compromised as a person’ extending the medical use of the word to encompass her entire 
identity. In common with each interview, Holly asserts that she ‘wasn’t herself’, as though the 
‘self’ had somehow disintegrated through the process of becoming unwell. When asked 
whether she viewed herself as an unwell person now, Holly judged this in terms of the 
immunologist’s question as to whether she can do everything that she wants every day: 
And in that regard I really can and that’s definitely true in the last maybe three years, 
the first three years of my recovery were really difficult and then the the fourth and the 
fifth year you could see changes, you could see myself re-emerging but um in the last the 
last three years of my life has been pretty per like perfect. (Holly) 
Holly highlighted a ‘re-emerging’ process and suggested her real ‘self’ had been obscured by 
the illness. She also mentioned ‘re-emerging’ in the same line as ‘perfect’, suggesting she 
thinks her life would be perfect if she was back to being herself before the illness. Most of the 
participants discussed ‘normality’ throughout the interview and only felt more ‘normal’ once 
they were more recovered. 
  I was a good communicator and I got along with people and I was a good worker, a good 
daughter, a good friend and but the illness just kind of changed, the period of time that I 
can remember, the illness changed that but I’m kind of starting to getting back to normal 
(Jane) 
Here Jane repeats the word ‘good’ in reference to her former self and frames the illness as 
something that stopped her being ‘good’, suggesting you cannot be unwell and ‘good’ 
simultaneously.  
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All participants described a difficult route to diagnosis and there was an overall sense that 
they viewed themselves as ‘abnormal’ because the illness was rare and the cause unknown. 
This is encapsulated by a short quote from Laura when discussing the causes of the disease: 
Yeah but it’s such a rare thing it’s strange to have you know (Laura) 
Additionally, all the participants gave the impression that they felt there is a socially acceptable 
level of illness, which they surpassed, and made them appear unusual: 
I was in intensive care I think for a little while and then yeah I went into the…, sort of 
ward, and then went up to the the normal ward as well [Laughs] (Sarah) 
Sarah’s reference to one ward as normal suggests that intensive care is not normal and that 
being critically unwell is out of the ordinary. Whilst few people acquire illnesses that cause 
them to require specialist intervention in critical care, Sarah appeared embarrassed and 
ashamed by needing to access this level of care.  
The participants all also discussed the diversity and uniqueness of the disease process, 
which also seemed to feed into their view of themselves as ‘abnormal’ when unwell: 
as far as my friends go, my family wasn’t [pauses] they didn’t let them come to the 
hospital a lot or until later on just because of how crazy the disease is and they didn’t 
know how I was going to act so they weren’t really allowing people to come visit me until 
later on (Jane) 
This extract suggests almost a level of detachment, as though Jane cannot recognise herself in 
her odd and unpredictable behavior. A great deal of the feeling of abnormality specifically 
seemed to stem from the experience of psychotic symptoms: 
Those aren’t normal things for like I guess at least my culture (Natalie) 
Five participants discussed their experience of psychiatric symptoms, most women had been 
received treatment on a psychiatric ward either prior to or after diagnosis, and appeared to 
attempt to distance themselves from a mental health narrative: 
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Yeah see I was one of the lucky ones, many people with NMDA they present with 
psychosis first. I I to be honest I don’t I feel like, my mum would agree, I don’t see 
psychosis as a major part of my journey (Natalie) 
These quotes suggested evidence that the women recognised the potential stigma of mental 
health difficulties as part of their illness. Furthermore, three participants seemed to need to 
actively normalise their illness by directly comparing it to a disease process that is perhaps 
more socially acceptable. As evidenced by Sarah when discussing attributions about the 
potential causes of the disease: 
Yeah, I don’t mind, I think everyone does it, it’s a bit like if someone has cancer, and they 
think like this must be something I’ve done as it’s such a terrible thing why do I deserve 
this sort of thing? (Sarah) 
Therefore, despite anti-NMDAR being a medically recognised and diagnosed illness with a 
protracted immunological/neurological recovery period, participants seemed to be striving for 
legitimisation. This could be related to the disease being unknown in the lay population 
meaning the women frequently felt pressure to explain the illness to others. For example, when 
Laura is discussing needing to explain her word finding difficulties to others: 
why I’m doing it so that’s one thing like um you need people to know that the reason why 
you’re um [pauses] oh I can’t think of the word now umm you know just looking for words 
and stuff you want to say oh the reason why, just not that you’re a bit crazy and can’t 
think of things 
 
 
3.4.2 A ‘special’ identity: ‘He always called me his star patient’ 
Five participants discussed how they were identified as their doctor’s ‘special’, ‘star’ or ‘best’ 
patient: 
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I still send him emails and he still keeps up with me and he was like if you ever think 
you’re relapsing head straight out here and we’ll get you in immediately so he always 
called me his, what do you call it, his star patient, because he absolutely loved me and 
every time I mean there for, for the last four years we were out there every probably 6 
weeks (Bridget) 
This extract demonstrates a very strong and positive doctor-patient relationship, which Bridget 
portrayed as very important for her recovery. Some people with anti-NMDAR can make a rapid 
recovery and their doctor’s role in their treatment is crucial. The underlying reason for being 
termed a ‘star’ patient could be due to the often quite dramatic recovery a person with anti-
NMDAR can make. An individual can progress from an induced coma to being almost 
recovered within a few months. It could be that this recovery time gives the doctors a sense of 
achievement and fulfilment, which is not always possible with other 
neurological/immunological cases, as identified by Jane: 
And all the care they’re putting into me and all you know they often, they’d consider me 
one of their best patients like they they often say their aim is to get everyone as well as I 
am (Jane) 
These five women also spoke about the time and effort their doctors expended, feeling like 
they chose to go over and above their duty of care, which could have contributed to feeling 
viewed as ‘special’: 
I think my my story is kind of special because just the way my doctor ended up going to 
this conference and talking to the leading doctor who who named this and then finding 
out (Sarah) 
It was not just in relation to the medical profession that the participants referenced this 
‘specialness’, they also discussed being treated favourably by friends and family, being allowed 
to ‘get away with more’: 
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Yeah I think there’s a lot less expectations of me than say my siblings for example, or 
someone I went to school with, like people don’t, don’t necessarily treat me differently, 
but like [pause] I don’t think if I hadn’t had the brain injury my parents would be so 
happy with me living at home but then because I have it’s kind of just like [pause] they 
don’t mind as much? (Natalie) 
This extract suggests that Natalie is happy to be viewed in some way as ‘special’ as it releases 
her from typical Western society restrictions of needing to be independent.  
By receiving special treatment and by the nature of the disease being rare, it seems that 
on one level the women came to view themselves as ‘unique’ and perhaps ‘special’. However, 
combined with this ‘unique’ and ‘special’ identity was also the feeling of being ‘compromised’ 
by the illness. 
Yeah I mean yeah I think being sick or you know is so much part of my identity now like 
you know you know like I never like, the interesting thing about brain injury I think over 
a lot of different illnesses is and I say this all the time like you spend your whole life 
becoming somebody becoming whoever you’re becoming and then like literally overnight 
that’s all challenged and compromised (Bridget) 
One particular way in which the participants described feeling compromised was in thinking 
they were less cognitively able, specifically regarding persistent word finding difficulties. 
Three participants also had concern over their weight and appearance, due to steroid use and 
all the participants disclosed lack of self-esteem and confidence. This feeling is elaborated by 
Bridget: 
I think after a brain injury you really feel less than for a long time afterwards like 
particularly you know cognitively you’re compromised you don’t feel as smart, you 
don’t feel as quick you don’t feel as… you know there’s a lot of things you don’t feel 
(Bridget) 
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Bridget seems to be describing feeling ‘less than’ she was before the illness but possibly also 
feeling ‘less than’ others. She could also be describing some emotional numbing during the 
recovery process, or of consciously trying to detach from the new identity that she is forming.  
 It appears that the women held two views of themselves, simultaneously feeling both 
‘special’ and ‘compromised’. ‘Specialness’ seemed to relate to being ‘unique’ and a ‘good’ 
patient who recovered well, whilst ‘compromised’ seemed to be more closely related to their 
true beliefs about their own self-worth and abilities. 
  
3.4.3 Evolving from the illness: ‘I’m a much stronger person now’ 
Five participants described the experience of having had anti-NMDAR as associated with 
opportunities for growth. The interviews were interspersed with a sense of acceptance and 
gratitude for the increased insight and development the experience had given them. Five 
participants used the words ‘strong’, ‘strength’ and ‘fighter’ to describe themselves now. They 
felt that having survived the encephalitis made them a more resilient and overall ‘stronger’ 
person. They way in which the participants described becoming stronger differed slightly but 
was exemplified by Katie who felt that she had become a mentally stronger person, in that she 
no longer worried about things to the extent that she did before. Overall she felt that her mental 
health had improved as her anxiety levels had decreased: 
Well since I was young I was diagnosed with an anxiety disorder and so I lived with that 
for a long time really severely and um after being diagnosed and treated I I have very 
little anxiety and I’m a lot more secure I just feel a lot more confident than I ever did, I 
just find this kind of [pause] people just think I’m better overall I guess than I was before. 
I was very insecure with just myself and being alone and things like that but I’ve found 
now I’m a lot stronger (Katie) 
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It appears Katie has developed a greater sense of her own resilience. The words she uses to 
describe how she feels about herself give a sense of perpetuity ‘secure, confident, stronger’, 
and seem to have released her from worrying about the smaller difficulties in life: 
Yeah maybe I don’t worry as much about about things like I used to (Katie) 
Four participants showed pride in their recovery, Sarah exemplifies this: 
Well I became like more positive in a way, it’s more like I survived from this that I can 
do anything and other people are like yeah I can’t do this because it’s too hard, it’s like, 
I will say, that’s nothing, if I can survive from this, you can do that (Sarah) 
She suggests that, due to the severity of the illness and the unpleasant treatments for anti-
NMDAR, she has survived something largely incomparable to other life experiences, and that 
this has given her a mental strength somewhat over and above other people. Not all the 
participants felt the illness had made them stronger, one participant felt the opposite: 
umm yeah …you know I, I don’t know I think I think as myself as a little bit more 
[laughs] fragile than I used to be in some ways you know (Bridget) 
Although, in context, her perceived fragility appeared more in relation to her physical stamina, 
as opposed to the mental strength described by the other participants. As shown when 
discussing a charity 5km run she had committed to: 
I wanna try it and I wanna feel like I’ve given it an effort without them assuming it’s 
something I can’t handle but at the same time if I can’t handle it [laughs] I want them, 
my family, to understand that (Bridget) 
Bridget seems to be evidencing resilience; she is pushing herself to do something at the limits 
of her stamina and is somewhat fearful at the prospect of this. However, she is determined to 
push herself and appears to feel confident in the knowledge that she will be supported and 
understood by her family. 
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Another way in which all the participants felt they had grown was in compassion towards 
others. They spoke about having greater understanding of other people’s suffering, having 
experienced their own. The participants spoke about ways in which they had tried to ‘give 
back’ to other people diagnosed with anti-NMDAR, wanting to prevent others going through 
what they experienced: 
Yeah I would say that and just not letting it be this you know bad thing that happened to 
me but turning it into something good for other people at least so that you know there’re 
less people or maybe someone out there wouldn’t have to go through the same thing or 
wouldn’t have to go through it alone you know (Rachel) 
Aside from the altruism of wanting to help others, there was also a sense of trying to find 
‘meaning’, i.e. a reason for why they became unwell. The conclusion being that it was so they 
could then help others: 
Um yeah I mean well I mean I I’m not allowed some people would say it’s [pauses] had 
a positive impact on their life, I don’t think I would go that far but I feel like for me I’ve 
been able to you know with this thing like a really rare disease I sort of felt like there’s a 
reason I’m surviving these things and I need to turn a negative into a positive, for me 
that’s the only way to sort of make sense of it (Laura) 
This extract captures that, even if the positives were not immediately obvious, there appeared 
a deep need to create something positive from the illness, most tangibly perhaps through 
helping others. 
 
2.4.4 Revised roles: ‘I’ve just felt really inspired to write my own path’ 
The subject of life roles was consistent across all the transcripts. All of the participants focused 
on a change in their role in life with regards to their career or education. The women felt the 
illness had greatly impacted their planned career paths, either because of extended treatment 
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interfered with studying or availability for work, or because they now do not feel they have the 
same level of intelligence or energy to pursue their planned careers. Despite this, most of the 
participants appeared to re-frame this, describing feeling freed from obligation or not under the 
same social pressure to focus on their career. Instead they felt more able to focus on what they 
believed made them happy and on living more in the present rather than the future. This 
sentiment is summarised very clearly in a statement by Rachel: 
the fatigue obviously means that I probably wouldn’t be able to have a high job like I 
wanted to but then in other ways that’s good because it’s made me not worry about that 
sort of thing anymore and I tend to enjoy life more (Rachel) 
Rachel’s emphasis is on moving away from the drive to have a ‘high job’; whilst for other 
participants the sense of freedom and re-prioritisation was more about the shift to a different 
career:  
So I struggled a lot in the past three years thinking about where I wanted to go you know 
I went back to that idea of teaching and should I work with kids that way but in the bottom 
of my heart I knew it’s not really what I wanted… in the last while I’ve just felt really 
inspired to write my own path whatever that may be but I would really like to start 
building a career (Natalie) 
Natalie’s use of words ‘write my own path’ implies she thinks that she now has greater control 
of her choices. Whereas before she might have felt that her life was on a particular trajectory, 
she felt liberated to reconsider her values and pursue choices that might build a career aligned 
with what she ‘really wants’. 
Four participants discussed the impact of anti-NMDAR on parenting and commented on 
its effects on their families or parenting plans. Two participants already had children when they 
became ill and one saw no long-term effects on parenting associated with the anti-NMDAR: 
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No not at all that’s that’s what’s strange, no I’ve just, no I’ve just got on with everything 
but I’ve had my youngest since I had it last time and obviously I wasn’t with them the 
time I was in hospital and when I came out I was just back to normal you know, cooking 
and getting them ready and stuff so really it hasn’t it hasn’t affected me like that, my 
lifestyle really, in that sense (Bridget) 
Whereas, one mother spoke about the long-term impact on her relationship with her daughter: 
Yeah that was probably the hardest part of my recovery was my daughter because when 
I got out of the hospital I still wasn’t well and I was looking after her and I had a lot of 
resentment towards her I was very jealous of my husband with anybody and I had a lot 
of resentment towards my daughter and I, we, kind of our bond was broken and I am 
actually, we’re still, we’re going to counselling my daughter and I trying to, uhum so still 
trying to work on it, it’s been a it’s been that’s been the hardest part about the sickness. 
(Holly) 
Holly uses the term ‘broken’ in the extract, suggesting she feels there was a complete rupture 
in the relationship. For the other three women, there was concern about starting a family in the 
future and the long-term effects of anti-NMDAR and its treatment may have on fertility. For 
example, Natalie discussing taking Rituximab: 
And I’m on it every like wha… what like is it going to affect me long term, in ten or fifteen 
years will I be suffering from something as a result of my them, my Rituximab and then 
again the daily immunosuppressants like they’re grand I don’t mind them, they don’t 
affect me at the moment but if I were ever to plan to plan a family like er I’d have to come 
off them, they’d be toxic to anything like that. So there are things in the future that I’ll 
just have to deal with when I come to them. (Natalie) 
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This extract shows how the illness can cause women to re-evaluate their future roles, with an 
emphasis on motherhood and the anxiety of wondering whether it will be possible to have 
children and take on a mothering role.  
 
3.5 Discussion  
The aim of this study was to explore the experience of women diagnosed with anti-NMDAR 
encephalitis and the phenomenon of identity change. The themes revealed that the rarity and 
unfamiliarity of the disease appeared to affect the women’s views of themselves as ‘normal’. 
How actively they were being treated and medically monitored appeared to influence how 
recovered and ‘normal’ they perceived themselves. This is consistent with research suggesting 
diagnosis of diseases can lead individuals to feel different or abnormal (Roger et al., 2014; 
Dickson et al., 2008) and to experience stigma (Charmaz, 2000). Particular to anti-NMDAR, 
was the presence of psychiatric symptoms appeared to exacerbate this feeling of abnormality. 
All but one of the women experienced a delay in receiving a diagnosis, partly as their presenting 
symptoms were attributed to mental health difficulties and most participants had spent time in 
a psychiatric ward initially. Varma and Sapra (2015) assert that psychiatrists need to keep a 
high level of vigilance with regards anti-NMDAR, particularly when patients are only partially 
or non-responsive to antipsychotics. They go on to argue this is most crucial when younger 
women present with acute onset neurobehavioural symptoms citing pre-existing stressors, 
because their diagnosis could potentially be missed or delayed. During the interviews, it was 
evident participants were keen to distance themselves from this mental health narrative but 
sanguine about acknowledging the neurological and immunological impact of the disease. This 
perhaps reflects research that has found individuals diagnosed with psychiatric disorders often 
report experiencing stigmatisation (Corrigan, Watson, & Barr, 2006; Dinos et al., 2004). 
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Three of the women made direct comparisons between anti-NMDAR and cancer during 
their interviews. They contrasted the rarity and lack of understanding of their ‘strange’ illness 
and its treatment with the perceived legitimacy of common, long-term physical health 
conditions such as cancer. Making this link might be primed perhaps, given that one of the 
main treatments for anti-NMDAR is Rituximab, which is also used to treat certain types of 
cancer (Cancer Research, UK, 2015). 
Another theme revealed that most of the women felt they were viewed as ‘special’ by 
both health professionals and family/friends. This was due to being called ‘special, ‘star’ or 
‘best’ patients by their physician or, by having ‘special’ treatment at home, i.e. being allowed 
to behave in ways they felt they could not have in the past. Health professionals may treat 
individuals with anti-NMDAR in this way because the differential diagnostic process is 
specialist and because, given it is life threatening, clinicians promoting recovery take pride in 
how some people with anti-NMDAR return to full health under their treatment. Participants 
reported friends and family would have often witnessed them being critically ill, so displayed 
a sense of relief and gratitude when they achieved recovery, thus playing a part in treating them 
as ‘special’. However, the women also reported low self-esteem, largely due to word finding 
difficulties, suggesting that the women held dual beliefs about themselves, as both special but 
also simultaneously compromised. It is possible that the ‘specialness’ did not relate to their 
beliefs about themselves and their own self-worth, as they had little control over fighting their 
illness, which largely required an intensive biomedical approach. Instead feeling ‘special’ 
appeared to be more related to having developed this ‘unique’ illness and having surviving it, 
despite feeling they had no power over this. The influence of others on identity reconstruction 
is consistent with existing qualitative data investigating identity in chronic illnesses (Arroll & 
Howard, 2013; Atkin et al., 2010; Karnilowicz, 2011; Gelech & Desjardin, 2011). Researchers 
assert social relationships can influence how individuals with a chronic illness view themselves 
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and can either be nurturing or damaging to their own sense of self (Karnilowicz, 2011; 
Mathieson & Stam, 1995). In a study exploring psychological ownership and identity in 
chronic illness, Karnilowicz (2011) argued that to gain control over an illness, individual’s 
must take some ownership. However, often this role is taken over by a loved one or medical 
professional, which can be problematic. They assert healthcare professionals need to be aware 
of this and allow individuals to take psychological ownership (Karnilowicz, 2011).  
Impact on identity was not found to always be a negative process, with the women 
frequently reporting personal growth. Many of the women thought they were mentally stronger 
following the illness and better able to face life’s adversities. They also felt they had greater 
compassion and empathy and were more willing to help others. This growth could be 
contextualised within the post–traumatic growth (PTG) literature, which has found PTG 
following severe physical illness and psychosis, with themes such as development of personal 
strength (Dunkley & Bates, 2015), reappraisal of life and priorities (Hefferon, 2009) and 
greater appreciation of life (Silva et al., 2011). This study also revealed impact on identity in 
relation to the roles the women felt they could hold in life following the illness, a finding 
consistent with the work of Charmaz (2000). Firstly, with regards their careers; overall it 
seemed the women had either shifted away from seeing themselves as ‘career women’ and 
were more focused on other elements of life, or were keen to ensure that their job was 
rewarding. This impact on career role has been found in other chronic illness studies. In a postal 
survey of 308 people with chronic illness, Bhatti et al., (2014) found major life-changing 
decisions (MLCDs) related to employment were found in 34% of patients, with some common 
decisions being career plan abandonment or going into part-time employment. Although there 
was a sense of loss with regards this, largely the impact on career appeared to link with the 
theme around PTG, with most of the women positively changing their career plans due to a 
shift in life priorities. 
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Another subordinate theme within ‘Revised roles was the impact on the mothering role. 
Some of the women began to question whether they would be able to adopt a role as a mother 
in the future due to the uncertainty around the long-term effects of the illness and its treatment, 
on both fertility (Abdul-Rahman et al., 2016; Sanmaneechai, Song, Nevadunsky, Moshé, & 
Overby, 2013) and their health (Titulaer et al., 2013). One of the women worried about her role 
as a mother to her child after being discharged home. She felt she was still not ‘herself’ and 
that this affected her ability to parent her child. Another woman was concerned about their 
ability to conceive a healthy child in the future or had decided not to factor motherhood into 
their future at all, due to fears around their future health. This is also consistent with the findings 
of Bhatti et al., (2014) who found 24.3% of their participants made MLCDs with regards 
motherhood, for example deciding not to have children or delaying plans to have children. This 
was due to concerns, for example, about looking after their health and baby’s health 
simultaneously and long-term treatment.  
The themes generated in this study suggest that the identity of the women interviewed 
was impacted in several ways following development of anti-NMDAR encephalitis. The 
majority of the women felt their identity was altered whilst they were unwell in that they 
viewed themselves as ‘abnormal’. However, they discussed feeling more ‘themselves’ once 
they were more recovered immunologically and neurologically. The women also discussed a 
‘special’ identity as a result of the illness, but this was coupled with a feeling of being 
‘compromised’ by the long-term effects of the illness, such as cognitive difficulties. Many of 
the women also saw themselves as more empathic and mentally stronger. Change in life roles 
was also discussed, which appeared to alter the way in which the women viewed their identity. 
The themes therefore suggest that, consistent with some existing literature, there is a degree of 
biographical flow (Faircloth et al., 2014), with some of the women emphasising a re-emergence 
of their previous identities once the more severe symptoms of the illness had receded. This is 
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consistent with the research by Gelech and Desjardins (2011) that suggests whilst people do 
experience some loss of self post-illness/injury, there is also endurance and stability of self, 
combined with moral growth and transcendence. However, given the many other ways in 
which the women discussed that their identity had altered, it seems that there was a large degree 
of biographical disruption (Bury, 1982). The women were beginning to form new identities 
post-illness, based on the ways in which they felt they had altered, grown, and their change in 
life roles.  
 
3.5.1 Critical evaluation  
As is consistent with  using the IPA method, this study focused on a homogenous sample of 
participants and as such the findings are not intended to be generalised. Instead they represent 
the experience of a small population of women with anti-NMDAR. This allowed for a deeper 
exploration of the women’s experiences, and examination of psychological convergence and 
divergence within the group (Smith, Flowers & Larkin, 2009). However, it is recognised that, 
whilst the participants reported feeling comfortable discussing their experiences, the richness 
of the data could have been affected by use of Skype (Cater, 2011). 
Sampling bias may have been present via the process of recruitment from an online 
research page, which may have led to people with particular characteristics/motivations being 
sampled, for example those more familiar with using the internet and possibly those seeking 
out/giving social support via online communities (Nambisan, 2011). These factors could 
therefore have affected the narratives of the participants and the themes derived.  
3.5.2 Areas for future research and clinical implications 
All the participants were at different perceived milestones in terms of their recovery, therefore 
a longitudinal study could track participant’s views on identity at different stages of recovery 
or re-uptake of roles.  
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Researchers in acquired brain injury (ABI) have found that PTG increases with time 
since ABI (Gangstad, Norman, & Barton, 2009; Powell, Ekin-Wood, & Collin, 2007). A 
longitudinal study could also investigate whether PTG is experienced after anti-NMDAR and 
what mediates this, for instance, time since onset. Despite participants describing feeling 
viewed as ‘special’, all disclosed lacking self-esteem and feeling ‘compromised’. One clinical 
implication would be to investigate psychological wellbeing in this client group and offer some 
form of psychological support. Mindfulness-based techniques (MBT) have been investigated 
in other illnesses (cancer, HIV, chronic fatigue) with significant improvements found in 
measures such as, anxiety and fatigue and overall fostering of PTG (Garland, Carlson, Cook, 
Lansdell, & Speca, 2007; Milam, 2004; Surawy, Roberts, & Silver, 2005). A randomised 
control trial, comparing treatment as usual with MBT on a population of people with anti-
NMDAR could be beneficial to see if this intervention is acceptable and helpful.  
One theme that arose was regarding motherhood and fertility and, given this illness is 
more prevalent in women, this could be an important avenue for future research, particularly 
because resection of ovarian teratomas and use of Rituximab have been associated with fertility 
risks (Dalmau et al., 2008; Irani et al., 2010; Cancer Research UK, 2015). Exploring views on 
fertility and pregnancy would be important for this population and could go on to inform both 
the health information available to this population and how health professionals sensitively 
communicate this information (Bach, 2014). Patient counselling around infertility should also 
be integrated into standard care (Bach, 2014). Given the women’s discussions around 
family/motherhood, future research could also investigate the impact on families, particularly 
the relationship between mother-child. 
One of the themes revealed the women felt they were viewed as ‘special’ by health care 
professionals. This bears consideration, given the potential cognitive difficulties in this 
population, which could give rise to vulnerability. Furthermore, patients might also feel 
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pressurised into presenting themselves as 'recovered' in order to be the 'best' when they might 
actually be suffering cognitive, psychological or behavioural difficulties. Thus, missing the 
chance for detection of these difficulties/potential relapses, and not receiving the therapeutic 
intervention they might need to maximise recovery and functioning. Therefore, whilst 
establishing a strong doctor-patient relationship is important, caution would be recommended 
for inter-professional communication and use of ‘best’ patient labels.  
 
3.5.3 Conclusions 
To conclude, this study has presented the experience of the impact on identity in eight women 
diagnosed with anti-NMDAR. It is the first piece of psychological research into anti-NMDAR 
and provides an exploration of how being diagnosed with a newly categorised and rare illness 
can affect an individual’s identity. It offers insight into psychological factors both common to 
survival of many severe physical illnesses, such as not feeling oneself whilst unwell and moral 
and personal growth, but has also revealed factors particular to anti-NMDAR encephalitis. 
These include, feeling abnormal due to the novelty/rarity of the disease and the presence of 
psychiatric symptoms and feeling viewed as ‘special’; and experiencing uncertainty around the 
long-term impact on fertility and parenting. It is hoped that this study will prompt further 
psychological research into anti-NMDAR, to provide increased insight into how this illness 
and its treatments are experienced by those diagnosed, and ultimately give further 
recommendations for professionals working with this population.  
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3.7 Appendices 
 
 
Appendix G: Ethical approval confirmation email 
 
psychethics!
!!!
!!
Reply!all|!
Tue!10/11/2015,!11:58!
Della!Nicolle;!
+1!more!
Inbox!
You!forwarded!this!message!on!13/11/2015!14:04!
Dear!Della,!
!!
The! Chair! of! the! Ethics! Committee! has! considered! your! revised! postgraduate! project! proposal:!
Experience! of! recovery:! An! interpretative! phenomenological! study! of! people! who! have! been!
diagnosed!with!anti1nmda!encephalitis!(EC.15.10.13.4209R).!
!!
The!project!has!been!approved!on!the!following!condition:!!
!!
1!!!!!!It!should!be!made!clear!on!the!materials!when!the!data!will!be!anonymised!–!when!any!possibility!of!
being!able!to!link!the!data!to!the!individual!will!be!removed.!
!!
Please!note!that!if!any!further!changes!are!made!to!the!above!project!then!you!must!notify!the!Ethics!
Committee.!
!!
Best!wishes,!
!!
Natalie!!
!!
School&of&Psychology&Research&Ethics&Committee!
Cardiff!University 
Tower!Building! 
70!Park!Place 
Cardiff 
CF10!3AT 
! 
Tel:!+44(0)29!208!70360 
Email:!psychethics@cardiff.ac.uk 
Prifysgol!Caerdydd 
Adeilad!y!Tŵr 
70!Plas!y!Parc 
Caerdydd 
CF10!3AT 
! 
Ffôn:!+44(0)29!208!70360 
E1bost:!psychethics@caerdydd.ac.uk 
! 
http://psych.cf.ac.uk/aboutus/ethics.html!
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Appendix H: Email confirming permission to recruit via the Encephalitis Society website 
 
 
 
From:&Ava&Easton&<Ava@Encephalitis.info<mailto:Ava@Encephalitis.info>>&
Sent:&25&September&2015&09:04&
To:&Della&Nicolle&
Subject:&RE:&Research&proposal&antiGnmdar&encephalitis&
&
&
Hi&Della&
&
&
We&would&be&keen&to&support&your&project&and&help&you&recruit&through&our&membership&even&as&a&
primary&source?&
&
&
I&just&need&your&proposal&and&evidence&of&ethical&approval&in&the&first&instance.&&And&we&would&be&
delighted&to&help&you&disseminate&findings.&
&
&
We&are&a&global&organisation&with&a&substantial&UK&membership&as&you&might&imagine.&
&
&
Happy&to&help.&&Just&let&me&know&what&you&need.&
&
&
You&might&be&interested&to&attend&our&forthcoming&annual&encephalitis&seminar&in&London&on&7/12&
where&some&of&the&top&research&in&the&country&and&top&profs&specialising&in&the&condition&will&be&
presenting&and&networking.&&Let&me&know.&&In&the&future&it&might&be&a&useful&environment&in&which&to&
present&your&findings.&
&
&
Become&a&member&which&is&free&and&takes&2&minutes&online&http://www.encephalitis.info/getG
involved/membershipGonline/professionalGmembership/&and&you&will&be&kept&in&touch&with&our&
research&and&professional&work.&&You&are&also&welcome&to&visit&us&anytime.&
&
&
Let&me&know&your&further&thoughts.&
&
&
Kind&regards&
Ava&Easton&
Chief&Executive 
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Appendix I: Advert for recruitment 
 
 
 
!!!!!!!!!!!!VOLUNTEERS!NEEDED!
!!!!!!!!!!!!The!Lived!Experience!of!Anti1NMDA!Encephalitis !
&
What&is&this&study&about?&
My!name!is!Della!Nicolle,!I!am!a!trainee!clinical!psychologist!based!at!Cardiff!University,!Wales.!I!am!
in!the!process!of!completing!my!large1scale!research!project!for!the!third!and!final!year!of!my!clinical!
psychology!doctorate.! I! am! interested! in!understanding! the! lived!experience!of!women!diagnosed!
with! anti1NMDAR! encephalitis,! by! interviewing! those! who! have! the! diagnosis.! In! particular! I! am!
interested!in!your!experience!of!having!the!diagnosis!and!receiving!treatment!for!this1!how!you!get!by!
from!day!to!day!and!cope.!I!hope!that!the!general!findings!from!the!study!could!help!increase!public!
awareness!of!the!disease!and!have!implications!for!services.!
!
What&will&the&study&involve? &
You!and!I!will!arrange!a!time!to!discuss!your!experiences!of!anti1NMDAR!encephalitis.!We!might!talk!
for! around! an!hour! or! a! little! less! or! a! little!more,! depending! on!what! you!would! like.!With! your!
permission,! I! will! record! our! conversation! so! that! I! can! type! it! up! afterwards,! following! this,! the!
recordings!will!be!deleted!and!the!transcripts!will!have!all!identifying!details!removed.!!
!
Who&can&take&part?&
We! are! inviting!women! between! the! ages& of& 18& and& 65! with! a! diagnosis& of& antiCNMDAR&
encephalitis!within!the!last&eight&years!i.e.!since!official!recognition!of!the!disease!in!2007.!!
!
How&do&I&find&out&more? &
If! you! would! like! to! participate! in! this! study! then! please! contact! Della! Nicolle,! Trainee! Clinical!
Psychologist:!
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Email:!NicolleD@cardiff.ac.uk!
Phone:!+44!(0)29!208!70582!
 
This!project!has!been!reviewed!and!was!ethically!approved!by!The!
Cardiff!School!of!Psychology!Ethics!Committee!on!the!10/10/2015.!
Deadline:!01/12/2017!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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!
 
Appendix J: Information sheet 
 
 
&Study&Information&&
!
!
Dear,!
!
My!name!is!Della!Nicolle!and!I!am!a!trainee!clinical!psychologist!based!at!Cardiff!University,!
Wales.! I!am!in!the!process!of!completing!my!large1scale!research!project!for!the!third!and!
final! year! of!my! clinical! psychology! doctorate.! I! am! interested! in! understanding! the! lived!
experience!of!women!diagnosed!with!anti1nmdar!encephalitis,!by!interviewing!people!who!
have!the!diagnosis.!!
!
This!letter!describes!my!study.!Please!read!this!to!help!you!decide!whether!you!would!like!to!
take!part!by!being!interviewed.!If!you!like!you!can!contact!me!to!discuss!it!further.!Then,!if!
you!would!like!to!be!interviewed!I!will!ask!you!to!sign!and!return!the!consent!form,!which!I!
will!post!or!email! to!you.!Once!this! is!signed!and!received,! I!can!then!either!drive!to!your!
home,! if! it! is! within! commutable! distance! from! Cardiff,! or! I! can! call! you! via! Skype.!
Alternatively,!we!can!pay!for!your!travel!expenses!for!you!to!come!to!Cardiff!University,!if!it!
is!within!commutable!distance!from!Cardiff.!
!
This!project!has!been!reviewed!and!ethically!approved!by!The!Cardiff!School!of!Psychology!
Ethics!Committee.!!
!
What&is&this&study&about?&
I!am!interested!in!women’s!experiences!of!having!a!diagnosis!of,!and!living!with,!anti1nmdar!
encephalitis.!
!
Why&have&I&been&invited&to&take&part?&
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I! am! inviting! women! between! the! ages! of! 18! and! 65! with! a! diagnosis! of! anti1nmdar!
encephalitis!within!the!last!nine!years!i.e.!since!official!recognition!of!the!disease!in!2007.!!
!
Do&I&have&to&take&part?&
No,!you!do!not!have!to!take!part.!It!is!completely!up!to!you.!!
If!you!decide!to!take!part,!you!can!still!change!your!mind!at!any!time!and!withdraw!from!the!
interview!and!study!without!having!to!give!a!reason.!!
!
What&happens&if&I&do&not&take&part?&
Nothing!will!happen!if!you!decide!not!to!take!part,!or!if!you!withdraw!from!the!study.!You!will!
not!lose!the!support!of!any!support!groups!or!services!that!you!may!be!using.!
!
What&is&involved&if&I&do&take&part?&
You!and!I!will!arrange!a!time!to!discuss!your!experiences!of!anti1nmdar!encephalitis.!This!will!
take!place!in!either!a!room!at!Cardiff!University,!your!house!or!via!Skype,!wherever!is!mutually!
convenient.!
We!might!talk!for!up!to!an!hour,!but!we!can!go!on!for!longer!if!you!would!like,!or!talk!for!less!
time.!With!your!permission,!I!will!record!our!conversation!so!that!I!can!type!it!up!afterwards.!
!
Confidentiality&and&anonymity&
The!audio!recordings!of!the!interviews!will!be!deleted!once!they!have!been!transcribed.!!
!
All!information!that!is!collected!about!you!during!the!course!of!the!study!will!be!kept!strictly!
confidential.(This!means!that!in!the!write1up!of!the!study,!your!name!and!any!information!
that!could!be!used!to!identify!you!will!be!removed!or!changed.!!
!
The!only!circumstance!in!which!we!may!pass!on!your!details!to!another!professional!would!
be!if!you!either!tell!us!that!you!are!planning!on!harming!yourself!or!somebody!else,!or!if!you!
give!us!serious!reason!to!believe!that!you!intend!to!commit!a!crime.!This!is!to!keep!you!and!
others!safe.!If!this!happens,!we!will!talk!to!you!first!before!talking!to!anyone!else!and!hopefully!
together!we!can!decide!on!a! course!of! action.! ! I! am!working!under! the! supervision!of!Dr!
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Jennifer!Moses!and,!if!I!remain!concerned!about!you,!I!will!also!contact!her!for!advice!and!to!
assist!in!deciding!on!any!action.!
!
Are&there&any&disadvantages&to&taking&part?!
We!do!not!think!that!there!are!any!disadvantages!to!taking!part!in!this!study.!However,!some!
of!your!experiences!of! the! illness!might!have!caused!you!distress!and!be!upsetting!to!talk!
about.! It! is! up! to! you! whether! you! talk! about! upsetting! experiences.! If! you! do! find! the!
interview!distressing,!you!can!contact!Dr!Jennifer!Moses,!Consultant!Clinical!Psychologist!on!
02920!870582!for!further!support!or!the!Encephalitis!Society,!Website:!www.encephalitis.info!
Email:!mail@encephalitis.info.!!
!
Are&there&any&benefits&to&taking&part?&
We! hope! that! you! will! find! the! conversation! interesting! and! even! useful,! as! you! will! be!
encouraged!to!think!about!your!unique!strengths!and!how!you!have!coped!with!having!anti1
nmdar!encephalitis.! The! information!you!provide!and! the!general! findings! from! the! study!
could! help! to!make! services! better! for! people!with! anti1nmdar! encephalitis! and! increase!
public!awareness!of!the!disease.!!
!
What&will&happen&to&the&results&of&the&research&study?&
Once!I!have!completed!all!of!the!interviews!I!will!write!up!my!findings!in!a!thesis!that!will!be!
submitted!to!my!university.!In!the!future!I!may!decide!to!shorten!the!write!up!and!submit!for!
publication!in!a!scientific!journal!or!present!it!as!a!poster.!Both!the!thesis!and!journal!will!be!
able!to!be!accessed!by!yourselves!and!other!members!of!the!public,!but!all!information!will!
be!anonymised!and!you!will!not!be!identifiable.!!
!
What&if&there&is&a&problem?&
If!you!experience!a!problem!or!have!concerns!related!to!the!study!please!do!not!hesitate!to!
contact!me,!or!either!of!my!supervisors.!If!you!would!like!to!make!a!formal!complaint,!you!
can! contact! the! Cardiff! School! of! Psychology! Ethics1! Email:! psychethics@cardiff.ac.uk,!
Telephone:!+44!(0)29!2087!0360!
!
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I!appreciate!you!taking!the!time!to!read!this! letter.! If!you!have!any!questions!or!concerns!
please!contact!me,!or!the!study!supervisors!listed!below.((
(
(
Contacts(
If!you!have!any!questions!about!this!letter!please!contact!me:!!
Della!Nicolle!!
Trainee!Clinical!Psychologist!
Telephone:!+!44!(0)29!208!70582!!
E1mail:!NicolleD@cardiff.ac.uk!
!
Alternatively,! you! can! speak! to! my! academic! supervisor,! Dr.! Jennifer! Moses,! who! is! a!
Consultant!clinical!psychologist!at!Rookwood!Hospital,!Cardiff!and!the!Academic!Director!of!
the!Cardiff!University!Clinical!Psychology!Doctorate!on:!Email:!Jenny.Moses@wales.nhs.uk,!
Telephone:!+44!(0)29!208!70582.!!
!
*If&you&would&like&to&participate&in&this&study&then&please&call&Della&Nicolle&on&
the&number& above& to&discuss& this& further.&Alternatively,& email&Della&Nicolle&
with&your&contact&number*&
!
Many!thanks!for!your!time,!!
Della&Nicolle&
Trainee(clinical(psychologist(
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Appendix K: Consent form 
&
CONSENT&FORM!
& !
Study&Number:&EC.15.10.13.4209R,
Study&Location:,DClinPsych,Programme,,Cardiff,University,,Tower,Building,,70,Park,Place,,Cardiff,,CF10,3AT,
 
Participant&Identification&Number&for&this&trial:&!
Title&of&Project:&Impact!on!identity:!An!interpretative!phenomenological!study!of!women!
who!have!been!diagnosed!with!anti1nmdar!encephalitis&
Name&of&Researcher:!Della!Nicolle!
Please(initial(box((
•! I!confirm!that!I!have!read!the!information!sheet!for!the!above!study.!I!have!had!the!
opportunity!to!consider!the!information,!ask!questions!and!have!had!these!answered!
satisfactorily.!
!
•! I!understand!that!my!participation!is!voluntary!and!that!I!am!free!to!withdraw!at!any!
time!without!giving!any!reason.!
!
•! I!understand!that!I!can!refuse!to!answer!any!question!I!am!asked!without!giving!any!
reason.!!
!
•! I!agree!for!the!interview!to!be!recorded!and!then!typed1up.!I!understand!that!the!
recording!will!be!kept!in!a!safe!place!and!then!destroyed!once!it!has!been!typed!up.!!!
!
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•! I!understand!that!once!the!interview!is!typed1up,!any!information!I!provide!that!can!be!
used!to!identify!me,!for!example,!my!name,!will!be!changed!so!that!I!cannot!be!
identified.!!
!
•! I!understand!that!everything!I!say!in!the!interview!will!remain!confidential.!A!relevant!
professional!will!only!be!told!about!me!if!in!the!interview!I!say!that!I!am!thinking!or!
planning!to!harm!myself!or!someone!else!or!commit!suicide!or!a!crime.!!
!
•! I!give!permission!for!anonymised!parts!of!the!interview!to!be!included!in!the!thesis!
and!in!academic!articles,!posters!and!conferences.!
!
•! I!understand!that!the!anonymised!transcripts!may!be!used!to!support!other!research!
in!the!future,!and!may!be!shared!anonymously!with!other!researchers.!!
!
•! I!understand!that!where!possible!my!GP!will!be!notified!that!I!am!taking!part!in!the!
study!so!that!they!can!better!support!me!if!I!need!support!following!the!interview.!
!
•! I!agree!to!take!part!in!the!above!study.!!
!
!
! ! ! ! ! ! ! ! ! ! ! !
Name!of!Participant! ! Date! ! ! ! Signature!
!
Della!Nicolle! ! ! ! ! ! ! ! ! ! !
Name!of!Person! ! Date! ! ! ! Signature!
taking!consent!
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Appendix L: Demographics form 
 
!
!
!
DEMOGRAPHICS!FORM!
!
!
Please!do!not!write!your!name!on!this!form.! It!will!be!stored!separately!from!your!consent!
form!and!interview!transcripts!and!will!not!be!linked!with!your!other!information!in!any!way.!
This!information!just!allows!us!to!provide!an!accurate!description!of!the!sample!of!participants.!!
!
For! the! following!questions,!please!check! just!one!response!that!you!think!most!accurately!
describes!you,!and!please!leave!the!others!blank.!
!
!
Gender:!
!
Male! ! Female! ! Transgender!
!
!
Age:!
!
18M20!
21M25!
26M30!
31M35!
36M40!
41M45!
46M50!
51M55!
56M60!
61M65!
!
Ethnicity:!
!
White!British!
Irish!
Gypsy!or!Irish!Traveller!
Other!White!
White!and!Black!Caribbean!
White!and!Black!African!
White!and!Asian!
Other!Dual/Mixed!Heritage!
Indian!
Pakistani!
Bangladeshi!
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Chinese!
Other!Asian!
African!
Caribbean!
Other!Black!
American!Indian/Alaska!Native!
Native!Hawaiian/Other!Pacific!Islander!
Arab!
Any!other!ethnic!group!
!
!
Current!employment!status:!
!
Employed!full!time!
Employed!part!time!
Volunteering!
Not!currently!in!education/employment/volunteering!
In!education/learning!!
SelfMemployed!!
Retired!!
A!combination!of!the!above!!
!
!
Do!you!consider!yourself!to!have!a!disability?!!
!
No!
Yes!M!I!have!a!physical!disability!!
Yes!M!I!have!a!sensory!disability!!
Yes!M!I!have!difficulties!processing!information!
Yes!M!I!have!social,!behavioral,!or!emotional!difficulties!
Yes!M!A!combination!of!the!above!
!
!
Approximate!time!since!diagnosis:!(≥!equal!to!or!more!than)!
!
!1!month!M!11!months!
!≥!1!year!
!≥!2!years!
!≥!3!years!
!≥!4!years!
!≥!5!years!
!≥!6!years!
!≥!7!years!
!≥!8!years!
!≥!9!years!
Thank!you!very!much!for!completing!this!questionnaire!
!
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Appendix M: Interview schedule 
!
LSRP!Interview!Schedule!
!
!
Research!question:!What!is!the!impact!on!identity!of!women!diagnosed!with!antiMNMDAR!
encephalitis?!
!
Second!(theory!driven)!question:!To!what!extent!does!the!commonMsense!model!of!illness!
help!us!to!understand!women’s!experience!of!antiMNMDAR!encephalitis!and!its!impact!on!
their!identity?!
!
!
Impact!!
!
1.! Can!you!tell!me!about!the!role!antiMNMDAR!has!in!your!life!at!the!moment?!
Prompt:(Do(you(feel(unwell(at(the(moment?(How(do(you(cope?(
!
2.! Can!you!tell!me!about!if!and!how!you!think!your!life!has!changed!since!having!antiM
NMDAR?!!
Prompt:(For(example,(the(people(who(are(important(to(you.(
(
3.! Has!having!antiMNMDAR!changed!your!plans!for!the!future,!and!if!so!how?!
Prompt:(Life(goals(such(as(relationships,(career.(Then:(How(do(you(feel(about(this?(
!
!
Explanation!for!cause!
!
4.! Sometimes!people!go!think!about!why!they!might!have!developed!a!particular!illness,!
do!you!have!any!ideas!around!why!you!think!you!in!particular!developed!antiM
NMDAR?!!
Prompt:(Doing(a(particular(activity?(Eating(a(particular(diet?(
!
5.! What!do!you!think!other!people!believe!is!the!cause!of!your!antiMnmdar?!
Prompt:(Family,(health(professionals(
!
!
Controllability/Timeline!
!
6.! Do!you!view!yourself!as!being!an!‘ill’!person!now!and!how!has!this!changed!over!
time?!
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Prompt:(Did(you(ever(view(yourself(as(an(ill(person?(Do(you(now?(
(
7.! What!or!who!do!you!think!has!been!instrumental!in!controlling!your!illness?!
Prompt:(For(example,(health(professionals,(family,(a(particular(treatment.(
(
Identity!!
(
8.! Before!you!developed!antiMNMDAR!how!did!you!feel!about!yourself?!
Prompt:(For(example(your(abilities,(qualities(as(a(person,(selfDimage.(
(
9.! How!do!you!think!others!viewed!you!before!the!diagnosis?!
Prompt:(For(example(how(would(they(define(your(personality?(
(
10.!Has!antiMNMDAR!changed!the!way!you!view!yourself!now,!in!what!way?!
Prompt:(Has(it(affected(for(example(your(confidence,(your(personality,(your(priorities(
in(life?(
(
11.!Do!you!think!having!this!condition!has!changed!the!way!others!view!you!now?!
Prompt:(Do(others(treat(you(differently(now?(Family/friends/mental(health(
professionals?(
!
Conclusions!and!Reflections!on!the!Interview!
Thank!you!for!taking!part!in!the!interview,!how!did!you!find!it?!
Is!there!anything!else!you!would!like!to!add?!
!
(
!
(
!
(
!
!
!
!
!
!
!
!
!
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Appendix N: Example of an annotated script 
 
.! hasn’t sort of talked through 
himself and also just the 
practicalities of the impact on the 
business, things like that? 
#00:21:17-0#  
.!  
.! respondent: exactly 
#00:21:17-0#  
.!  
.! interviewer: Ok, has having 
anti-nmdar changed your long 
term plans for the future do you 
think? #00:21:27-7#  
.!  
.! respondent: Yea I think, 
before I got sick I was studying 
theology and um like my hope 
was to be a teacher and uh I 
continued my degree after after 
my year out but my confidence 
was really affected at the time 
and I just couldn’t and my dream 
of being a teacher or whatever is 
was at the time sort of strayed  
#00:21:58-9#  
.!  
.! interviewer: Yea #00:22:00-
1#  
.!  
! respondent: Yes but like I I 
always valued kind of you know 
Emergent Themes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Denial to protect self 
 
 
 
 
 
 
 
 
 
Change of career plans 
 
 
 
 
 
Illness as a gift 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exploratory Comments 
 
 
 
 
 
 
 
 
 
 
 
Describes illness almost 
as a choice ‘year out’ 
 
 
Minimising of her 
previous dream- perhaps 
as feels she would no 
longer be able to achieve 
this? 
 
 
 
 
 
 
 
 
 
 
 
Describes illness almost 
as a gift, insight it’s 
given her 
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kind of talking with people and 
being with people you and I 
think my perspective at the 
time and everything I’d been 
through and everything erm 
like the life experience I had 
been offered through this 
experience I kind of you know 
I thought this would be a great 
opportunity for me to come 
into a role where I’m kind of 
available for somebody you 
know like cancer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exploratory Comments 
 
 
 
 
 
 
Why mention cancer? 
More understandable 
illness or socially 
acceptable? 
 
 
 
 
 
 
 
 
Emergent Themes 
 
 
 
 
 
 
 
Striving for legitimisation 
 
! 133!
Appendix O: Example of coding for themes with numbers on each transcript 
 
Emergent themes Transcript 1 
Working subordinate themes: 
11! Strength!
21! Old!self!as!superior!
31! Low!self1esteem!
41! Loss!of!role/impact!on!life!trajectory!
51! Relationship!with!Dr/illness!(medicalization/special)!
61! Compassion/empathy!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Living with uncertainty 
 
Blaming of oneself 3 
 
Denial (of loss & considering cause) 
 
Medical skepticism 
 
Jealousy towards those recovered 
 
Depersonalising 
 
Comparisons to other illnesses 
 
Questioning why 
 
Impact across life 4 
 
Physical & Emotional impact  
 
Developmental disruption/regression 4 5  
 
Loss of intelligence 3 
 
Loss of professional career 4 
 
Sense of freedom 1 
 
Criticism of past self 2  
 
Transitions/growing up 4 5 
 
Finding inner strength 1 
 
Selfishness/selflessness 6 
 
Idealising of former self 2 
 
Self-esteem 3 
 
Mental health 
 
Personality change 2 
 
Impact on relationships 
 
Loss of friends 
 
Acknowledgment of struggles 
 
Historical mental health difficulties 
 
 
 
 
Reversion to old self 2 
 
People not understanding 
 
Feeling overprotected 5 
 
Frustration 
 
Anger at illness  
 
Having no one to blame 
 
Fear of judgment 3 
 
Rejection of sick role 2 
 
Loss of identity 2 
 
Medicalisation 5 
 
Relearning skills 
 
Loss/misplacement of social skills 3 
 
Gaining independence  
 
Expert patient 
 
Steroids 
 
Impact of medication 
 
Relationship with doctor 5 
 
Dependency on others 
 
Embarrassment at disability 3 
 
Difficulty coping 
 
Physical versus emotional support 
 
Relief at being alive 
 
Strength 1 
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Appendix P: Refining subordinate themes, creating Superordinate themes and finding 
complementary quotes 
 
 
 
Working subordinate themes Transcript 1: 
•! Increased mental strength 
•! Old self as superior 
•! Low self-esteem 
•! Loss of role/impact on life trajectory 
•! Relationship with health care professionals/illness (medicalisation/special) 
•! Compassion/empathy 
 
 
Working subordinate themes Transcript 2: 
•! Increased mental strength 
•! Compromised 
•! Psychotic symptoms 
•! Loss of career 
•! Best patient 
 
 
Working subordinate themes Transcript 3: 
•! Low self-esteem 
•! Career 
•! Increased mental strength 
•! Feeling special  
•! Compassion/empathy 
•! Motherhood 
 
Working subordinate themes Transcript 4: 
•! Increased mental strength 
•! Psychotic symptoms 
•! Re-emerging 
•! Education 
•! Relationship with Dr 
 
Working subordinate themes Transcript 5: 
•! Comparison to other illnesses 
•! Re-emerging 
•! Low self-esteem 
•! Impact on life trajectory 
•! Treated as special by family 
•! Compassion/empathy 
 
Working subordinate themes Transcript 6: 
•! Old self as superior 
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•! Feeling less than 
•! Impact on career 
•! Treatment by family and friends 
•! Compassion/empathy 
 
Working subordinate themes Transcript 7: 
•! Old self as superior 
•! Low self-esteem 
•! Severity of illness 
•! Motherhood 
•! Treatment by healthcare professionals 
•! Helping others/giving back 
 
Working subordinate themes Transcript 8: 
•! Increased mental strength 
•! Severity of symptoms  
•! Re-emerging 
•! Cognitive difficulties (feeling compromised) 
•! Impact on motherhood 
•! Helping others/giving back 
 
 
Subordinate themes revised: 
 
Re-emerging 
Factors pertaining to abnormality 
Feeling Special 
Feeling compromised 
Increased mental strength 
Increased compassion and empathy 
Change in career/education 
Impact on motherhood 
 
 
Superordinate themes: 
 
Superordinate theme 1= Re-emerging 
 
Superordinate theme 2 –Feeling ‘special’  
 
Superordinate theme 3= Evolving from the illness  
 
Superordinate theme 4= Revised roles 
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Refining of theme titles:  
 
Re-finding the ‘normal’ self: ‘I’m kind of starting to getting back to normal’ (Transcript 4; 
359) 
  
A ‘special’ identity: ‘He always called me his star patient’ (Transcript 5; 167) 
 
Evolving from the illness: ‘I’m a much stronger person now’ (Transcript 6; 395) 
 
Revised roles: ‘I’ve just felt really inspired to write my own path’ (Transcript 3; 222) 
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Appendix Q: Emergent themes lifted from each transcript  
 
 
Transcript 5 
 
Living in the present 1 
 
Emotional liberation 1 
 
Happiness with life now 1 
 
Thankful for recovery 1 
 
Increased respect for self 1 
 
 
Transcript 6 
 
Stronger person 1 
 
Self as a fighter 1 
 
 
 
Transcript 1 
 
Sense of freedom 1 
 
Selfishness/selflessness 1 
 
Strength 1 
 
Transcript 2 
 
Illness improving the self 1 
 
Improved mental health 1 
 
Strength 1 
 
Greater clarity 1 
 
Transcript 3 
 
Prioritizing of wellbeing 1 
 
Change in life perspective/prioritization 1 
 
Strengthening of relationships 1 
 
Greater self-care 1 
 
Positives of illness 1 
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Appendix R: Frequency of subordinate themes within transcripts (including line numbers) 
 
Subordinate 
Theme 
Rachel 
 
Jane Natalie Laura Sarah Katie Bridget Holly 
Re-emerging from 
the illness 
 121; 337; 
341 
206; 495; 
644 
347; 359 276 50  19; 429 
Factors pertaining 
to ‘abnormality’ 
(psychosis, rarity, 
severity) 
 313 443; 449 19; 315 38;   573 
Feeling’ special’ 48; 76; 
141;161; 
363; 385 
181 507; 538  162;   209;213  
Feeling 
‘compromised’ 
44 63 69; 145; 
589; 644 
  34; 272; 303 377 3; 293; 358 
Feeling stronger 332 1; 267  255; 395 19; 383; 
387; 415; 
435 
133;   
Increased 
compassion and 
empathy 
68  672 167; 423 84;    
Change in 
career/education 
44; 48; 96; 100 210; 214 143; 171; 
407 
85; 89; 104 341; 113 357; 377  
Impact on 
motherhood 
  522  7  488; 492 271; 274 
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Appendix S: Respondent verification 
 
A summary of the super and subordinate themes was emailed to the participants for their 
opinion on the derived themes, whether they felt they resonated with their personal experience 
and whether they felt the concepts would be useful for the community. Half of the participants 
responded verifying that the themes resonated with their perspective and welcoming the 
findings as providing legitimacy for them in voicing their experience.  
 
Sarah: 
 
“I've just got a chance to read your analysis and I have to say it really speaks to me and I feel 
it captures my journey in a very wholesome way.  In many ways this is the first time I have 
read an academic piece that focuses on the inner/emotional journey of people who have 
survived this illness. For me, that was the first part of the recovery process that I had any control 
over and the part that really emphasised to me what it takes for me to be "normal" again.  I 
appreciate the point of view you have captured with your research and feel that it will contribute 
greatly to people understanding this condition more.   
I can only thank you again!” 
 
Rachel: 
 
“Thanks for sending me your draft. It sums everything up well and I think the topics covered 
are very relevant and are able to reflect individual’s experiences. It was interesting to know 
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that others have really gone through the same experience and have felt the exact same, in some 
cases.” 
 
Bridget: 
 
“Thank you! It is awesome! Thank you also for bringing light to this ugly disease! If you ever 
need anything else, please let me know” 
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Appendix T: Researcher’s Position Statement 
 
This position statement outlines the potential influences on the researcher, it was developed via 
the process of reflexive bracketing (Ahern, 1999).  
 
The researcher writes from the position of a single, twenty-eight-year old British middle-class 
trainee clinical psychologist. The researcher’s aim is to gain a doctorate in clinical psychology 
and possibly have the work published. With regards the power hierarchy, the researcher sits 
below the thesis supervisors (qualified clinical psychologists). The researcher potentially sits 
above the participants given their qualifications and the position of being an interviewer. The 
researcher only had one experience of working with this client group, whilst working as an 
assistant psychologist within a neuropsychology department. Once the neuropsychological 
assessment had been conducted and the results fed back to the patient, the patient revealed that 
they did not find the process very helpful for their wellbeing. This was because it highlighted 
to them their cognitive weaknesses and how much ‘intelligence’ they felt they had lost since 
having had the illness. This perspective led the researcher to consider the utility of 
neuropsychological assessments, as well as the overall cognitive profile of this population. It 
was this initial exposure that led to an interest in the illness and subsequent reading of the book 
Brain on Fire: My month of madness (Cahalan, 2013). This revealed to the researcher how 
novel the illness is and the potentially difficult road to diagnosis and treatment. As well as the 
perceived unpleasantness of the initial psychiatric symptoms. Combined, this motivated the 
researcher to investigate this population. 
The researcher recognises that given their previous experience in a neuropsychological 
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department, there is a tendency to over focus on the cognitive difficulties an individual might 
have and the impact of these on their wellbeing and identity. The researcher has also worked 
on a six-month placement in a recovery and rehabilitation unit for people with severe and 
enduring mental health difficulties, predominantly schizophrenia, and has an interest in 
psychotic experiences. Therefore, this also may be an area the researcher is drawn to in the 
analyses. The group of participants will be working age females, like the researcher, and so it 
must be considered that the researcher may at times draw parallels between herself and the 
participants. This will need to be reflected on throughout the interviews and analyses.  
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Appendix U: Extract from Reflexive Diary  
 
10th September 
 
I have my fifth interview booked in for this evening. The participant is in another country and 
so I will be staying up late to do the interview via Skype. I need to be aware that my tiredness 
may make me rush the interview and potentially make more assumptions. I have completed the 
demographics sheet with the participant and know that she is quite young and had anti-
NMDAR whilst she was a teenager. I need to not make assumptions about how this may have 
affected her cognitive and social development, for example her scholastic attainment and 
ability to build peer friendships. I know I have an interest in neuropsychology, and also 
neurology, so must not let this dictate the direction of the interview.  
 
11th September 
 
I think that my interest in the illness generally, it’s trajectory, how it is treated, what the side 
effects are and long term effects, are affecting my follow-up questions and potentially 
becoming more medical, in order to satisfy my own curiosity. I need to be aware of this when 
I go into the next interview and analyse the data.  
 
19th September 
 
I have just conducted my sixth interview and I think I am summarising and reflecting too much, 
as I would in a clinical psychology assessment. I think that next time I should allow for more 
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silences so that the true phenomena can come to light, as opposed to trying so much to put the 
participant at ease and let them know that I empathise with what they’ve been through.  
 
1st October 
 
I have my seventh interview tonight and I need to remember not to go into the interview as a 
clinical psychologist trying to elicit therapeutic change, but rather as a researcher trying to 
explore the phenomena of the illness for this particular group of women. The participant tonight 
was very informal and chatty over their email when arranging this interview, therefore I need 
to be mindful of maintaining boundaries and a level of professionalism whilst building 
therapeutic rapport. It will be important to try to strike this balance.  
 
2nd October 
 
I think I managed to keep a professional boundary in the interview last night and think it was 
a successful interview with a lot of rich data, as the participants spoke at length for 90 minutes 
and was very self-reflective, to a level I was not expecting for someone who does not reflect 
as part of their profession. This just goes to show that you should try not to have preconceptions 
about what a person will speak about. I am feeling so grateful for the time these women are 
taking to email me, send the consent forms back etc. and to do the interviews, particularly as 
they are not being paid. At the end of the interviews the majority of participants are thanking 
me for conducting this research, which they feel needs to be done. I find this a very humbling 
experience as I do not feel that I am doing anything particularly impactful at this stage, 
however, on reflection this study could have an impact for the community once it is written up 
and disseminated. On listening to the transcript back I notice that I double up my questions, 
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which means that the participant either gets a little confused or only answers one question. I 
need to stick to asking one question and pause, instead of qualifying it with another question, 
as this is making the data a bit messier perhaps? 
 
13th October 
 
The eighth participant was the only participant that was not Caucasian and was brought up in 
a non-Western culture. I felt during the interview that the cultural difference was quite 
apparent, particularly when the participant was discussing her families views on the psychiatric 
symptoms. She was explaining that they did not understand why she was behaving in the way 
that she was and that they thought she was very “weird”. This was made more difficult as her 
mum (who was the person who supported her most) does not speak very good English and so 
could not have the psychiatric symptoms qualified by the doctor. I felt quite shocked by this 
lack of understanding and empathy for the participant by their family and had sympathy for 
her. However, I was very mindful of reflecting on this (in my mind) during the interview and, 
whilst we discussed the impact of this on her, I made a conscious effort not to show any shock 
I felt at this or to ‘side’ with the participant. I also tried not to make any assumptions on the 
what the participant would be thinking and feeling or make predictions on how they would 
answer the rest of the questions based on their cultural background. I think I was successful, in 
as much as you can be perhaps, in bracketing off my opinions and preconceived ideas about 
collectivist culture.  
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20th October 
 
This participant seemed to have difficulty discussing the psychiatric symptoms and was keen 
to move on from any line of questioning about this. I found this very interesting and perhaps 
stayed on this topic too much. I need to be mindful of my interest in psychosis and not lead the 
questioning in this direction/stay on this topic when the participant wants to move on. Also, I 
am aware that it may just be my perception that they did not want to be associated with 
psychiatric illness, when actually they may not have thought it was very relevant. I need to 
think about this some more when I listen to the transcript back and begin to transcribe, see if I 
can notice any nuances in the way they spoke about the psychiatric symptoms.  
 
20st November 
 
I met with Jenny Mercer today to show her my exploratory comments and emerging themes. 
She discussed with me different ways of beginning to cluster the themes. I am feeling a bit 
overwhelmed as there seems to be quite a lot of themes and not all of them related to identity, 
which is my research question. Jenny encouraged me to re-focus on what it is I am asking in 
the research question and to just disqualify anything else even if it is interesting data. I find this 
hard as I want to do justice to everything that the participants shared with me. However, this is 
something I need to do to keep the empirical study focused. I am trying to let the data speak 
for itself and not draw upon the literature I have carried out so far, for example on biographical 
flow and disruption. I do not think I am thinking about scientific theories very much when 
considering themes, as the data is so rich with the patients’ experiences that they are more 
dominant in my mind.  
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28th November 
 
Feeling overwhelmed again, I don’t know whether this is just the nature of the research process, 
of trying to bring things together like pieces of a jigsaw puzzle. Or if, because I am listening to 
the interviews, I am somehow assimilating the feelings of the participants of feeling 
overwhelmed by their illness. I expect it is a combination of both. However, there are some 
very interesting and novel themes now emerging, which I am pleased with.  
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Appendix V: Email from participant regarding taking part in the study 
 
Re:!Debriefing!sheet!
!
XXX!XXX!<XXX.XXX@gmail.com>!
!!!
!!
Reply!all|!
Thu!07/07/2016,!16:07!
Della!Nicolle!
Inbox!
Flag!for!follow!up.!!
Hi! Della,! absolute! pleasure! and! thanks! for! lending! your! expertise! to! finding! out!more! about!
ANMDARE.!It!was!very!easy!to!talk!to!you!and!that's!such!a!gift.!Thank!you!so!much!and!best!of!
luck!with!your!study.!I!have!contacted!X!in!X!for!you!too.!!!
!
Kind!regards,!!
X!
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Appendix W: Debriefing sheet 
 
!
!!
!
!
Debriefing)Sheet)
)
Title)of)Project:)Impact!on!identity:!An!interpretative!phenomenological!study!of!women!who!
have!been!diagnosed!with!antiXnmdar!encephalitis)
Name)of)Researcher:!Della!Nicolle!
!
Thank)you!
!
Many!thanks!for!taking!part!in!this!study.!We!hope!that!you!have!found!it!interesting.!Please!
feel!free!to!ask!the!Researcher!any!questions!you!have!about!the!interview!and!the!research!
area.!
!
!
What)was)the)purpose)of)the)study?)
!
This!study!investigated!women’s!experiences!of!having!a!diagnosis!of!antiXnmdar!encephalitis,!
how!you!get!by!from!day!to!day!and!cope.!We!were!also!interested!in!how!you!think!your!
identity!has!changed!since!diagnosis.!As!you!know,!antiXNMDAR!is!a!relatively!new!diagnosis,!
having! gained! official! recognition! in! 2007,! and! as! such! there! has! been! little! research,!
particularly!qualitative,!about!people’s!experience!of!this!disease.!We!felt!it!was!vital!to!begin!
to!explore!the!individual!experience!of!antiXNMDAR,!in!order!for!people’s!voices!to!be!heard!
and!to!help!improve!services!for!people!with!antiXNMDAR!encephalitis,!whilst!also!increasing!
public!awareness!of!the!disease.!
!
Please!note!that!the!data!analysis!can!be!very!lengthy.!The!researcher!may!not!be!able!to!give!
you!any!feedback!as!to!what!was!found!until!the!middle!of!2017!However,!if!you!would!like!
to!be!contacted! in!the!future!regarding!the!final!write!up!of!the!study!then!please! let!the!
researcher!know.!
!
!
!
)
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Are)the)procedure)and)results)confidential?)
!
The!audio!recording!of!your!interview!will!be!deleted!once!it!has!been!transcribed.!
All!information!that!is!collected!about!you!during!the!course!of!the!study!will!be!kept!strictly!
confidential.!This!means!that!in!the!writeXup!of!the!study,!your!name!and!any!information!
that!could!be!used!to!identify!you!will!be!removed!or!changed.!!
!
!
What)will)happen)to)the)results)of)the)research)study?!
!
Where! appropriate,! the! results! of! this! study! will! be! presented! at! medical! and! scientific!
conferences! and! published! in! journals.! The! results! may! also! be! disseminated! by! The!
Encephalitis!Society!via!their!website,!newsletters!and!conferences.!You!will!not!be!identified!
in!any!report,!presentation!or!publication.!The!results!of!this!study!may!also!help!us!to!design!
future!research!projects!and!future!researchers!may!use!your!anonymised!data.!
!
!
What)do)I)do)if)I)am)unhappy)with)the)way)I)was)treated?)
)
In!the!first!instance,!you!should!contact!the!supervisor!of!the!leader!of!the!Research!Project:!
!
Dr!Jennifer!Moses!
Consultant!Clinical!Psychologist!and!Academic!Director!
Cardiff!University!
Email:!Jenny.Moses@wales.nhs.uk!
Telephone:!+44!(0)29!208!70582!
!
If!you!are!still!unhappy,!you!should!contact!the!relevant!Ethics!Committee:!
!
Psychology!Ethics!Committee!Secretary!
School!of!Psychology!
Cardiff!University!
Tower!Building!
Park!Place!
Cardiff!
CF10!3AT!UK!
!
Tel:!029!2087!4007!
Fax:!029!2087!4858!
Email:!psychethics@cf.ac.uk!
!
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!
What)if)I)have)become)distressed)as)a)result)of)this)study?)
)
If!you!have!found!the! interview!distressing!you!can!contact!Dr!Jennifer!Moses,!Consultant!
Clinical! Psychologist! on! 02920! 870582! for! further! support! or! the! Encephalitis! Society,!
Website:! www.encephalitis.info! Email:! mail@encephalitis.info.! Your! doctor! is! also! an!
important!person!to!speak!to!if!you!are!distressed!and!concerned!about!yours/others!safety.!
)
)
Who)has)reviewed)the)study?!
!
This!study!has!been!reviewed!and!approved!by!the!Cardiff!University!School!of!Psychology!
Ethics!Committee.!
!
!
Contact)for)Further)Information!
!
!
Della!Nicolle!!
Trainee!Clinical!Psychologist!
Telephone:!+!44!(0)29!208!70582!!
EXmail:!NicolleD@cardiff.ac.uk!
!
!
We! would! just! like! to! take! this! opportunity! to! say! once! again,! many! thanks! for! your!
participation!in!this!study!and!all!the!very!best!for!the!future.!!
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4.! Commentary 
 
 
A critical evaluation of the empirical paper and systematic review investigating the 
impact of anti-NMDAR encephalitis 
 
D. Nicollea* 
aDoctorate Clinical Psychology, Cardiff University, Cardiff, Wales; bCardiff School of 
Health Sciences, Cardiff Metropolitan University, Cardiff, Wales 
*NicolleD@cardiff.ac.uk 
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4.1 Abstract 
This paper offers a critical appraisal with discussion of the strengths and limitations of the 
papers and their line of enquiry, as well as implications for further research and clinical 
practice. Ethics and diversity are considered for the empirical paper and personal and 
professional development is discussed overall, along with a reflection on the research process. 
The commentary is divided into, firstly, discussion of the systematic review and secondly the 
empirical paper. The two papers are considered together for the dissemination plan, to discuss 
their potential impact for the anti-NMDAR encephalitis community.  
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4.2 Commentary on the systematic review 
4.2.1 Strengths and weaknesses of the present study  
Given that there is such a paucity of research in this area it could be argued that a systematic 
review is premature, and this was considered extensively within supervision. Broad search 
terms (anti-NMDAR OR Anti-N-Methyl-D-Aspartate AND encephalitis AND 
Neuropsycholog* OR cogniti*) were used to try to capture any neuropsychological articles 
within this area. Despite this wide-ranging approach only four appropriate studies could be 
located (Bach, 2014; Finke et al., 2012; 2013; Marcos-Arribas et al., 2013) during the time 
allocated for searching for papers (May 2016 to December 2016). However, at the beginning 
of 2017, four newly published studies were found whilst undertaking a final searching 
(Loughan et al., 2016; McKeon et al., 2016; McIvor & Moore, 2017; Urakami, 2016) and a 
further two via hand searching of these references (Martin-Monzon et al., 2012; Vahter et al., 
2014). Therefore, once ten papers were identified, this was deemed sufficient to begin to 
investigate the neuropsychological sequelae of anti-NMDAR. It is possible that the search 
terms were too broad and neuropsychological studies missed. However, a trial was conducted 
of different search terms, before applying the chosen string systematically across databases, 
and the former string captured more appropriate studies. A strength of the systematic review is 
that, to the best of the researcher’s knowledge, this was the first attempt at synthesising 
neuropsychological data to try to draw together a cognitive profile for anti-NMDAR.  
A quality assessment tool was created for this systematic review as a literature search 
revealed no existing tool to assess the quality of neuropsychological case studies and case 
series. A search of other systematic reviews of neuropsychological case studies/series revealed 
it was typical for a tool to be created for the purpose of their study (Mahan, Rous, & Adlam, 
2017; O׳Sullivan & Newman, 2014), highlighting the need for professional consensus on a 
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validated quality tool. The tool created for this review appeared to be successful (k=0.72) in 
capturing quality indices such as, whether the studies reported pertinent background 
information and described the procedure in replicable detail. However, it perhaps did not 
manage to weight the importance of completing a case series and assessing more than one 
patient. Therefore, single case studies such as Loughan et al., (2016) scored higher on the 
checklist, whereas other, larger scale, studies such as Finke et al., (2013) scored lower. This is 
despite the study by Finke et al., (2013) potentially having greater impact and generalisability. 
Furthermore, whilst scoring, some of the factors appeared more prone to subjectivity than 
others, for example determining whether the informant perspective on cognitive functioning 
was sought. In Loughan et al., (2016) there was a narrative report of the clinical interview “mild 
daily forgetfulness was noted”, however, it was unclear whether this was the clinician’s 
perspective, the informant’s or the participant’s. Consequently, at times the rater’s scores 
differed. Moreover, even though the tool identified weaker papers, these were not then 
excluded due to the lack of a psychometric basis on which to operate a cut-off. For instance, 
the Standard Quality Assesssment Tool for Evaluating Primary Research Papers from a Variety 
of Fields (Kmet, Lee and Cook, 2004) has a cut-off of 50% and Ghannouchi, Speyer, Doma, 
Cordier and Verin (2016) have operated this cut off to exclude papers falling below 50% on 
Kmet et al’s (2004) scale. As such, further development of this tool would be recommended 
for any future portfolio research.  
There could be a case for this review to have focussed more on the chronic phase of the 
illness, as opposed to both stages, for a more in depth analysis. As the systematic review 
discusses, it is likely that cognitive functioning would be different at the various stages of 
recovery, due to the systemic effects of the illness and factors such as side effects of medication 
(Buchman, 2001; Ikeguchi et al., 2012; Cancer Research UK, 2015; Mayo Clinic, 2017). 
Current theory is that the antibodies cause selective but reversible decrease in NMDAR surface 
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density and synaptic localisation, which then deregulates the glutamatergic pathways, and 
although NMDARs can be reactivated, some neuronal damage may remain (Martin-Monzon 
et al., 2012; Finke et al., 2016). Arguably, the most effective time to assess for a cognitive 
profile is once recovery is more established, for example after the 12-month period. This could 
then elucidate longstanding cognitive effects of anti-NMDAR itself. However, it was felt that 
understanding the neuropsychological sequelae of the acute phase could prove useful to 
neuropsychologists assessing patients within this period. It could help inform the support and 
management patients need at this time. 
This current review focused on an adult population, using 18 years as a cut-off point, 
based on the general UK definition of an adult (GOV.UK, 2014). An adult population was 
chosen due to the specificities of neurodevelopment on cognitive functioning. Furthermore, 
currently there are fewer published paediatric studies and as yet there is not an established adult 
cognitive profile for anti-NMDAR. Therefore, this systematic review may provide a model for 
a similar review of research emergent from work on anti-NMDAR in the paediatric population. 
There are a number of neurological case/cohort studies and series that appear to combine adult 
and paediatric cases (Dalmau et al., 2007; Iizuka et al., 2010; Titulaer et al., 2013; Chen et al., 
2016). McKeon et al., (2017) included patients that were 16 years of age. Therefore, it could 
be argued that 16 is a more appropriate cut-off for the adult population, given that young people 
are deemed to have capacity to consent to treatment from age 16 (Care Quality Commission, 
2015). However, 21 up to 30 years could also be argued to be a more appropriate cut-off for an 
adult population due to increasing neuroscientific evidence that synaptic pruning continues 
well into adulthood, particularly in the frontal lobes (Johnson et al., 2009). Furthermore, 
differences in child and adult presentations of anti-NMDAR have been reported (Florance et 
al., 2009; Dalmau et al., 2011; Zhang et al., 2017). Considering the epidemiology of anti-
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NMDAR and the neuro-developmental psychology of adolescence, 18 was chosen as an 
appropriate compromise. 
Examination of the impact of the timeliness of immunosuppressive treatment on 
cognitive outcome was beyond the scope of this systematic review, particularly given that this 
information was not explicitly provided in at least four of the articles. However, researchers 
did report significantly better cognitive outcome in patients with early immunotherapy in 
comparison with patients with delayed treatment (Finke et al., 2012; Urakami, 2016). This 
finding has been more recently replicated in children (Matricardi et al., 2016).  
 
4.1.2 Limitations of the articles and line of enquiry 
As discussed in the systematic review, whilst a cognitive profile appears to be emerging from 
current neuropsychological studies, there remains a scarcity of research in this area, particularly 
high quality research. Reporting of the cases was typically weak, with insufficient detail given 
to pertinent neuropsychological variables such as premorbid intellectual functioning, 
psychiatric history and any existing acquired brain injury (Lezak, 2012; Hebben & Milberg, 
2009). Without full reporting of historical information, the association between cognitive 
difficulties and anti-NMDAR remains uncertain and subject to question. Furthermore, often 
participants were acting as their own control, but sufficient discussion was not given to 
replicable detail. Therefore, if a change in score is found, it cannot be solely attributable to the 
effects of the illness.  
Additionally, a specific battery of cognitive assessments has not yet been devised to 
screen for cognitive deficits in anti-NMDAR (Bornstein, 1990). Whilst there were overlaps 
between tests used across the studies, there remains disparity between the cognitive domains 
tested and which tests are used to examine performance in these domains (Appendix F). A 
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‘scattergun’ approach appears to have been used, which could have led to Type I errors (Schatz 
et al., 2005).  
As mentioned in the systematic review, it is also important to consider the ecological 
validity of neuropsychological assessments; most tests currently used were not specifically 
designed to predict real-life functioning, such as the ability to live independently or return to 
work (Chaytor & Schmitter-Edgecombe, 2003; Sbordone, 2001). In many tests, the real-world 
context is absent and so the tests can be completed with little distraction, which can give an 
artificial performance. One approach utilised to address ecological validity is the verisimilitude 
approach, whereby tests attempt to emulate the cognitive demands of day-to-day life (Spooner 
& Pachana, 2006). Such tests include The Test of Everyday Attention (TEA; Robertson et al., 
1996), the Behavioral Assessment of the Dysexecutive Syndrome (BADS; Wilson et al., 1996), 
the Rivermead Behavioral Memory Test (RBMT; Wilson, Cockburn, & Baddeley, 1985), and 
the Cambridge Test of Prospective Memory (CAMPROMPT; Wilson et al., 2004). A second 
approach to consider ecological validity is veridicality; statistical analyses are used to assess 
the relationship between performance on traditional neuropsychological tests, (such as, 
Wechsler Memory Scales—Fourth Edition, 1997) and measures of everyday functioning (such 
as, employment status, clinician's ratings, behavioral observations) (Spooner & Pachana, 
2006). These approaches have both been used to assess ecological validity of 
neuropsychological tests in people with a traumatic brain injury (Cuberos-Urbano et al., 2013; 
Odhuba, Broek, & Johns, 2005). Whilst some neuropsychological tests may not have been 
designed to predict how people would live day-to-day, Jung (2017) argues they have 
advantages. Typically, they have standardised norms, which allows for group comparisons, and 
they more directly assess cognitive performance than other injury/severity related assessments, 
such as the Glasgow Coma Scale or location of a lesion (Jung, 2017). Furthermore, they can 
be completed in conjunction with imaging techniques to give greater evidence for cognitive 
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impairment and whether this relates to functioning (Martin-Monzon et al., 2012). For example, 
using resting state fMRI, Finke et al., (2013) found significantly reduced functional 
connectivity between the anterior hippocampus and the anterior default mode network, which 
correlated with individual memory performance on a neuropsychological test battery in 24 
participants. More recently, Finke et al., (2016) found reduced volumes of hippocampal input 
and output structures and impaired microstructural integrity, which strongly correlated with 
memory performance in 40 patients with anti-NMDAR. Considering these studies, there is an 
argument for the pairing of neuropsychological testing and brain imaging to track the pathology 
of the illness (Finke et al., 2012). Harvey (2012) asserts serial neuropsychological assessment 
alone will likely be a cheaper way of tracking cognitive functioning, rather than repeated 
scanning. Furthermore, there is an argument that imaging techniques for assessing cognitive 
functioning in brain injury patients are not always reliable (Bigler, 2001). Bigler (2001) claims 
brain lesions are not always detected via traditional MRI scans and that absence of detectable 
abnormalities does not always mean there is an absence of functional abnormality. However, 
Lees-Haley et al., (2003) argue not to assume cognitive dysfunction without evidence, also not 
to underestimate psychological explanations for any cognitive effects that are observed, such 
as effort, response bias and compensation-related contexts, which were largely not addressed 
in the current studies. Therefore, arguably neuropsychological testing can help elucidate 
cognitive impairment, particularly when combined with a comprehensive clinical interview, 
effort tests and clinical observation (BPS, 2009). Importantly, when ecological validity is 
addressed, neuropsychological testing can help inform clinicians regarding a person’s day-to-
day functioning and assist in informing neurorehabilitation plans (Bach, 2014; Bradley, 2015; 
Loughan et al., 2016; Martin-Monzon et al., 2012; Urakami, 2016). Finke et al., (2012) assert 
that neuropsychological testing can help to monitor the illness activity after the acute stage and 
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track the “precise characterisation” of any cognitive difficulties, which would be important for 
“appropriate neuropsychological rehabilitation”.  
As discussed in the systematic review there was little examination of the interaction 
between cognitive functioning, QoL and psychological wellbeing across the 
neuropsychological studies. Only Bach (2014) administered a formal QoL measure 
(QOLIBRI-OS; von Steinbuechel et al., 2012), finding significant increases in satisfaction at 
follow-up. Psychological wellbeing (such as levels of anxiety and/or depression) was explored 
in four of the ten articles (Bach, 2014; Finke et al., 2012; Loughan et al., 2016; McIvor & 
Moore, 2017; McKeon et al., 2016). Researchers who did assess psychological wellbeing 
largely administered either the Hospital Anxiety and Depression Scale (Snaith, 2003) or the 
Beck Anxiety and Depression Inventories (Beck 1990;1996). One of Bach’s (2014) patients 
showed a significant increase in anxiety from baseline to six-month follow-up (HADS score 9 
to 15) and McKeon et al., (2016) found a significant difference between control and anti-
NMDAR patient anxiety scores, the latter of which were just within ‘caseness’ i.e. clinical 
levels of depression/anxiety. However, it is not possible to draw conclusions on patients’ level 
of distress based on this limited set of research outcomes. Both depression and anxiety would 
be important to consider in future studies; understanding people’s level of distress is crucial if 
appropriate psychological support is to be offered. Furthermore, with regards 
neuropsychological testing, distress can impact an individual’s ability to fully concentrate on 
the cognitive tasks at hand, due to either a heightened arousal system and/or their mind 
understandably being preoccupied with psychological stress (Lezak, 2004 p. 127). Only the 
latter two articles (Bach, 2014; McKeon et al., 2016) discussed the impact of mood on day-to-
day functioning. Specific psychosocial difficulties such as the impact on identity (Charmaz, 
1983; 2000), were also not explored in these articles, which gave rise to the focus of the 
empirical study. 
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A further consideration is the studies’ aims and their utility. As these are the first 
neuropsychological studies investigating anti-NMDAR, largely their aim was to report on 
neuropsychological sequelae (Finke et al., 12; 13; Loughan et al., 2016; Marcos-Arribas et al., 
2012; McIvor & Moore, 2017; Vahter et al., 2014). However, four of the studies did aim to 
elucidate effective rehabilitation methods for this population (Bach, 2014; Loughan et al., 
2016; Martin-Monzon et al., 2012; Urakami, 2016). Nevertheless, none of the studies reported 
on the patients’ understanding or views on being tested, nor how it benefited them as 
individuals, with regards person-centred care (NHS Wales, 2017). Therefore, whilst the studies 
were beneficial to furthering understanding of the illness, there is a need for questions around 
the ethics of conducting, sometimes quite lengthy, neuropsychological batteries (Wong, 2006). 
Attention should be paid to the third BPS ethical principle of ‘Responsibility’, within the Code 
of Ethics and Conduct (British Psychological Society, 2009), which cites “Avoid harming 
clients, but take into account that the interests of different clients may conflict”.   
 
4.1.3 Suggestions for further research 
Overall there is a lack of research into the cognitive difficulties associated with anti-NMDAR 
encephalitis, larger case studies are needed to help develop a stronger evidence-based cognitive 
profile for this group. Persistent cognitive deficits have been found in seven articles, with two 
studies reporting difficulties up to six years after onset (Martin-Monzon et al., 2012; Finke et 
al., 2013). As such, longitudinal neuropsychological testing would be recommended for this 
population, taking into consideration the ethics of extensive and repeated testing (BPS, 2009).  
As discussed, a small number of studies (N=5) have begun investigating the benefits of 
neurorehabilitation for this population, however, further studies are also needed to confirm 
evidence-based strategies for people with anti-NMDAR. Lessons learned in other 
neuropsychological rehabilitation programmes may be applicable (Gracey, Evans & Malley, 
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2009; Holleman, Vink, Nijland, & Schmand, 2016; Rohling, Faust, Beverly, & Demakis, 2009) 
but currently rehabilitation is not able to be guided by evidence-based practice in anti-
NMDAR.  
The area where research is significantly lacking is investigation of the patient’s 
experience of their cognitive difficulties. Future studies should aim to contextualise the 
neuropsychological results with clinical observation, informant report and patient self-report, 
in conjunction with administration of tools such as the FIM and FAM and QOLIBRI-OS. 
Understanding the cognitive profile of an illness is arguably only beneficial if health care 
professionals also understand how any impairments impact on people’s daily functioning, how 
this impairment is perceived by individuals and therefore how it affects their overall QoL and 
mental health (Dijkers, 2004). The experience of people with anti-NMDAR goes beyond the 
examination of their neuropsychological impairments, and investigation of the process of role 
re-uptake, vocational rehabilitation, peer support, or parenting in the presence of cognitive 
difficulties is crucial to determine, however this has not yet begun for this group.  
Other avenues for future research could focus on the delay in diagnosis and the initial 
treatment for psychiatric symptoms. These could potentially be areas where there is particular 
psychological impact given the literature base in chronic fatigue syndrome around 
deligitimisation (Dickson, Knussen, & Flowers, 2007; Ware, 1992) and stigma in psychiatric 
disorders (Corrigan, 2004; Corrigan, Watson, & Barr, 2006; Dinos et al., 2004). Furthermore, 
these were both themes highlighted within the empirical paper. 
Research into the child and adolescent population, and the impact of anti-NMDAR on 
neurodevelopmental functioning, is even more lacking, and as such would be an important 
research area. As has been explored in other chronic childhood illnesses, such as viral 
encephalitis, exploration into the impact on the young person’s education, family systems and 
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social development would be pertinent (Hooper, Williams, Sarah, & Chua, 2007; Starza-Smith, 
Talbot, & Grant, 2007; Wiseman, 1996). 
 
 
4.2.4 Implications for clinical practice 
This systematic review could serve as a useful tool to clinical neuropsychologists who have 
not previously been referred someone with anti-NMDAR. The review will allow them to 
quickly access a preliminary cognitive profile of 54 patients in order to make a more informed 
choice on selection of tests for the neuropsychological test battery.  
It is important to consider that all the participants in the empirical paper discussed a 
loss of confidence in their intelligence post-illness. Therefore, one clinical practice implication 
would be for professionals to be particularly mindful of this vulnerability whilst undertaking 
neuropsychological tests. Careful consideration should be given to the utility of performing 
neuropsychological tests and how the results are fed back to patients (Monden et al., 2016). 
As previously discussed by other researchers, clinicians are potentially at risk of 
misdiagnosing anti-NMDAR as a psychiatric disorder given the common psychiatric 
symptoms at onset (Dalmau et al., 2011). The participant studied in the Loughan et al., (2016) 
paper was initially misdiagnosed and treated for an anxiety disorder, the medication of which 
exacerbated his psychotic symptoms, with later suicidal ideation. In addition, significantly 
better cognitive outcome has been found in patients with early immunotherapy in comparison 
with patients with delayed treatment, in both adults and children (Finke et al., 2012; Matricardi 
et al., 2016). Both these factors highlight the importance of early diagnosis, from a 
psychological and neuropsychological perspective, which could be achieved via thorough 
history taking and an awareness of comorbid neurological symptoms (Loughan et al., 2016).  
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Neurorehabilitation recommendations, based on the current study’s findings are not 
possible due to lack of reporting on the techniques. However, Bach (2014) and Martin-Monzon 
et al., 2012 suggest that a variety of models may be beneficial to people presenting with 
cognitive deficits and emotional distress, such as multimodal consolidation techniques, 
stimulus valence for encoding, behavioural learning paradigms, and use of compensatory 
strategies (for example, diaries, checklists, smartphone alerts, visual cuing). As well as 
psychoeducation to improve health literacy and adjustment around acquired brain injury and 
psychological therapies (for example, CBT, systemic family therapy) (Bach, 2014). Gracey, 
Evans and Malley (2009) propose a Y-shaped model for rehabilitation in ABI, which could be 
suitable for this population, and integrates research from psychosocial adjustment, awareness 
and well-being following brain injury. 
Once researchers have gained greater understanding of the perceived impact of 
cognitive difficulties, both practical and emotional, it can aid health care professionals in 
offering appropriate, person-centred care (NHS Wales, 2017). It could also influence 
guidelines and policy maker’s recommendations for the care of people with anti-NMDAR. 
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4.3 Commentary on the Empirical Paper 
4.3.1 Choice of research topic  
Anti-NMDAR encephalitis is unique in its biopsychosocial presentation because, it differs 
from other forms of encephalitis in its auto-immune genesis, there is a risk of it being 
misdiagnosed as a psychiatric condition, and in the recency of its ‘discovery’, meaning 
people affected have sought to raise awareness of it in the media (‘My Brain on Fire’; 
Cahalan, 2013). Although there is growing interest in anti-NMDAR, medical research into 
the illness is still in its relative infancy (Chen et al., 2016; Dalmau et al., 2007, 2011; Finke et 
al., 2012; Gresa-Arribas et al., 2014; Iizuka & Sakai, 2008; Kayser et al., 2013; Kuppuswamy 
et al., 2014b; Titulaer et al., 2013) and how to improve its diagnosis and management 
medically remains the subject of debate, with the rarity of the condition making a systematic 
approach to trialing treatments difficult (Zhang et al., 2017). Similarly, there are few studies 
providing evidence on which to base prognosis or rehabilitation. Neuropsychological studies 
into this illness are just starting to address the question of its impact on cognitive functioning 
(Iizuka et al., 2010; Iadisernia et al., 2012; Finke et al., 2013; Bach, 2014; Loughan, Allen, 
Perna, & Malkin, 2016; Matricardi et al., 2016; McKeon et al., 2016; Urakami, 2016; McIvor 
& Moore, 2017; Hinkle et al., 2017). However, as people affected by anti-NMDAR seek to 
find a way to live with its long-term consequences, and clinicians seek ways to support them, 
there is little beyond anecdote and case series to guide them. There have been no previous 
studies to the author’s knowledge that have used either a qualitative or a quantitative method 
to explore the lived experience of anti-NMDAR encephalitis.  
Impact on identity is a well-researched topic within psychological literature on other 
chronic and traumatic physical health conditions, such as chronic fatigue syndrome and 
acquired brain injury, other auto-immune conditions, such as multiple sclerosis, and severe 
mental illness (Arroll & Howard, 2013; Bury, 1982; Charmaz, 1983; Faircloth et al., 2004; 
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Gelech & Desjardins, 2011; Karnilowicz, 2011; Medved & Brockmeier, 2008; Musser et al., 
2015; Roger et al., 2014; Yanos, Roe, & Lysaker, 2010). Furthermore, identity was a topic that 
a member of the Encephalitis Society thought important for exploration, when consulted on 
their opinion regarding the direction of the empirical study. Therefore, identity was chosen as 
a suitable research topic for introductory psychological research within anti-NMDAR. 
A qualitative approach was deemed appropriate to describe the experience in the words 
of those affected, before seeking to quantify the experience of the group as a whole or, to 
attempt to test theories that might be applicable. A quantitative approach was considered; 
however, this approach is typically of value if the aim is, for example, to test theories or broad 
explanations and apply these results to many people (Creswell, 2012). However, given the 
reasons above, the aim was to explore the perceptions of individuals, which lends itself to a 
qualitative approach. It is hoped that beginning with rich data will avoid pre-judgements about 
how people experience this illness and stimulate exploration into new areas, such as the 
findings regarding ‘specialness’. Furthermore, understanding people’s experience of an illness 
can further understanding of their health-related choices and treatment adherence (Munhall, 
1994).  
Interpretative Phenomenological Analysis (IPA) was chosen as a methodology due to 
its focus on the experience of individuals, providing an inductive approach, in contrast to the 
more typical ‘top-down’ health psychology approach, which is deductive and derivative (Reid, 
Flowers & Larkin, 2005). Grounded theory (GT) was considered as it is a popular qualitative 
method (Charmaz, 2014), furthermore, Creswell (2012) asserts that GT can generate a theory 
when there is not an existing theory that addresses the identified problem or the participant 
population. Therefore, GT could arguably have been a viable qualitative model for the 
empirical study. However, Creswell (2012) also suggests that GT is used when a broad theory 
or explanation of a process is needed; given there is no pre-existing psychological literature 
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into anti-NMDAR the authors concluded that developing a theory may be premature, and what 
may me more pertinent is an initial exploration of the lived experience of the illness. Discourse 
analysis (Starks, Brown & Trinidad, 2007) was also considered but dismissed, as IPA similarly 
includes examination of the use of language and discourse (Larkin, Smith & Flowers, 2009), 
but with an overall examination of phenomena. Finally, thematic analysis was considered, 
Braun & Clarke (2006) assert that thematic analysis is a qualitative method in and of itself, and 
that other methods such as IPA can be constrained by their theoretical underpinnings. However, 
Pringle et al., (2011) argue that theoretical underpinnings can add both purpose and depth to 
the exploration. Brocki & Wearden (2007) suggest that IPA aims to go further than a ‘standard 
thematic analysis’ by using direct quotes and metaphors to root the analysis directly in 
participant’s words. Furthermore, Hefferon and Gil-Rodriguez (2011) discuss that when IPA 
is poorly carried out and remains broadly descriptive, with little interpretation, then the data 
lacks depth and “demonstrates little difference to a standard thematic analysis”. Therefore, 
suggesting that IPA provides something above analysis for themes, and therefore why IPA was 
finally chosen as a qualitative model. Pringle, McLafferty & Hendry (2011) suggest this 
approach appears to be in keeping with the current National Health Service efforts to consider 
service-user perspectives and provide person-centred care (Five year forward view, NHS 
2014). IPA is thought to allow “more room for creativity and freedom” than other qualitative 
approaches, which Pringle, McLafferty and Hendry (2011) state may be pertinent for unusual 
groups or situations, where “beliefs and expectations may be ‘outside the perceptual field’ of 
healthcare professionals’” (Biggerstaff & Thompson, 2008). Overall, in a systematic review of 
IPA studies, Brocki and Wearden (2007) concluded that IPA can be a useful research tool 
within health psychology. However, it is important to acknowledge certain assumptions of the 
model, for example the interpretations are bound by a participant’s ability to sufficiently 
articulate their thoughts and experiences (Brocki and Wearden, 2007). Capacity was judged as 
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being present in all the participants by the researcher, however, as discussed patients did report 
difficulties with word finding. As such, it is possible that these difficulties impeded some of 
their ability to fully articulate the depth of their experience.  
 
4.3.2 Methodological decisions 
IPA typically focuses on a fairly homogenous sample (Smith, Flowers & Larkin, 2009), 
working on the premise that it is important to recruit a closely defined group for whom the 
research question will be significant. The participants in the empirical paper were already 
closely defined given that the illness is rare, however, it was decided that the sample would be 
further homogenised via recruitment of adult women. This decision was taken due to findings 
that there are significantly more women affected by the illness than men and children (Titulaer 
et al., 2013), which would aid recruitment. 
It was decided that eight participants would be recruited to the study, based on advice 
by Turpin et al., (1997) that between six to eight participants is appropriate for an IPA study 
for a clinical psychology trainee. This sample size is also recommended by Smith, Flower and 
Larkin (2009).  
The empirical study used a semi-structured interview (Appendix M), designed by the 
author using guidelines from Smith, Flowers and Larkin (2009). The interview was co-
constructed with the member of the Encephalitis Society, who gave their opinion via a Skype 
interview on types of questions they thought would be important to explore, given their 
experiences. A draft of the semi-structured interview was then sent to the member for their 
comments, and relevant changes made. Semi-structured interviews are the most common form 
of data collection for IPA (Reid, Flowers & Larkin, 2005). They are deemed to be a flexible 
data collection tool, as they allow for modification of the questions based on the participant’s 
responses and exploration of interesting and important topics by the interviewer (Smith, 2008). 
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This contrasts with questionnaires or a structured interview, which purposefully limits what a 
participant can discuss and is therefore arguably less likely to uncover novel phenomena or 
their complexity (Smith, 2008). The semi-structured interview was framed with regard to the 
domains of the Common-Sense Model of Illness Representation (CSM) (Leventhal, Meyer & 
Nerenz, 1980; Weinman, Petrie, Moss-Morris, & Horne, 1996). Health psychology is 
concerned with understanding the factors that influence a person’s management of their illness 
and identifying targets for intervention (Petrie et al., 1996). The CSM hypothesises that people 
create mental representations of their illness based on concrete and abstract information 
available to them, to make sense of the illness and its impact (Hagger & Ordell, 2003). 
Understanding individuals’ health representations can help predict coping behaviours and 
outcomes. As such, this model was chosen to help elicit an overall understanding of women 
with anti-NMDAR’s illness representations and their impact on identity. However, it should 
be noted that using a model to help structure the semi-structured interview is not advised by 
the IPA model (Smith, Flowers & Larkin, 2009) and could be viewed as superfluous or even 
as a barrier to being a flexible data collection tool, i.e. too structured to allow fluidity of 
patients’ responses. This should be taken into consideration for any portfolio studies arising 
from this study. However, from the researcher’s perspective, using the model did not seem to 
affect the flow of the interviews and provided a good guide from which to form broad and 
relevant interview questions. 
Smith, Flowers and Larkin (2009) recommended using between six to ten interview 
questions with prompts, which would establish the area of interest without dictating the flow 
of narrative. The semi-structured interview contained eleven questions, with a focus on 
identity, co-constructed with the member of the Encephalitis Society. This amount of questions 
could be a potential limitation of the study. Hefferon and Gil-Rodriguez (2011), in an article 
on the method of IPA for The Psychologist, assert that students tend to produce semi-structured 
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schedules that are too long and detailed. They argue that this is restrictive and that producing 
a schedule with shorter, general questions helps to ensure that the researcher does not impose 
their understanding of the phenomenon on the participant’s narrative. However, it should be 
noted that not all the questions were asked in every interview, the first author was guided by 
the participants and remained on topic with the participant, as opposed to halting the flow of 
narrative to ask another question. This seemed to allow for collection of data that was 
‘interviewee focussed’. Frequently the questions from the semi-structured interview had 
already been covered by the participant and did not need to be asked. The questions around 
identity were asked later in the interview. This was in line with Smith, Flowers & Larkin’s 
(2009) opinion that this topic will likely be easier talked about once other topics have been 
discussed and a rapport has been built, which the researcher thought was appropriate and 
seemed to then fit well within the interviews.  
The procedural steps for IPA analysis outlined by Smith, Flowers & Larkin (2009) were 
loosely followed. This was in line with the authors opinion that IPA is non-prescriptive and the 
steps should be adaptable given the research situation. Giorgi (2000) also asserts that IPA 
should not be followed in prescribed stages. Participants were recruited via an online research 
page through the Encephalitis Society website. Therefore, the findings will be partially defined 
by those participants who were willing to be involved (Smith, 2008). 
Approximately only 500 cases of anti-NMDAR have so far been reported in studies 
(Barry, Byrne, Barrett, Murphy & Cotter, 2015). As such, recruitment of this group could have 
been very challenging. This was managed via flexibility with the interview technique, allowing 
use of Voice over Internet Protocol (VoIP) technologies, in this instance Skype. Other 
researchers such as Cater (2011) have found building a therapeutic rapport via Skype 
challenging. However, Deakin and Wakefield (2013) found rapport building was quicker via 
Skype and only more difficult when the participant was particularly reserved. To overcome the 
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latter they exchanged a series of emails to establish connection with participants over time 
(Deakin & Wakefield, 2013). Due to the nature of setting up the interviews, sending 
information and consent forms and arranging convenient times for interview, a series of emails 
were exchanged between the researcher and interviewees in the empirical study. Therefore, the 
researcher felt that some rapport was already established before the interview. Furthermore, it 
is possible that some participants felt more able to speak freely whilst in their own chosen 
environment. Additionally, both interviewer and interviewee were able to maintain their own 
personal space. All of which may have created greater opportunity for gathering richer data 
(DiCicco-Bloom & Crabtree, 2006; Seitz, 2015). Iacono, Symonds and Brown (2016) 
concluded, in their discussion on Skype as a tool for qualitative research, that whilst VoIP 
mediated interviews cannot completely replace face-to-face interviews, they are a viable and 
effective alternative, particularly when there is a large geographical range, as there was in this 
current study. Overall, use of VoIP was not deemed by this study’s researcher to be an 
impediment to developing rapport, this is evidenced by most participants voluntarily emailing 
after the interview to thank the researcher for taking up this study, and sharing that they felt it 
easy to talk to them about their experiences (Appendix R).  
 
4.3.3 Bracketing 
The researcher’s role and potential biases/influence in development and conducting of the 
study was considered using reflexive bracketing. This was achieved by taking into 
consideration the three areas of presupposition outlined by Ashworth (1996) and Ahern’s 
(1999) ten tips for bracketing. Smith, Flowers and Larkin (2009) suggest that you may want to 
widen your knowledge with a literature review once you have chosen a topic. By doing so one 
is therefore assimilating scientific knowledge. The first area Ashworth (1999) suggests 
bracketing is scientific theories, knowledge and explanations “the life-world is to be studied in 
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its own terms, irrespective of any connection with external “variables” that science alleges”. 
Given that there is not any psychological research into anti-NMDAR to date, there were not 
any specific theories found in relation to the illness. However, there were several theories and 
hypotheses for other chronic and traumatic illnesses/injuries that were examined, such as 
‘biographical flow/disruption’ (Bury, 1982, 1991; Gelech & Desjardins, 2011; Medved & 
Brockmeier, 2008; Roger et al., 2014). As scientific theory was examined, this knowledge 
therefore needed to be bracketed, both throughout the interview and interpretation stages. This 
was achieved by keeping a reflexive diary (Finlay, 2008; Appendix Q) and regular supervision. 
Ashworth (1996) asserted that ‘the life-world’ should not be attempted to be explained with 
regards the causes from ‘objective reality’. Whilst there were questions referring to perceived 
cause in the semi-structured interview, their aim was to open the possibility of exploring 
philosophical and/or spiritual beliefs, as well as any potential feelings of personal responsibility 
around developing the illness. The aim was not to try to uncover the facts around the cause of 
the illness. However, sometimes the participants answered these questions with regards the 
scientific cause, which led onto a mutual discussion of this. As such it must be recognised that 
this may have gone against Ashworth’s first presupposition. Ashworth’s (1999) second area to 
bracket was around the researcher adopting no position on the correctness or falsity of the 
claims that are implicitly made by the research participants. Again, this was explored via the 
reflexive journal (Finlay, 2008) and supervision. It was felt that this was largely achieved, with 
the researcher remaining accepting of the participant’s perceived experiences. The third area 
(Ashworth, 1999) focused on bracketing the personal views and experiences of the researcher; 
this was attempted by writing a position statement (Appendix P). Whilst this identified personal 
feelings and preconceptions, it is arguably impossible to be completely objective (Schutz, 
1994) and the themes formed are largely a subjective experience (Smith, Flowers & Larkin, 
2009). It cannot be overlooked that the women interviewed were broadly the same age, 
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ethnicity and educational level as the researcher. This could have influenced the saliency of 
certain themes to the researcher, for example impact on motherhood and career, as they are 
common subjects for this life stage (Baltes, 1987). The researcher’s demographics may also 
have influenced the topics that the participants felt comfortable to discuss and possibly thought 
the researcher may have been able to empathise with. In this sense, the themes may have been 
co-constructed between the participants and researcher. This was discussed in depth via 
supervision and there was careful examination of the transcripts to ensure these themes were 
discussed frequently.  
 
4.3.4 Limitations of the line of enquiry 
IPA is an idiographic approach, the results of which are not intended to be generalised (Smith, 
Flowers & Larkin, 2009), therefore the results of this study are limited to the homogenised 
group from which they have been developed. Therefore, this approach could be criticised for 
having limited impact (Anderson, 2010).  However, Smith, Flowers and Larkin (2009) suggest 
that if the analysis is detailed and transparent, and related to previous literature then it is 
possible to have ‘theoretical transferability’ (rather than ‘empirical generalisability’). It may 
be possible for the reader to use their existing professional and experiential knowledge to assess 
the findings, and possibly combine with claims from quantitative studies, to help “illuminate 
the universal” (Hefferon & Gil-Rodriguez, 2011). Smith, Flowers & Larkin (2009) argue that 
the aim of IPA is to “ensure that the account produced is a credible one, not the only credible 
one”. Furthermore, Smith (2008) discuss that with cumulative studies, conducted with other 
groups, more general claims may be possible.  
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4.3.5 Future research and clinical implications 
The current study provides insight into how anti-NMDAR is experienced by patients, with 
emphasis on the impact on identity. This study extends the evidence base for the impact on 
identity from chronic and traumatic health conditions. It suggests that there can be both 
biographical disruption (Bury, 1982), whereby the individual feels their sense of self has been 
lost, but also biographical flow, where facets of the self remain consistent (Faircloth et al., 
2004). This understanding of identity is crucial if healthcare professionals aim to provide 
person-centred care (NHS Wales, 2017) and help patients with self-management. Unless 
professionals understand the meanings people attribute to their illness, they cannot help to alter 
health behaviours and lifestyles (Munhall, 1994) via adequate psychoeducation and support. 
For example, one patient in this study discussed how she did not like to inform her doctor when 
she thought she was having a relapse as she did not want to go back onto steroids, of which 
one of the side effects was weight gain.  
Respondent: But I suppose for me as soon as I tell anyone that I’m ill, I know what the 
consequences are, so, I don’t like it? if that makes sense? So I tend to leave it 
Munhall (1994) asserts that only by maintaining an open and adaptable approach can we truly 
reach, hear and understand participants’ experiences, particularly those who may need the most 
support.  
The empirical study is preliminary in nature and therefore also highlights several 
possibilities for future research. Both clinical implications and research opportunities will now 
be discussed under the four superordinate themes.  
 
‘Re-finding the ‘normal’ self’ 
All the participants were at different perceived milestones at different time points in terms of 
their recovery (for example, leaving hospital, completing rehabilitation, stopping medications). 
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Therefore, a longitudinal study could track participant’s views on identity at different stages of 
recovery or re-uptake of roles, particularly given that the participants described feeling “odd”, 
“compromised” and “abnormal” whilst they were acutely unwell.  
Most of the women had received psychiatric care before being diagnosed with anti-
NMDAR, and this association appears to have increased their feeling of ‘abnormality’.  
Researchers assert that psychiatrists need to be aware of misdiagnosis of this client group and 
should maintain a high-level of suspicion when patients are only partially/non-responsive to 
antipsychotics (Varma & Sapra, 2015). This is particularly important to consider given that 
mental health difficulties are often diagnosed more in women, for example, unipolar depression 
is currently reported as nearly twice as common in women (WHO, 2017). However, Norman 
(2003) suggests sex differences in rates of depression may be to do with culturally defined 
differences in factors such as gender differences in help seeking, coping styles and/or life stress, 
as opposed to biological factors. The age range of women in this study was 21-35 years, with 
most of the women diagnosed some years previously, presenting a young population of women. 
Recent reports/surveys in England have found young women to be the highest-risk group for 
diagnosis of common mental health disorders, self-harm, PTSD and bipolar disorder (Lessof 
et al., 2016; McManus et al., 2016). Therefore, whilst the novelty and rarity of the disease will 
likely play a large role in the delay in diagnosing anti-NMDAR, potential bias towards viewing 
women’s symptoms as mental health related, cannot be overlooked and it may be beneficial 
for clinicians to have awareness of this.  
 
‘Evolving from the illness’ 
As discussed in the empirical study, researchers in ABI have found that PTG increases with 
time since ABI (Collicutt, McGrath & Linley, 2006; Gangstad et al., 2009; Powell et al., 2007). 
As such, a longitudinal study could investigate whether PTG is experienced after anti-NMDAR 
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and if time since onset is a significant correlate. Furthermore, Silva et al., (2011) found people 
were more likely to experience PTG if they perceived greater functional consequences of their 
ABI. Therefore, a future avenue of research could investigate whether relapse and an increased 
treatment length are more likely to lead to subjective beliefs about change post-injury that are 
aligned with PTG, such as re-evaluation of life goals (Devine, Reed-Knight, Loiselle, Fenton, 
& Blount, 2010; Grace, Kinsella, Muldoon, & Fortune, 2015; Mehrabi, Hajian, Simbar, 
Houshyari, & Zayeri, 2015). Outcome measures could also be administered such as, the 
posttraumatic growth inventory (Tedeschi & Calhoun, 1996), the Hospital Anxiety and 
Depression Scale (Snaith, 2003), the Beck Anxiety and Depression Inventories (Beck 1990; 
1996) and tracked over time, along with qualitative interview, to investigate the psychological 
impact of anti-NMDAR. 
 
‘Roles and identity’ 
One theme that was revealed centred around motherhood and fertility and, given women are 
currently more likely to be diagnosed, this would be an important avenue for future research, 
as highlighted in the empirical study. Dalmau et al., (2008) found diagnosis of anti-NMDAR 
was associated with ovarian teratomas in 59% cases (100 participants, 91 women). However, 
Irani et al., (2010) reported only 26% cases had associated ovarian tumours (9 of 34 cases). 
Nonetheless, if a tumour is detected/suspected an oophorecetomy is conducted, which can pose 
a risk to fertility (Abdul-Rahman et al., 2016; Bach, 2014). Additionally, treatments such as 
Rituximab, one of the more common second-line treatments (Dalmau et al., 2011) has been 
linked with loss of fertility (Cancer Research UK, 2017). The US Federal Drug Administration 
(FDA, 2017) asserts there are no adequate, well-controlled studies in humans for Rituximab 
with regards risk to pregnant women. They also suggest that the potential benefits may 
outweigh the potential risk but strongly advise avoiding pregnancy 12 months after its last 
! 177!
administration (FDA, 2017). In a case study of three patients, Ojeda-Uribe et al., (2013) found 
no significant adverse effects or complications were observed during the pregnancy of three 
women given Rituximab for varying autoimmune diseases (not anti-NMDAR), and all three 
patients delivered healthy newborns. However, they do suggest that there is low level risk to 
the foetus, which could be outweighed by the benefit to the mother. Nevertheless, there appears 
to be limited research into this area and the health information available is arguably confusing 
for the lay public. It suggests reduced fertility without adequate explanation of why, and 
highlights some small risk to unborn babies, which is likely to be salient to women aiming to 
start a family. Exploring views on fertility and pregnancy would be important for this 
population, research could help shape the health information available to people with anti-
NMDAR and assist health professionals in how to sensitively deliver this information (Bach, 
2014). Bach (2014) recommends that patient counselling regarding infertility should be 
“integrated into standard guidelines of best practice” and routinely offered to this patient group. 
 
‘A special identity’ 
One of the themes in the empirical study revealed the women felt viewed as ‘special’ by 
healthcare professionals. This bears consideration, particularly given the potential cognitive 
difficulties in this population (Martin-Monzon et al., 2012; Finke et al., 2012; 2013; Marcos-
Arribas et al., 2013; Vahter et al., 2014; Bach, 2014; Urakami 2016; Loughan et al., 2016; 
McKeon et al., 2016; McIvor & Moore, 2017), which could give rise to vulnerability. Whilst 
it was extremely positive to hear of the strong relationships between participants and their 
physicians, one clinical implication could be to urge caution with use of ‘best’ patient labels. 
Miscommunication might be particularly impactful whilst the individuals are still trying to re-
establish their identity during the recovery process (Karnilowicz, 2011).  
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Despite participants often describing being thought of and labeled by healthcare 
professionals as ‘special’, they all also discussed low self-esteem and confidence, and rarely 
attributed their recovery to their own efforts. Therefore, one clinical implication would be to 
offer some form of psychological support to this client group, which promotes internal locus 
of control for health outcomes. Mindfulness-based techniques (MBT) have been investigated 
in other populations with significant improvements found in measures such as, anxiety and 
fatigue and overall fostering of PTG (Garland et al., 2007; Milam, 2004; Surawy et al., 2005). 
MBT could therefore be a successful treatment option for people with anti-NMDAR. A 
randomised control trial, comparing treatment as usual with MBT on a population of people 
with anti-NMDAR could be beneficial to see if this intervention is acceptable and helpful. It is 
recognised that this could be difficult given the rarity of the disease, however, studies with 
larger numbers of participants have been achieved (Finke et al., 2013).  
 
4.3.6 Ethics and Diversity 
Capacity to consent was considered extensively before recruitment of participants, due to the 
potential for participants to have cognitive difficulties (Finke et al., 2012; McIvor & Moore, 
2017). Assessing capacity to consent was discussed in detail on the university ethics application 
(Appendix G), in line with the Mental Capacity Act (2005). Ethical considerations were also 
considered due to the sensitive nature of the topics being discussed in the interview. The 
interviewer used their professional judgement as to whether the interview was becoming too 
distressing to the participant and if they felt it was, checked how the participant was feeling 
and whether they were ok to continue and, if necessary, changed the topic. Only on one 
occasion did one of the participants become distressed; she explained that she felt her emotions 
were more labile since having the illness. The participant did not seem particularly concerned 
about becoming tearful and naturally let her feelings run their course before moving on from 
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the topic. This process required minimal input from the interviewer aside from a naturally 
empathic approach. None of the participants contacted the researchers (as was offered via the 
Debriefing form) with concerns regarding emotional distress. This does not guarantee there 
was not residual emotional distress. However, it was the researcher’s opinion that none of the 
participants required further emotional support as a result of having taken part in the interview. 
Power imbalance during the interview process was also considered, as the researcher 
was aware that the interviewees often viewed them as a professional with, potentially, 
“organisational and institutional power” (Das, 2010). However, the power appeared well 
balanced from the researcher’s perspective, due to the anxieties the researcher had regarding 
recruitment numbers for the study and ensuring that rich data was collected (Karnieli-Miller, 
Strier, & Pessach, 2009). This would then have come across in their communication style with 
the participants. The researcher was aware of the potential for power imbalance and so 
endeavoured to create an open and equal stance in the interviews, which seemed to be effective 
given the feedback from participants (Appendix R). 
Diversity and culture were also considered throughout the research process. The sample 
were predominantly white, middle class women from Western countries and educated to, at 
least, college level. The similarity of the participants was in keeping with recruitment of a 
homogenised sample, as recommended for IPA ( Smith, Flowers & Larkin, 2009). There was 
only one participant whose first language was not English. During the interview, some of the 
questions were rephrased and some additional prompting given, to aid the participant’s 
understanding. An interpreter was not offered to conduct the interview in the participant’s first 
language, however this could have been considered (BPS, 2008). This may have allowed the 
participant to express themselves more fluidly and articulately. Language is crucial to bear in 
mind given that it is often tied to identity (Joseph, 2004). However, researchers have asserted 
that phenomenological studies, which involve translating transcripts, are not amenable to cross-
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language designs generally as they require exact focus on “how participants use language to 
describe their experiences and language is a part of the identity of the person experiencing the 
phenomenon, translation disrupts the fluid process from inception through dissemination of 
studying the participants’ use of language to describe the experience of the phenomenon” 
(Squires, 2009; p.279). Therefore, not ensuring that all participants’ first language was English 
may be a limitation of the study. There did appear to be some salient themes around cultural 
norms within the participant’s transcript: 
respondent: Even I came back home, I was diagnosed, I was all acting all weird, like I 
was saying I’m hearing things, someone’s telling me something, like those things and 
she was like oh you’re creepy  
interviewer: Okay  
respondent: Those aren’t normal things for like I guess at least my culture  
There were also cultural and societal nuances across the other interviews, for example when 
discussing the impact of the illness on their lives, for some participants the financial impact 
was great due to lack of free healthcare in their country and differences in sickness pay: 
respondent: Umm [pauses] no I mean everyone it really affects every aspect of your 
life you know, I know that there’s you know a financial concern too for some people 
and it’s not that I don’t have that, it’s just my dad did a really good job of stockpiling 
umm [pauses] disability and stuff for me when I was out so I was okay, and my job I 
still had my job which was like the biggest miracle of all 
Interestingly, despite these cultural differences, many of the themes remained consistent across 
cultures. Nonetheless, culture and language were important diverse factors to consider whilst 
the author was undertaking the interviews and conducting the analysis. 
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4.4 Dissemination  
Permission was sought at the end of each interview to save the participants’ email addresses 
on an encrypted word file so they could be contacted with copies of the completed studies. All 
the participants gave their consent to keep their email address and as such will be emailed final 
drafts of the papers. It is hoped these studies will further legitimise patient experience and act 
as a platform for voicing their experience, as was suggested by the participants in the 
respondent verification. The studies may then be further disseminated by the participants 
sharing them with their wider networks. Both the studies will also be submitted to the 
Encephalitis Society and will be featured in their newsletter and on their website. Relevant 
conferences such as the Science Conference and Encephalitis Society conferences will also be 
explored, to give an oral or poster presentation of the studies. The researcher will also present 
the studies at the fortnightly Neurosciences meeting within their local health board.  
Wide reaching dissemination is important given that anti-NMDAR is a rare illness, but 
is being diagnosed internationally. There are many health professionals who will not yet have 
heard of or encountered the illness. However, it is crucial to raise awareness given that the 
illness, when not treated, can be fatal or have long-term effects (Titulaer et al., 2013). More 
widespread knowledge of the early stages of anti-NMDAR, such as psychiatric and prodromal 
symptoms, could help health care professionals query and potentially identify the illness 
earlier, which could lead to a better outcome (Finke et al., 2013). Approximately 77% of 
patients diagnosed with anti-NMDAR were first assessed by a psychiatrist (Kuppuswamy, 
Takala & Sola, 2014). Therefore, there is increasing literature discussing the need for 
psychiatrists to have increased awareness of anti-NMDAR and to maintain suspicion for the 
illness. Particularly when there is no history of psychiatric illness (Barry et al., 2011; Ryan et 
al., 2013) or when patients are only partially or non-respondent to antipsychotic medications 
(Varma & Sapra, 2015). Varma and Sapra (2015) also highlight increased vigilance is needed 
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when treating young women, where the illness may be overlooked when in the background of 
a stressor. Chapman and Vause (2011) highlight that psychiatrists can encounter patients with 
anti-NMDAR in a range of settings such as inpatient units, consultation-liaison services and 
outpatient offices. Therefore, they should have some understanding of the clinical 
characteristics, differential diagnosis, treatments and unique management of dilemmas of this 
condition (Chapman & Vause, 2011). Varma and Sapra (2015) urge that an interdisciplinary 
approach, including psychiatrists, neurologists, paediatricians, gynaecologists, oncologists and 
immunologists, is needed for timely identification and treatment. It is therefore hoped that these 
studies will be added to the growing literature for anti-NMDAR and help to raise awareness of 
the illness both in the health profession and lay public. Publishing the empirical study and 
systematic review in different journals should raise awareness in different spheres.  
 
4.5 Personal and professional skills and values  
Undertaking this research has overall improved my knowledge base of anti-NMDAR and other 
chronic and traumatic illnesses and the role clinical psychology takes with regards research 
and intervention. It has also strengthened my knowledge of systematic reviews, interpretative 
phenomenological analysis and the literature around identity and illness. The process has 
developed my competence in the use of critical appraisal of neuropsychological research and 
its methods, and provided me with insight into the importance for clinicians to reflect on their 
communication strategies with those in recovery from a rare and traumatic illness.  The latter 
of which will influence the way in which I will work clinically in the future. It has also been 
an exercise in being a reflective scientist-practitioner and has provided me with strong research 
skills that can be transferred into my qualified role.  
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4.6 Reflections on the research process 
I was keen to develop a research project that would make a genuine and impactful contribution 
to a service user population and so undertook to create a project myself that I felt could achieve 
this. I had an existing interest in anti-NMDAR from having carried out a neuropsychological 
assessment with a patient with anti-NMDAR whilst an assistant psychologist within a 
neuropsychology outpatient clinic. I then went onto read the book Brain on Fire: My week of 
Madness (Susannah Calahan), which furthered my interest, largely due to the initial presenting 
psychiatric symptoms and the possible acute and chronic cognitive difficulties, both of which 
appeared to be important topics for involvement of clinical psychology. Creating my own 
research question was an interesting and rewarding experience and generated a feeling of being 
an autonomous researcher. I also feel this allowed me to develop the full breadth of research 
skills, from the initial stages of identifying an area of research need, to the process of being 
submission ready. However, this also meant that I was involved in every aspect of the decision-
making process from the initial to final stages, which proved demanding at times. As there is 
no current psychological research in this area, it meant that the direction of the study was 
largely limitless. Therefore, whilst creating a research project was exciting, it was also at times 
overwhelming and I used supervision with both of my tutors to refine my ideas and create a 
definite direction for the research. This was not one discussion but rather involved constant 
self-reflection and discussions with my supervisors. This ensured that I remained on track with 
the set research questions and did not get diverted by other ideas that arose, particularly during 
the literature search and in the analyses.  
Another challenge that arose during the research process was balancing the workload 
of the research project with working on other assignments, working on placement and keeping 
a good work-life balance. Overall, I feel I was able to maintain a good balance due to 
organisation of research days and setting very strict boundaries regarding only doing the 
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appropriate work/activities in the appropriate setting. This process clearly highlighted to me 
the challenges that can arise when endeavouring to carry out a piece of research as a qualified 
clinical psychologist. However, it also showed me the fulfillment that can be achieved in 
creating a piece of work you feel may be of benefit to a specific population. Additionally, it 
allowed me to begin to practice the skills needed in balancing different work demands.  
I was conscious when developing the empirical study that the process of conducting the 
interviews could be emotionally taxing for me personally, with the women discussing the 
emotional impact of the illness. Whilst I was very engaged in the women’s’ experiences and 
felt empathy for their situation, I feel my skills as a trainee clinical psychologist, and experience 
prior to training, prepared me well for managing the themes that arose during the interviews. I 
did not feel distressed following the interviews and could manage the participants’ occasional 
distress, with them not reporting any additional distress from participating in the research as 
discussed. I found the interview process enjoyable, I was interested to hear of the women’s 
experiences, particularly of the growth that they felt from having had the illness. I also felt 
proud to be making some small contribution to the understanding of the illness and its impact 
and in increasing awareness.  
I did not have any prior experience of conducting a systematic review and did not have 
extensive knowledge of how to conduct one. Therefore, entering this process was intimidating, 
however, I was keen to build expertise in this area, which I felt was lacking.  
There were very limited studies into neuropsychological sequelae of anti-NMDAR 
overall, but particularly up until January 2017. Therefore, there was a taxing period where I 
was unsure whether a systematic review in this area would be possible and as such several 
different avenues were explored. This uncertainty created a high level of stress and I used self-
care and supervision to work through these difficulties. This experience served as a useful 
lesson in the practicalities of conducting research.   
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Overall, I found the research process genuinely intellectually stimulating and 
rewarding, despite the challenges that arose. I was pleased I could see my research topic 
achieved and am hopeful that it will be the start of a portfolio of research into this interesting 
area of autoimmune diseases.   
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